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ABSTRACT OF Ph.D. THESIS 
METABOLISM IN THE 
(GALLUS DOMESTICUS) 
The aim of this study was to investigate the early lipogenic events 
occurring in the liver after oestrogen treatment of the male chick in vivo. 
Liver weight increased with time after an injection of 17S-oestradiol 
(0·75 mg or 1 mg/100 g body wt.) to at least 40 hours. A dose-related in-
crease in liver weight was observed 48 hours after an injection of 17S-
oestradiol over the dose range 0- 1·25 mg/100 g body weight. Coincident 
with the increase in liver weight was a decrease in the DNA content and, in 
many cases, the soluble protein content of a unit weight of liver, substan-
tiating the view that cell expansion, caused by accumulating water and lipid, 
contributes considerably to the liver enlargement after oestrogen treatment. 
Plasma triacylglycerol and phosphoprotein concentrations increased after 
an injection of 17S-oestradiol (1 mg/100 g body wt.), and became significantly 
greater than control values at 5 - 7~ and 14 - 18 hours post-injection, res-
pectively. 
Liver slice lipogenesis was studied by measuring the incorporation of 
[1-14c] acetate and 3H20 into total lipid, and of [9,10-
3H] palmitate into 
complex lipids. The incorporation of the radioisotope was predominantly into 
triacylglycerol in all cases. The livers of oestrogenized male chicks 
developed a significantly enhanced capacity to synthesize fatty acids de novo 
and to incorporate fatty acids into glycerolipids at times later than 14 hours 
after hormone injection. Results indicated that a stimulation of de novo 
lipogenesis at early times after injection (~ 17 h) may be caused by handling 
and/or the injection of the vehicle propane-1,2-diol. 
Treatment of chicks with an optimum dose of 17S-oestradiol (0·75 mg/ 
100 g body wt.) yielded results which suggested that early increases in 
hepatic fatty acid synthetase activity (~ 26 h) are caused by handling and/or 
the injection of propane-1,2-diol, and that oestrogen-dependent changes occur 
within 48 hours. 
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SYNOPSIS 
The aim of this study was to investigate the early lipogenic events 
occurring in the liver after oestrogen treatment of the male chick in 
vivo. 
Liver weight increased with time after an injection of 176-
oestradiol (0·75 mg or 1 mg/100 g body wt.) to at least 40 hours. A 
dose-related increase in liver weight was observed 48 hours after an in-
jection of 176-oestradiol over the dose range 0- 1·25 mg/100 g body 
weight. Coincident with the increase in liver weight was a decrease in 
the DNA content and, in many cases, the soluble protein content of a 
unit weight of liver, substantiating the view that cell expansion, 
caused by accumulating water and lipid, contributes considerably to the 
liver enlargement after oestrogen treatment. 
Plasma triacylglycerol and phosphoprotein concentrations increased 
after an injection of 176-oestradiol (1 mg/100 g body wt.), and became 
significantly greater than control values at 5 - 7~ and 14 - 18 hours 
post-injection respectively. 
Liver slice lipogenesis was studied by measuring the incorporation 
of [1-14c] acetate and 3H2o into total lipid, and of [9,10-3H] palmitate 
into complex lipids. The incorporation of the radioisotope was pre-
dominantly into triacylglycerol in all cases. The livers of oestro-
genized male chicks developed a significantly enhanced capacity to 
synthesize fatty acids de ~ and to incorporate fatty acids into gly-
cerolipids at times later than 14 hours after hormone injection. 
Results indicated that a stimulation of de novo lipogenesis at early 
times after injection c~ 17 h) may be caused by handling and/or the in-
jection of the vehicle propane-1,2-diol. 
Treatment of chicks with an optimum dose of 176-oestradiol (0·75 mg/ 
iii 
100 g body wt.) yielded results which suggested that early increases in 
hepatic fatty acid synthetase activity c~ 26 h) are caused by handling 
and/or the injection of propane-1,2-diol, and that oestrogen-dependent 
changes occur within 48 hours. 
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GLOSSARY 
The abbreviations suggested by the Biochemical Journal (Policy of 
the Journal and Instructions to Authors; (1984) Biochem. J. 217, 1 -
26) have been adopted. Other abbreviations are as follows:-
G.P.R. 
VLDL 
LDL 
HDL 
FLKS 
FLHS 
PHLA 
mRNA 
tRNA 
rRNA 
TCA 
DHAP 
PPO 
PoPoP 
BSA 
DTNB 
OTT 
PFS 
r 
av. 
general purpose reagent 
very low density lipoprotein(s) 
low density lipoprotein(s) 
high density lipoprotein(s) 
fatty liver and kidney syndrome 
fatty liver-haemorrhagic syndrome 
post-heparin lipolytic activity 
messenger RNA 
transfer RNA 
ribosomal RNA 
trichloroacetic acid 
dihydroxyacetone phosphate 
2,5-diphenyloxazole 
1,4-di(2-(5-phenyloxazolyl))benzene 
bovine serum albumin 
5,5 1 -dithiobis(2-nitrobenzoic acid) 
dithiothreitol 
particle-free supernatant 
average radius of rotation 
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MATERIALS 
All reagents were of analytical grade unless stated otherwise. 
Materials were obtained from the following sources:-
Amersham International plc, White Lion Rd., Amersham, Bucks., U.K. 
[1-14c] Acetic acid, sodium salt 
[9,10(n)-3H] Palmitic acid 
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Nitrogen 
Oxygen:carbon dioxide (95%:5%) 
J. Burrough Ltd., Fine Alcohols Division, 60. Montford Place, 
London, U.K. 
Absolute alcohol 
Fisons Scientific Apparatus, Loughborough, Leics., U.K. 
Acetic acid, glacial 
Acetic anhydride 
Acetone 
Chloroform 
Cupric sulphate 
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Iodine 
Isopropanol 
Light petroleum (b.p. 40 - 60°C) 
Methanol 
Potassium iodide 
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Trichloroacetic acid 
Triton X-100 
Xylene 
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Koch-Light Laboratories Ltd., Colnbrook, Bucks., U.K. 
1,4-Di(2-(5-phenyloxazolyl))benzene (PoPoP) 
New England Nuclear, 2. New Rd., Southampton, U.K. 
Water, tritium labelled, 100 mCi/g 
Sarstedt Ltd., Leicester, U.K. 
Semi-micro polystyrene cuvettes (1·6 ml cap.; 1 em light path) 
vii 
Sigma (London) Chemical Co., Kingston-upon-Thames, Surrey, U.K. 
Ascorbic acid 
Bovine serum albumin (fatty acid poor) 
Cholesterol 
Coenzyme A (sodium salt) 
Deoxyribonucleic acid (sodium salt from calf thymus, Type 1) 
Diagnostic Kit anq Reagents for Colorimetric Determination 
of Triacylglycerols (Technical Bulletin No. 405) 
Diphenylamine 
5,5'-Dithiobis(2-nitrobenzoic acid) 
B-D(-)-Fructose 
Lipid standards (mono-, di- and triolein) 
Malonyl coenzyme A (lithium salt) 
B-Nicotinamide adenine dinucleotide phosphate, reduced form 
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17B-Oestradiol 
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Propane-1,2-diol 
Tris(hydroxymethyl)aminomethane 
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CHAPTER 1 
GENERAL INTRODUCTION 
2 
1. The site of lipogenesis 
Many organs and tissues are able to synthesize fatty acids, but 
the liver, adipose tissue and lactating mammary gland have been found 
to be. the major sites of lipogenesis in most species ( 1 ' 2). The meta-
bolic pathways of de ~ fatty acid synthesis are similar in the 
different tissues, but the relative importance of these tissues in fatty 
acid synthesis may vary as a result of differences in hormonal, 
nutritional and enzymatic control among species. In many cases, the 
relative roles of the liver and adipose tissue in lipogenesis are based 
on the assumption that other tissues and organs are not important in this 
respect. However, studies in the chick have indicated that this 
assumption may. not be justified, since the intestine, skin and skeleton 
have been shown to contribute substantially to the total fatty acid syn-
thesizing activity (1 , 3 - 5) 
In most non-lactating domestic mammals and commonly used laboratory 
rodents, the adipose tissue is considered to be the principal site of 
de novo fatty acid synthesis (B) For example, the adipose tissues of 
the mouse (7, B) and rat (9, 10 ) have been shown to contribute at least 
50% and sometimes up to 95% of the fatty acids synthesized. Contrary 
to these observations, some studies have revealed the liver to be more 
. t t th d . t . . d l' . . . ( 11 - 1 3) 1mpor an an a 1pose 1ssue 1n ~ ~ 1pogenes1s 1n m1ce 
and rats (14 ). Adipose tissue has been shown to account for nearly all 
fatty acid synthesis in the pig (15 - 17 ) and guinea-pig (18 ). In non-
lactating ruminants, both the liver and adipose tissue contribute to 
fatty acid synthesis, although adipose tissue is regarded as the more 
important site (2, 19). 
In contrast to the situation thought to exist in most mammals, the 
liver has been shown to be the principal site of lipogenesis in avian 
species, including the chicken (20 - 22 ), pigeon (23 ), duck (24 ) 
~~ ~ 
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turkey (25 ), Japanese quail (2B), starling and white wagtail (2?) 
The adipose tissue of the chicken is capable of synthesizing fatty 
acids (28 ' 29 ), but the capacity of chicken liver for de ~ fatty acid 
synthesis is much greater than that of chicken adipose tissue (20, 30 , 
31 ) When compared with rat adipose tissue, the adipose tissues of 
the chicken and pigeon exhibit a very low rate of de novo fatty acid 
(29 32 - 34) 
synthesis ' , although the ability of avian adipose tissue 
to manufacture the glycerol portion of triacylglycerols is reasonably 
h . h (23, 29) J..g • On the assumption that the liver and adipose tissue 
are the only lipogenic sites, the contribution of the liver of the 
chicken to de ~ fatty acid synthesis has been calculated to be be-
tween 90 and 95% (21 ). Conversely, theadipose tissue of the pigeon has 
been implicated as contributing only about 4% of the total fatty acids 
synthesized (23 ' 32 ). On the other hand, when sites such as the in-
testine, skeleton and skin are considered, extra-hepatic tissues have 
been reported to account for more than 50% of the total fatty acids 
synthesized by the chick (3, 4) It would therefore appear that, in 
avian species, adipose tissue is relatively insignificant as a site of 
de ~ fatty acid synthesis, and functions primarily as a depository 
for fatty acids synthesized elsewhere in the body. In contrast to the 
situation in most of the mammals that have been studied, the liver has 
also been considered to be the major site of de ~ lipogenesis in 
(35 - 39) 
man , although some studies have yielded results implicating 
. t t •t (40 - 43) adipose tissue as an 1.mpor an s1. e • 
Obviously, a discrete organ such as the liver lends itself more 
readily to metabolic investigations than does adipose tissue with its 
dispersed location. Since the liver of avian species is very active 
in lipogenesis, birds have been much used in studies of the mechanisms 
and regulation of this process. Lipogenesis in bird liver has been 
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shown to respond to dietary changes in much the same way as that in the 
liver and adipose tissue of the rat (1 ) Hence, starvation or feeding 
a diet rich in fat depresses lipogenesis and associated enzyme activities, 
whereas refeeding following a fast or feeding a low fat, high carbo-
hydrate diet results in increased lipogenesis and increased lipogenic 
( 1 6, 44) 
enzyme activities ' In both the chicken and the rat, re-
feeding after fasting has been shown to result in increased lipogenesis 
as compared with ad libitum-fed animals (1 , 6 ' 45 , 46 ) In the rat, 
this increased lipogenesis is accompanied by an 'overshoot' of lipogenic 
t . . t. ( 1 ' 6 ' 4 7) h . d . ff tl th enzyme ac lVl les , w ereas blr s respond dl eren y and e 
lipogenic enzyme activities recover to normal or slightly elevated 
levels (1, 32,, 45, 46, 48- 51) . d d. t• 1 th d t• Blr s, an ln par lCU ar e ames lC 
fowl, have been extensively used in studies of this kind as, in spite of 
the crop which serves as a food storage organ, food passes through the 
gut rapidly, and changes in lipogenesis can be evoked relatively quickly. 
Yeh & Leveille (45 ) investigated the effects of short-term fasting and 
refeeding in chicks, and observed that 30 minutes after food removal 
hepatic fatty acid synthesis from acetate or glucose was depressed. 
After fasting for 2 hours, the rate of fatty acid synthesis was re-
duced to about 10% of the rate in ad libitum-fed chicks. Similarly, 
the return of fatty acid synthesis to normal levels was equally as 
rapid, occurring after 30 to 60 minutes of refeeding. 
2. Egg formation 
It is now well-established that the production of eggs by female 
oviparous vertebrates involves dramatic changes in the composition of 
the blood and in the metabolism of the liver and oviduct. The onset 
of breeding in the domestic fowl and other oviparous vertebrates is 
associated, in the female, with alterations in the types and quantities 
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of lipids and proteins in the blood (52 - GO). Furthermore, certain 
plasma proteins of the egg-laying female show a striking similarity to 
proteins of egg yolk (61 - 65 ), whilst the uptake of plasma proteins by 
developing chicken and amphibian oocytes has been demonstrated in vivo 
d · · t (58 ' 66 - 70 ) Ch · th . t. f th bl d an 1n Vl ro • anges 1n e compos1 1on o e oo , 
therefore, are related to the requirements of the developing egg, and 
the liver is considered to be the major site of synthesis of these com-
ponents (58, 71 - 74). It is now generally agreed that, in many ovi-
parous vertebrates, proteins and lipids destined for the egg yolk are 
synthesized in the liver, secreted into the blood and are carried to 
the ovary for deposition in the developing oocyte, whilst egg white pro-
teins such as ·ovalbumin, conalbumin, ovomucoid and lysozyme are synthe-
sized by the oviduct (75 - 78 ). Thus, at the approach of lay in the 
female domestic fowl, the liver secretes large quantities of specific 
proteins and lipids into the blood and the hen spontaneously develops 
endogenous hyperlipaemia, making it a particularly useful experimental 
animal for studies of lipogenesis. 
The physiological changes that occur at the approach of lay in 
females of oviparous vertebrate species are considered to occur under 
the influence of steroid hormones, notably oestrogen (60, 79 ), although 
undoubtedly a complex interplay of endocrine secretions is involved. 
The importance of oestrogen in the induction of these changes in the 
mature female has been shown by the fact that if males and immature 
females of oviparous species are treated with oestrogens, they respond 
with increases in liver size and changes in blood composition that are 
similar to those observed in the laying female (56 ' 58 ' 59 ' 80 - 86 ) 
(a) Protein metabolism 
Changes in protein metabolism during the process of vitellogenesis 
have been studied in some detail in the domestic fowl and the African 
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clawed toad, Xenopus laevis. At sexual maturity, a large amount of 
a glycolipophosphoprotein (87 ' 88 ) is synthesized by the liver of female 
animals, and is secreted into the blood (79 ' 80 ' 89 ' 90 ) This protein, 
which has been named vitellogenin ( 81 ' 91 ' 92 ), is associated with high 
. (60 73 79 87 92) . levels of plasma calc1um ' ' ' ' , and 1s the precursor of 
the egg yolk proteins, phosvitin and lipovitellin (62 , 79 , 88 , 90, 93, 94) 
Like many proteins destined for secretion, vitellogenin is synthesized 
on membrane-bound polysomes, passes into the cisternae of the endoplasmic 
reticulum, and is transported to the Golgi apparatus before being se-
creted from the cell. During this passage to the ·Golgi apparatus, 
several secretory proteins undergo post-translational modification 
(95 - 98) In the case of vitellogenin, the nascent polypeptide is 
glycosylated, phosphorylated and becomes associated with lipid ( 99 - 106 ) 
In addition to the changes in vitellogenin production, some of the 
proteins that are deposited in the developing egg yolk are normally 
occurring plasma proteins which are made in the liver, and during 
vitellogenesis the concentrations of these proteins in the plasma are 
altered. For example, in the domestic fowl, the concentrations of low 
and very low density lipoproteins (58 ' 107 ) and of various vitamin-
binding proteins are increased (65 ), whilst the level of albumin appears 
to decrease (58 ), indicating that the stimulation of protein synthesis 
is specific rather than general in nature. 
(b) Lipid metabolism 
All plasma lipids, other than free fatty acids, are transported as 
part of macromolecular complexes called lipoproteins. The classifi-
cation and nomenclature of these lipoproteins is based primarily on 
their electrophoretic mobility or on their rate of ultracentrifugal 
flotation in salt solutions (108 ' 109 ' 110 ) Based on these criteria, 
the major vertebrate plasma lipoprotein fractions are (i) chylomicra, 
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in which the lipid is of dietary origin, and three fractions in which 
most of the lipid is produced endogenously, namely, (ii) very low den-
sity lipoproteins (VLOL), (iii) low density lipoproteins (LOL) and 
(iv) high density lipoproteins (HOL). A summary of the composition and 
properties of these lipoprotein classes, as they occur in the plasma of 
humans, is given in Table 1. All plasma lipoproteins have the same 
basic structure and consist of a hydrophobic core, comprising mainly 
triacylglycerol and cholesteryl ester, surrounded by an amphipathic 
surface layer of phospholipid, cholesterol and specific proteins 
( apoproteins) • As well as maintaining lipoprotein structure, some 
apoproteins have specific regulatory functions in lipid metabolism. 
For example, apo C-II activates lipoprotein lipase (EC 3.1.1.34) and 
apo A-I activates lecithin: cholesterol acyltransferase (EC 2.3.1.43). 
A major difference in the lipid metabolism of birds and mammals exists 
in the absorption of exogenous fat. In avian species, exogenous fat 
is absorbed via the portal system as large VLOL or'portomicr~ (111 , 112 ), 
rather than as chylomicra (and VLOL) via the lymphatic system as typi-
cally occurs in mammals. 
Under the influence of endogenous oestrogen at the approach of lay 
in the female domestic fowl, the liver synthesizes and secretes large 
amounts of lipoproteins, mainly VLOL, for export to the developing 
(58, 107) egg • This situation can be mimicked in males and immature 
females by administration of exogenous oestrogen, leading to hyper-
1 • • ( 58, 81 , 82, 11 3 - 11 7, 241} Th 1. · · t d. • th lpaemla . e lpaemla assocla e Wl egg-
laying in the hen and the oestrogen-induced lipaemia of immature pullets 
and cockerels are primarily due to increased triacylglycerol levels, 
occurring predominantly in the very low density fraction of lipo-
proteins (107 , 113 - 116 ' 118 ' 119 ) The liver is considered to be 
( 120 121 ) . the major site of synthesis of VLOL ' and thls, together with 
TABLE 1 
Composition and properties of the major classes of human plasma lipoproteins 
Density (g/ml) 
Diameter (nm) 
Classification by electrophoresis 
Components (Typical composition 
as % of dry wt. ) 
Protein 
Triacylglycerol 
Cholesterol and cholesteryl esters 
Phospholipids 
Major apoproteins 
Minor apoproteins 
Chylomicra 
< 0·95 
75 - 1000 
Omega 
1 - 2 
83 
8 
7 
B 
C-I, C-II, C-III 
A-I, A-II 
VI:.DL LDL 
0·95- 1·006 1·D19- 1 ·063 
30 - 70 20 - 25 
Pre-beta Beta 
10 25 
50 10 
22 43 
18 22 
B B 
C-I, C-II, C-III 
E 
A-I, A-II 
D 
HDL 
1 . 063 - 1 . 21 
10 - 15 
Alpha 
50 
3 
18 
29 
A-I, A-II 
C-I, C-II, C-III 
D 
E 
CD 
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the observation that without a liver the fowl fails to develop hyper-
t . 1 1 1 . . t t ( 1 22 ) . d. t th t t rlacy g ycero aemla ln response o oes rogen , ln lCa es a mos 
of the triacylglycerol is of hepatic origin. The normal chicken diet 
has a very low fat content and most of the lipid required for the syn-
thesis of egg yolk precursors has to be synthesized from carbohydrate. 
That the hypertriacylglycerolaemia is not dependent on a dietary source 
has been shown by the fact that the oestrogen-induced lipaemia still 
occurs even when birds are deprived of food (B2), and also by the fact 
that the 'portomicron' fraction has been shown to contribute only 
slightly, if at all, to the oestrogen-induced hyperlipaemia in 
h . k (113) C lC S . 
Much of this newly synthesized lipid, at least initially, is used 
for membrane synthesis and proliferation of the endoplasmic reticulum 
and Golgi apparatus (SB, 123 ' 124), but large amounts of lipid are in-
corporated into the vitellogenin molecule and are also secreted into the 
blood in the form of lipoproteins for transport to the egg. Differences 
between species occur as to the relative importance of synthesis of 
particular lipids, depending primarily on the composition of the lipid 
reserves stored in the egg. In contrast to birds and some reptiles, 
the plasma of Xenopus laevis does not become highly lipaemic (GO, SO, 
81 ), and large amounts of calcium are not observed in the blood of 
Xenopus laevis during vitellogenesis since there is no egg shell pro-
d t . . th• . (80) uc lOn ln lS specles • 
That increased hepatic lipogenesis is a major and specific feature 
of vitellogenesis in the domestic fowl, and not simply part of a general 
(125) 
increase in metabolic rate, has been indicated by the work of Pearce and 
(126) 
Pearce & Balnave Their studies showed that with the onset of laying, 
or after oestrogen treatment of immature pullets, the specific activities 
of certain lipogenic enzymes were increased while the specific activities 
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of a variety of gluconeogenic, glycolytic and amino acid metabolizing 
enzymes were unchanged. 
3. The action of oestrogen 
In mature females of oviparous vertebrate species, increases in 
hepatic lipid and protein production occur constitutively in response 
to endogenous oestrogens secreted by the ovary. The secretion of 
oestrogens, and hence vitellogenesis, is controlled by pituitary ganado-
trophins, which are regulated by stimulation via neurohormones from the 
b . ( 1 27 - 1 29) ra1n • All steroid hormones are thought to initiate their 
action by a similar process which involves an initial binding of the 
hormone to a receptor in the cytoplasm of the target cell, and then 
translocation of the hormone-receptor complex into the nucleus to combine 
with acceptor sites on the chromatin. The hormone-receptor complex 
then stimulates the transcription of selected genes, which results in 
th . d th . f . f. t . ( 1 30 - 1 32) e 1ncrease syn es1s o spec1 1c pro e1ns • 
Many organs and tissues are responsive to oestrogen, including the 
liver and oviduct of oviparous vertebrate species, and the liver, 
mammary gland and uterus of mammals. Each organ responds differently 
to oestrogen, indicating that oestrogen stimulates the transcription of 
different genes in the various organs. The liver of females of ovi-
parous species responds, as described above, by an increase in lipid 
production and the synthesis of specific proteins including vitellogenin, 
vitamin-binding proteins and the apoprotein moieties of lipoproteins, in 
addition to carrying out its normal functions. The oviduct, on the 
other hand, responds with a tremendous increase in growth and cell 
. h d t' f h' . (75 - 78) differentiat1on and t e pro uc 1on o egg w 1te prote1ns , 
The liver of the female viviparous mammal does not produce egg yolk 
proteins since the nutrients for embryonic development are provided by , 
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a placental mechanism, but responds to oestrogen with the increased 
synthesis of VLDL (133 - 137). Oestrogen also influences certain 
secondary sexual characteristics of oviparous vertebrates, such as 
changes in plumage colour and feather shape in avian species which 
exhibit plumage dimorphism (129 ) 
4. Model systems for the study of vitellogenesis 
No significant oestrogen exists in male and immature female animals, 
and consequently the physiological changes that occur in the mature 
female are not observed. Nevertheless, studies on male and immature 
73, 128, 138- 140) d h' k (81' 82, 113, an c lC ens female Xenopus 
115, 116, 118,, 
laevis (60 ' 
141 142) 
' have shown that, after oestrogen administration, 
hepatic lipid and protein synthesis increase, and specific lipids and 
proteins including vitellogenin, VLDL and vitamin-binding proteins 
appear in the blood. Male animals have been particularly useful experi-
mental animals for studying oestrogen-dependent changes in liver meta-
bolism which are normally associated with the onset of egg-laying in the 
female, si~ce any oestrogen-dependent changes in metabolism are caused 
by the exogenous hormone. This situation is not possible to predict 
absolutely in immature females, in which oestrogen levels and oestrogen-
receptor levels may increase gradually during development. There does 
not appear to be a limit to the age at which the chicken liver will 
respond to oestrogen, since even the administration of oestrogen to 
chick embryos results in the production of plasma lipids and egg yolk 
proteins (143 - 147 ) 
The oestrogenized male chicken and male Xenopus laevis, therefore, 
represent a situation in which oestrogen is able to induce or amplify 
the transcription of specific genes, some of which are normally ex-
. ( 11 5' 116' 148 - 1 50) pressed to varylng degrees This has proved a 
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valuable experimental system with which to study the early cellular 
events in the action of a hormone, particularly the role of steroid hor-
mone receptors and the control of transcription and translation (BO) 
Vitellogenesis has also been induced in vitro in cell and organ cultures 
of male Xenopus laevis liver (151 - 157) and embryonic and young chick 
1 . ( 1 58' 1 59' 1 61 ) th bl" . lver , us esta lshing that oestrogen lS the sole 
inducer required for the synthesis of egg yolk proteins, that the action 
of the hormone upon the liver is direct, and that DNA synthesis does not 
appear to be essential for the initial stages of induction. In vitro 
and in vivo studies have shown that the maintenance of the hormonally-
induced protein and lipid production depends upon the continuous presence 
of oestrogen (BD). This characteristic of the vitellogenic response to 
oestrogen distinguishes hormonal induction from embryonic induction in 
which the inducer is often dispensable after induction. A lag period 
normally precedes steroid hormone action, the length of the lag period 
being typical for a given hormone and a given target tissue. The 
length of the latent period also varies depending on whether the target 
tissue has been previously primed by the hormone. This effect is ob-
served in the livers of male oviparous vertebrates after oestrogen 
treatment, since secondary stimulation results in a shorter lag phase 
before vitellogenin synthesis is detectable, and also an enhanced res-
d . th th t bt . d . th . t. 1 t. ( 63 ' 81 ' ponse as compare Wl a o alne Wl prlmary s lmu a lOn 
141 ' 1 62) A notable difference between the response of the male 
Xenopus laevis and that of the cockerel is in the time course of the 
response. After a single injection of oestrogen, a peak in blood 
vitellogenin content is observed more rapidly in the cockerel than in 
the toad, in which the response is more extended. In each case, peak 
hepatic lipid production occurs at an earlier time than the peak in blood 
vitellogenin content (63 ' 81 ' 138 ), and both the time course and the 
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magnitude of the response are affected by the hormone dose level (80, 163 ). 
In mature females, the proteins and lipids synthesized and secreted 
in response to oestrogens are taken up by the ovaries and accumulate in 
(80 89) . the egg yolk ' , but 1n oestrogen-treated males, unable to dispose 
of them in this way, they accumulate in the blood. The accumulation of 
vitellogenin in the blood of the oestrogenized male is an important ad-
vantage in the purification of the protein, which is of particular 
interest as a complex protein. Its multicomponent nature makes it an 
ideal protein with which to study post-translational modifications and 
processing, which include phosphorylation, glycosylation and lipidation 
in the liver, and proteolytic cleavage in the ovary to yield phosvitin 
and lipovitellin. The male Xenopus laevis has been particularly useful 
in the study of vitellogenin since oestrogen administration does not 
result in marked lipaemia as in the oestrogenized cockerel, thus making 
purification procedures easier, and also because chronic treatment of 
Xenopus laevis with oestrogen results in vitellogenin almost totally 
replacing all the normal serum proteins (GO, 88 ). Therefore, a great 
deal of work has been done using birds and amphibia to examine the 
transcriptional events and protein synthesis resulting from oestro-
genization, but rather less appears to be known about the metabolic 
events underlying the increased membrane biogenesis and lipid synthesis 
during vitellogenesis. 
Although the administration of oestrogen to immature pullets and 
cockerels brings about changes in the blood and liver lipids which 
resemble those observed as the hen comes into lay, quantitative differ-
ences may nevertheless exist. Balnave (164 ) has reported an 'over-
reaction' of immature pullets to oestrogen treatment, resulting in 
he~vier livers and greater liver and blood levels of fatty acids re-
lative to those of the mature laying hen. Most notably, there was a 
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substantial increase in the percentage of palmitic acid in the liver 
and blood fatty acids of oestrogenized pullets, which was not observed 
in the mature hen. On the other hand, the mature hen has an increased 
capacity to retain dietary linoleic acid, which is not reproduced by the 
administration of exogenous oestrogen to immature female birds. It 
would, therefore, appear that the administration of oestrogen to the 
immature female bird does not entirely mimic the situation existing in 
the mature hen. Undoubtedly, the physiological state of the laying 
hen is not determined solely by oestrogen, and other ovarian and endo-
crine secretions may exert an influence. It has been shown that 
* androgens and progestagens may also be involved in the physiological 
changes associated with sexual maturity in the hen (165 ' 166 ), and the 
egg-laying process itself may exert a significant effect, since lipid is 
removed from the body when eggs are laid, and there is a continual de-
mand for lipid for deposition in the developing oocyte. No such lipid 
demand exists in the immature pullet and cockerel after oestrogen treat-
ment, and lipid and egg yolk proteins accumulate in the blood in the 
absence of an export system such as egg-laying. It would, therefore, 
seem likely that any similarities in the lipogenesis of the hen 
approaching lay and of the oestrogen-treated immature female bird or 
cockerel would exist before the lipids and egg yolk proteins accumulate 
in the blood of the oestrogen-treated birds to levels greater than those 
observed in the mature hen. 
5. Agricultural and medical implications 
The majoragticultural application of the oestrogen-treated domestic 
fowl, which develops fatty liver and hyperlipaemia, is in the elucidation 
of the metabolic disorders that give rise to hepatic steatosis in the 
fowl. Two diseases afflicting the domestic fowl in this way are fatty 
* See pages 26 and 34 
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liver and kidney syndrome (FLK5) and fatty liver-haemorrhagic syndrome 
(FLH5), which affect young chicks and laying hens respectively (167 ). 
Chicks suffering from FLK5 have widespread fatty infiltration of the 
tissues, particularly of the liver and kidneys which become pale and 
enlarged (168 ) In addition, the chicks are hyperlipaemic, having in-
creased levels of free fatty acids and triacylglycerol in the plasma 
despite a reduction in hepatic lipogenesis (169 ) It is generally be-
lieved that the accumulation of fat in the tissues is due to a decreased 
uptake of lipid by adipose tissue as a result of inhibition of lipo-
protein lipase (169 ). It has been demonstrated that FLK5 can be caused 
by a combination of nutritional factors, including low biotin, protein 
and fat levels in the diet, leading to an impairment of hepatic 
( 170, 171) gluconeogenesis Susceptibility to the disease seems to be 
precipitated by adverse environmental factors such as stress or fasting, 
and death occurs as a result of hypoglycaemia ( 172) FLH5 which 
affects laying females also manifests itself in the accumulation of fat, 
of which most istriacylglycerol, in the liver, kidneys and abdominal 
cavity, and tends to be accompanied by high plasma levels of free fatty 
acids andtriacylglycerol and reduced egg production (167 ). Death is 
usually caused by haemorrhage of the liver. Evidence suggests that the 
steatosis associated with FLH5 is the result of increased hepatic lipo-
genesis, and it seems likely that the syndrome is caused by an excessive 
intake of carbohydrate, leading to a positive energy balance, and 
results from an interaction of dietary and environmental factors. 
Hence, hens that are caged and at a high environmental temperature and 
which are unable to reduce their food consumption have a greater suscept-
ibility to FLHS. Other aetiological factors that have been implicated 
have been a dietary deficiency of some kind and high levels of endo-
(167 280) genous oestrogen ' In this latter respect, the oestrogen-
16 
treated fowl has received obvious attention, and oestrogen treatment has 
been shown to result in fatty liver and an increased incidence of 
hepatic haemorrhage in the domestic fowl (173 - 175). 
A number of clinical conditions exist in man in which severe hyper-
lipaemia is a major problem, notably the exogenous lipaemia of uncon-
trolled diabetes (176), genetically determined hyperlipoproteinaemia 
(177 ), and myxoedaema (178). In addition, several studies have shown 
that the level of blood lipids is correlated with the incidence of cardia-
vascular disease in man (179 ) In this respect, the domestic fowl has 
become a very useful experimental animal in the field of medicine during 
recent years, since it has been shown that the cockerel develops 
arteriosclerosis after prolonged oestrogen treatment or cholesterol 
feeding (180), and that the non-laying hen suffering from FLHS may 
develop aortic arteriosclerosis (181 ) In addition, the oestrogen-
treated fowl represents a model for use in studies related to the side-
effects of oral contraceptive therapy. The reason for this is that the 
common usage of oral contraceptives containing oestrogen has brought 
with it the realization that a major side-effect of such treatment is 
hyperlipaemia, due principally to elevated triacylglycerol levels (133 , 
182 - 184) The domestic fowl is a particularly suitable experimental 
animal for studies designed to elucidate the mechanisms underlying 
human endogenous hyperlipaemia, not only because it develops a similar 
hyperlipaemia when oestrogenized, but because the normal plasma levels 
of triacylglycerol, cholesterol and free fatty acid are similar to those 
in humans (113 ) In addition, the plasma lipoproteins of the domestic 
(109, 113, 185) fowl have similar lipid compositions to those of man 
Women have been shown to have significantly higher levels of plasma 
HOL at all ages after puberty than men (186 ' 187). In addition, women 
generally have lower levels of plasma VLOL and LDL than men in middle · 
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(187) 
age Epidemiological studies have linked low plasma HDL levels 
and high plasma VLDL and LDL levels with premature coronary arteria-
l . ( 188' 189) d . . t . . . t. h t sc eros1s , an 1n connect1on with h1s 1t 1s interes 1ng t a 
women appear to have a lower probability of suffering from arterio-
sclerotic vascular disease (190). The higher plasma HDL levels in 
women are attributed to endogenous oestrogen, and oestrogen admini-
stration to men and women leads to elevated levels of plasma HDL and 
VLDL ( 1 91 , 1 92) • The similar or slightly lower plasma VLDL and LDL 
levels observed in women,compared with the levels in men,are thought 
to be due to the higher progesterone levels in women (192 , 193 ) After 
the menopause, women have an increased risk of coronary heart disease, 
presumably because there is a decrease in the production of ovarian 
oestrogen which leads to decreased plasma HDL levels (190 , 194 ) As 
previously noted, cholesterol feeding induces aortic and coronary 
arteriosclerosis in cockerels (180), and it has been shown that oestro-
gen treatment exerts a protective effect against the development of 
cholesterol-induced coronary arteriosclerosis in chickens, although 
hyperlipaemia and aortic arteriosclerosis still occur (195 , 196 ). 
With regard to this, it is interesting that cholesterol feeding is un-
able to induce coronary arteriosclerosis in laying hens (197 ) 
Premenopausal women taking oestrogen-containing contraceptive pre-
parations have been shown to have elevated fasting plasma levels of 
triacylglycerol, phospholipid and cholesterol (133 , 182 - 184 , 198 ) 
The major increase is in the triacylglycerol fraction, and the in-
creases in plasma lipids are associated with increased amounts of pri-
marily VLOL (133 ' 184 ' 192 ), and also increased levels of HOL (192 ' 
199) . ( 133) 
and, 1n some cases, of LOL • Similar increases in plasma 
lipoprotein levels have been found in postmenopausal women receiving 
(200) 
oestrogen replacement therapy There are indications that the 
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increased lipoprotein levels in the plasma of oestrogen-treated women, 
together with long-term use of oestrogen-containing preparations, may 
put these women at an increased risk of cardiovascular disease. Evi-
dence has accumulated that the incidence of myocardial infarction (201 ) 
and cerebral vascular ~ccidents (202 ) is significantly increased in pre-
menopausal women taking oral contraceptives compared with those not 
taking such preparations. 
Most oral contraceptive preparations are a combination of an oes-
trogen and a progestagen, and it is the oestrogen component that is 
considered to be responsible for the hyperlipaemia (183 , 190 , 203 ). 
On the other hand, the progestagen appears to be either inert or anta-
. t• . th" t (134, 190, 193, 204- 206) Th . •t f gon1s lC 1n 1s respec • e maJorl y o 
women taking oestrogen-containing contraceptive steroids experience 
only mild hyperlipaemia which lies within the normal range, and which 
may revert to the pre-treatment level after short-term oestrogen therapy 
( 1 33' 1 83' 184) The plasma cholesterol concentration may or may not 
depending partly on the levels that exist before treatment (184 ' rise 
200, 207) Occasionally, severe hyperlipaemia develops as a result of 
oestrogen treatment, particularly in women who have a pre-existing endo-
genous hyperlipaemia (182 ' 200 ) The greater elevations of plasma 
lipids in these patients undoubtedly puts them at an increased risk of 
cardiovascular disease. A solution to this problem would be to develop 
oral contraceptives without the oestrogen component. Contraceptives 
containing only progesterone have been introduced, and when used by 
normal women plasma triacylglycerol levels have been shown to remain un-
changed or to decrease slightly (208 ' 209 ). However, reports have 
shown a higher pregnancy rate and a much higher occurrence of abnormal 
bleeding in patients receiving these preparations than in women using 
(200) the conventional oestrogen-containing contraceptives 
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The.domestic fowl and humans both respond to oestrogen treatment 
with an increase in plasma lipid which is predominantly triacylglycerol. 
The mechanism of the increase in plasma triacylglycerol levels is contra-
versial, although it seems likely that similar mechanisms are involved 
in the fowl and in humans. That the hypertriacylglycerolaemia is not 
the result of an input from a dietary source is supported by the obser-
vation that an increase in the concentration of chylomicra is not found 
in the oestrogen-treated human, and that only a minor increase in the 
level of portomicra may be seen in the oestrogenized chick (113). The 
elevated triacylglycerol levels observed in the plasma after oestrogen 
treatment could be the result of an increased rate of production of 
triacylglycerol-rich lipoproteins by the liver or of impaired removal of 
triacylglycerol from the plasma, or a combination of both of these, and 
the literature is full of reports 
In addition, in humans, increased 
growth hormone (213 ) and cortisol 
supporting each of these possibilities. 
1 1 f . 1' ( 1 83' 21 0 - 212) eve s o 1nsu 1n , 
(214 ) have been associated with the 
increase in plasma triacylglycerol, implying that the effect of oestrogen 
on the induction of elevated plasma triacylglycerol levels may be in-
direct. That the rise in plasma triacylglycerol levels after oral 
contraceptive treatment may possibly be related to oestrogen-induced 
changes in insulin and glucose metabolism is indicated by reduced glu-
. . ( 212 21 5 - 217) 
case tolerance in normal women rece1v1ng oestrogens ' • 
A number of clinical investigations have been carried out which have 
indicated that the increase in plasma VLDL associated with oestrogen 
contraceptive therapy is, at least in part, caused by an oestrogen-
induced increase in the hepatic syntheses of apoproteins and triacyl-
glycerol (133, 190, 192, 211, 218, 219) Similarly, studies on the 
oestrogenized fowl have shown that the oestrogen-induced rise in plasma 
VLDL levels is accompanied by increased VLDL synthesis by the liver 
( 114 - 11 9' 206) 
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The principal mechanism for the removal of triacylglycerol from 
the plasma is believed to be via the action of lipoprotein lipase in 
tissues (220 ). This enzyme is thought to function at the luminal sur-
face ofthe endothelial cells of capillaries, and hydrolyses triacyl-
glycerol in lipoproteins to free fatty acids and glycerol. The fatty 
acids released are then able to penetrate the tissue cells for further 
metabolism. Interestingly, some or all of these lipoprotein lipases 
can be released into the blood by the intravenous injection of heparin, 
and this has proved extremely useful in measuring lipoprotein lipase 
activity. Several investigators have reported depressed post-heparin 
lipolytic activity (PHLA) in women receiving oestrogen-containing pre-
parations ( 1 B~, 198 , 211 ' 221 - 223 ), and also in the female rat after 
similar oestrogen treatment (224 ). This phenomenon is also observed 
in women in the last trimester of pregnancy (225 ), when there are high 
levels of oestrogen and associated hypertriacylglycerolaemia. Studies 
of pregnant animals have shown a similar decrease in adipose tissue 
1 . t . 1' t. . t ( 226 ) 1popro e1n 1pase ac 1v1 y • Evidence has been presented which 
suggests that endogenous and exogenous triacylglycerols in the blood are 
cleared by a common,' saturable lipoprotein lipase system (227 ). It is, 
therefore, surprising to find that oestrogens depress PHLA, whilst exo-
genous fat tolerances have been reported to be normal in oestrogen-
treated patients ( 184 ' 190 ' 198 ' 228 ). Hazzard et al. ( 228 ) .have 
offered an explanation for this by suggesting that the decreased PHLA 
obtained after oestrogen treatment might be due to a form of resistance 
of the enzyme to release by heparin, rather than to an actual depletion 
of lipoprotein lipase. If this was the case, no impairment of plasma 
triacylglycerol clearance would be evident in vivo. On the other hand, 
some studies on the effects of oestrogen-progestagen oral contraceptives 
in women have revealed accelerated rates of triacylglycerol clearance 
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occurring concurrently with increased rates of triacylglycerol pro-
duction (190, 218, 219) 
It has been found that progesterone exerts a protective effect 
against oestrogen-induced hypertriacylglycerolaemia in rats and humans 
(134, 190, 204, 205, 224) h" h . 11 ·d d t be caused , w 1c lS genera y cons1 ere o 
by an acceleration of the rate of removal of triacylglycerol from the 
plasma. For example, Kissebah et aL (190) demonstrated that women 
using progesterone alone showed a decrease in plasma triacylglycerol 
concentration with increased triacylglycerol clearance and increased 
PHLA. Similarly, Glueck et al. (204 ) provided evidence to support the 
suggestion that progestational agents lower plasma triacylglycerol 
levels by bringing about an increase in the activity of lipoprotein 
lipase. Progestagens have also been shown to reduce plasma triacyl-
glycerol levels and increase PHLA in individuals with familial hyper-
lipoproteinaemia (229 ). It is interesting to note that for any given 
triacylglycerol production rate, women have been shown to have a lower 
plasma triacylglycerol level than men, implying that women have a 
greater capacity to clear triacylglycerol from the plasma (230 ). It 
seems likely that this difference in triacylglycerol clearance between 
men and women exists because of the higher levels of progesterone in 
women. Progesterone has not been shown to have any significant effect 
on the lipoprotein lipase of the domestic fowl (206 ), although PHLA in 
the plasma of laying turkeys is decreased relative to non-laying birds, 
and oestrogen treatment of male turkeys causes a similar decrease in 
PHLA (231) An interesting point is that phosvitin, one of the egg 
yolk proteins induced by oestrogen in birds, has been reported to have 
an inhibitory effect on lipoprotein lipase from humans, turkeys and 
chickens (231 ). The picture emerging from studies related to the use 
of oestrogen-progestagen oral contraceptives suggests, therefore, that 
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the oestrogenic component increases triacylglycerol production, whilst 
the progestational component may increase the efficiency of triacyl-
glycerol clearance from the plasma (190 , 218 ) 
6. The purpose of the present study 
It seems likely that oestrogen-induced increases in plasma triacyl-
glycerol levels are predominantly the result of increased VLDL synthesis 
in the liver. However, controversy exists as to the relative signifi-
cance of de novo fatty acid synthesis in the liver and the influx of 
fatty acids from extra-hepatic sites in the provision of precursors for 
complex lipid formation in the liver after oestrogen treatment. It is 
well-established that, in mammals, plasma free fatty acids are important 
precursors of plasma triacylglycerol ( 232 ). However, it is also well-
known that the liver of avian species has a high capacity for de ~ 
fatty acid synthesis. During oral contraceptive therapy elevated plasma 
free fatty acid levels have been observed (182 ' 233 ), and at the onset 
of lay in the domestic fowl the amounts of complex lipid and free fatty 
(57, 234) 
acid in the plasma increase simultaneously A similar in-
crease in plasma triacylglycerol and free fatty acid levels is seen in 
oestrogenized male and immature female birds (113 , 127 , 164, 235 ). 
Kudzma et al. (113) stated that the increase in plasma free fatty acids 
did not occur until the hypertriacylglycerolaemia was well-established 
in oestrogenized chicks, although the significance of this statement is 
uncertain because a parallel increase in plasma free fatty acids was 
(235) 
also observed in control chicks. The data of Pageaux et al. , who 
studied oestrogenized 16-day old female quail (0·2 mg oestradiol 
benzoate/kg body wt.), are interesting since they show a significant 
decrease in serum free fatty acid levels 1 hour after hormone injection, 
followed by increased levels over the next 23 hours. Again, the 
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significance of these results is uncertain, since values were not pre-
sented for control birds at equivalent times after injection, and hence 
it cannot be deduced whether the changes in plasma free fatty acid levels 
were hormone-induced or were caused by handling and/or injection of the 
vehicle. Oestrogen treatment of Xenopus laevis has been shown to lead 
to an increase in unesterified fatty acids in the plasma (60 ). 
Hawkins & Heald (236 ) have demonstrated that liver slices from the 
laying hen incorporate more palmitate into neutral lipids than do liver 
slices from immature female fowl. Similarly, liver slices from 
oestrogen-treated immature female domestic fowl exhibit an enhanced 
capacity to incorporate palmitate into neutral lipids ( 236 )~ In vivo 
studies have shown that there is increased incorporation of plasma free 
fatty acids into triacylglycerol by livers of oestrogenized immature 
fowl ( 114) However, reports of the rate of de ~ hepatic lipo-. 
genesis from non-lipid precursors have been confusing, with some inves-
tigators reporting a lower incorporation of acetate into fatty acid by 
t h 1 . . th . h. 1. 1. (33, 237, 238) rna ure en 1ver sl1ces an by grow1ng c 1ck 1ver s 1ces , 
others reporting similar incorporation rates of acetate into fatty acids 
by liver slices from hens and chicks ( 239 ), whilst others have demon-
strated increased levels of incorporation of acetate into fatty acids by 
liver slices from oestrogenized chicks compared with those of control 
chicks (113 ' 238 ). It would, therefore, seem possible that fatty acids 
from extra-hepatic sites, such as adipose tissue, may be partly in-
valved, if only in the initial stages of the response, in the increased 
production of triacylglycerol by the liver of the hen approaching lay 
and of oestrogenized individuals. An alternative, but perhaps unlikely 
explanation for the observed increases in plasma free fatty acids could 
be that such vast amounts of fatty acids are manufactured by the liver 
that some are able to 'leak out' unesterified into the blood. In the 
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long-term at least, it seems likely that the liver does increase its 
capacity to synthesize fatty acids de ~for incorporation into com-
plex lipids, as well as its capacity to manufacture these complex lipids 
from exogenous and endogenous fatty acids. The aim of this study was 
to add to the present knowledge of the early lipogenic events occurring 
in the liver after oestrogen treatment of the male chick in vivo. 
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CHAPTER 2 
CHANGES IN WEIGHT AND DNA CONTENT OF THE LIVER AND IN 
PLASMA TRIACYLGLYCEROL AND PHOSPHOPROTEIN LEVELS OF THE 
MALE CHICK AFTER 178-0ESTRADIOL INJECTION 
.. 
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INTRODUCTION 
1. Factors influencing avian liver morphology 
(a) Effects of oestrogen 
The changes that occur in the gross physiology of the liver and the 
constituents of the blood of the female domestic fowl approaching lay 
have been well-documented (53 ' 55 ' 57 ' 58 ' 240, 241) At this time the 
1 d b b th 11 · d 11 dl'v1's1'on (58 ' 125 ' liver becomes en arge y o ce expans1on an ce 
164, 241 ) 
, as the organ synthesizes egg components in addition to con-
tinuing with its normal functions. The hepatic parenchymal cells 
assume the appearance of active secretory cells, characterized by the 
extensive proliferation of the endoplasmic reticulum and Golgi 
(58, 123) 
apparatus These liver cells are responsible for the pro-
rl1 1rt. inn nf 1 RrnP Rmnttnt.s nf 1 :ioid and eoo volk oroteins. which are se-
INSERT 
* However, administration of oestrogen plus androgen to 6-week old male 
chicks h,as been found to emphasize changes in the liver produced by 
oestrogen alone, although the additional increases in liver dry matter, 
total liver lipid and lipid content (expressed as a percentage of liver 
weight) did not attain statistical significance (165). The changes in 
liver fatty acid patterns observed after oestrogen treatment became more 
pronounced after the administration of androgen with oestrogen (165 ). 
Balnave & Pearce (166 ) injected 4-week old pullets with oestrogen and 
androgen and observed significantly greater liver weights for these 
birds than for those treated with oestrogen alone at 3 and 6 hours after 
hormone injection. 
testosterone treatment (253 ). * A number of investigators have ad-
ministered oestrogens to the domestic fowl and have observed liver 
I. 
... 
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weights up to, and greater than, double those of control birds (31 , 58 ' 
166, 174, 236, 244, 254) An interesting observation has been reported 
by Balnave (164 ) which appears to involve an 'over-reaction' of the liver 
of the immature female domestic fowl to exogenous oestrogen. After 
treatment of 16-week old female chickens with 5 mg oestradiol dipropionate 
on alternate days over a 7-day period, the liver weights of these oestrogen-
treated birds were similar to those of heavier mature laying hens. 
Although the domestic fowl has been extremely popular in studies of liver 
and blood changes during the vitellogenic response following the admini-
stration of oestrogens, similar effects are also observed in other species 
of birds and other egg-laying vertebrate phyla down to, but not including, 
the cartilaginous fishes (56 ' GO). Another avian species on which much 
work has been done is the Japanese quail, and oestrogen treatment of 3 to 
5-month old male Japanese quail ( 4 • 36 mg 17 (3 -oestradiol/1 00 g body wt.) 
has been shown to result in a near doubling of liver weight 4 days after 
hormone administration (250 ) After longer periods of time, the in-
crease in liver weight became less, until gradually the liver weight 
began to approach the control values. 
Contrary to the general observation of increased liver weight after 
oestrogenization of the chicken, oestrogen treatment of 15-day old chick 
embryos (5 mg oestrogen/bird) has been found to cause an approximately 
15% decrease in liver weight after 3 days, compared with control embryo 
(255 ) Thirteen liver weights • A and 14-day old embryos and newly hatched 
chicks, that were injected with oestrogen 3 - 4 days beforehand, were 
found not to have responded to oestrogen treatment with a change in 
liver weight, whereas chicks oestrogenized at hatching and sacrificed 
3 days later had livers that weighed 28% more than the livers of un-
treated chicks (146 ' 255 ). 
Several research workers have demonstrated that oestrogen dose 
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level and duration of hormone treatment significantly affect the liver 
weight of the domestic fowl. F 1 8 1 & Pearce (166) 1.n-or examp e, a nave 
jected 4-week old immature female chickens with 2 mg oestradiol dipro-
pionate on alternate days over a period of 9 days, and observed a 
time-related increase in liver weight up to 4 days after the commencement 
of hormone treatment. At 9 days the response was depressed, although 
liver weights were still higher than control values. Pearce & Balnave 
(256 ) treated 4-week old female chickens with a single injection of oes-
tradiol dipropionate, and 2 days later observed increasing liver weights 
with progressively larger doses of hormone up to 2 mg/bird. With a dose 
of 4 mg oestradiol dipropionate/bird liver weight decreased but re-
mained higher than the control value. A similar pattern of response 
was obtained after 8 days of oestrogen treatment, during which time oes-
tradiol dipropionate (0·5 - 4 mg) was administered on alternate days. 
In addition, at all oestrogen dose levels the liver weights were signifi-
cantly greater after 8 days than after 2 days of oestrogen treatment. 
Pearson & Butler (1?4) also observed a dose-related increase in liver 
weight in 6 to ?-week old female chickens that received 5 doses of 0·25, 
0•5 or 1 mg oestradiol dipropionate/100 g body weight. Injections were 
given at 3-day intervals and the birds were sacrificed 2 days after the 
final dose. Similarly, Akiba et al. ( 249 ) have reported increases in 
liver weight which were proportional to oestradiol dose, after implanting 
silastic tubes filled with oestradiol dipropionate subcutaneously into 
the necks of 2 to 3-week old male chicks. Different lengths of oes-
tradiol tubes were implanted with release rates of 1 - 15•2 ~g 
oestradiol/day/bird, and chicks were killed and livers weighed 2 - 3 
weeks after implantation. 
Increases in liver size and weight of the oestrogenized domestic 
fowl are usually obvious within 24 hours of hormone administration (166 ' 
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242) ( 166) . 
, although Balnave & Pearce found no dlfference between the 
liver weights of oestrogenized and control birds 12 hours after oestrogen 
treatment. As the liver enlarges it becomes paler in colour and fatty 
in appearance, and develops into a softer, more fragile structure (242 ) 
The increase in liver size and weight occurring after oestrogenization is 
considered to be predominantly due to the increase in volume of existing 
cells as a result of water uptake and the accumulation of lipid, although 
it has been estimated that a proportion ( < 40%) of the parenchymal cells 
divide (242 ' 257 ) Hawkins & Heald (236 ) measured liver DNA in 11-week 
old female chickens treated with 2 mg oestradiol benzoate on alternate 
days for 7 days and which were sacrificed on the 8th day, and found that 
the DNA content· of a unit wet weight of liver was decreased in these 
birds compared with values from control birds. In addition, these in-
vestigators reported that the DNA content of a unit wet weight of liver 
was approximately 1·4-fold greater for the immature female domestic fowl 
than for the laying hen. These observations suggest that the process 
of liver 'growth' is similar in the hen approaching lay and the oestro-
genized male and immature female domestic fowl, in that cell expansion 
contributes considerably to the increase in liver size, although some 
DNA synthesis and cell division does occur (248 ). Interestingly, some 
reports have revealed a lack of hypertrophy and cellular proliferation 
in the livers of oestrogen-treated amphibia, and in these cases the ratio 
of liver weight to body weight remained unchanged (258 , 259 ). 
After oestrogenization of male and immature female domestic fowl 
and at the onset of lay in the mature hen, there is an increase in the 
total lipid content of the liver, particularly of triacylglycerol which 
is associated predominantly with LDL and VLDL, and this lipid contributes 
to the increase in liver weight observed at these times (114 , 125 , 166 , 
246, 256) The hepatocytes undergo marked changes in cytology, notably 
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in the proliferation of the endoplasmic reticulum and the Golgi apparatus 
with an increase in the number of associated ribosomes and mitochondria 
(58, 123, 124, 160, 242, 260, 261) The cisternae of the endoplasmic 
reticulum gradually assume a dilated appearance as they become in-
creasingly active in the production of secretory proteins, and become en-
gorged with lipid droplets and nascent lipoproteins (58 ). Therefore, in 
the initial stages of the transformation of these cells, much of the lipid 
and protein synthesized would appear to be used for membrane biosynthesis, 
to provide the necessary cellular structures for the ensuing production 
of large quantities of proteins and lipids for export from the cell. 
During this time, the number of glycogen granules in the hepatic paren-
chymal cells is·drastically reduced (242 ). 
Other oviparous vertebrates respond to endogenous or exogenous oes-
trogens with similar changes in liver morphology and cytology to those 
of the domestic fowl. For example, Xenopus laevis has been shown to 
respond with an increase in liver size ( 6D), with accompanying develop-
ment of the endoplasmic reticulum and Golgi apparatus, accumulation of 
. (128 262 - 265) 
membrane-bound rlbosomes, and decreased glycogen content ' • 
Liver cells of the lizard, Uta stansburiana, respond to oestrogen in a 
similar way, and fat vacuoles become prominent in the cytoplasm (242 ). 
The adipose tissues of this species normally become enlarged before egg-
laying, and it has been suggested that, when oestrogen levels rise, fatty 
acids are released from adipose tissue into the blood, and are carried to 
the liver where they are temporarily stored before being utilized. 
Similar fat vacuoles are observed in hepatocytes of oestrogen-treated 
Xenopus laevis (153 ) and domestic fowl (160 ' 266 ). It is perhaps in-
teresting to note at this point that oestrogen treatment of female rats 
has been shown to cause a slight increase in liver weight, involving 
primarily cell expansion with hypertrophy of the endoplasmic reticulum 
(136, 267) 
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(b) Effects of prolactin 
Certain other circumstances, apart from oestrogen treatment, have 
been found in which the avian liver responds with a change in weight. 
One of the best-documented is the liver enlargement and concomitant 
stimulation of hepatic lipogenesis associated with the action of pro-
lactin. Prolactin is a pituitary hormone which appears to play an im-
portant role in bringing about the metabolic changes necessary for the 
laying down of fat reserves in migratory birds. Goodridge & Ball (268 ' 
269 ) stud1" ed th f th · 1· t 1 t · d b d e response o e p1geon 1ver o pro ac 1n, an o serve 
that after a daily dose of 1 mg of a prolactin preparation for 5 days 
the liver had nearly doubled in mass, although liver weight changes were 
evident even after 1 day of prolactin treatment. It was suggested that 
imbibition of water was involved at least in the early stages of the in-
crease in liver size. Prolactin also causes the enlargement of the 
crop sac of the pigeon and the formation of crop milk. It was found 
that starvation eliminated the increase in liver size caused by pro-
lactin, but that the crop sac still responded ( 269 ). On the other 
hand, growth hormone was found to cause the same changes in liver size 
and metabolism as seen with prolactin, but failed to increase the size 
of the crop sac (269 ). These investigators concluded that prolactin 
causes hyperphagia, which leads to an increase in body weight together 
with increases in the weights of specific organs such as the liver, 
pancreas and intestine. Hyperphagia has been shown to cause an in-
crease in liver weight in avian species, principally as a result of 
1 . "d d •t· (26, 270, 271) I th" t ·t. f. t t 1p1 epos1 1on • n 1s respec , 1 1s o 1n eres 
to note that increased food consumption has been observed in oestrogen-
treated immature male and female chickens (174 , 246 ) 
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(c) Effects of the pattern of food intake and the composition 
of the diet 
The liver weight of the domestic fowl has been shown to fluctuate 
according to the pattern of food intake and the composition of the diet. 
Interestingly, chickens do not develop a fatty liver on fasting to the 
extent seen in mammals (272 - 275 ). Leveille (50) demonstrated that 
the liver weight of the chick decreased during a 3-day fast, increased 
to greater than the normal weight on refeeding for 2 days, and returned 
to the control value on the 3rd day of refeeding. During fasting there 
was a slight increase in the liver lipid content that amounted to about 
10%. The increase in liver weight after refeeding correlated with an 
increase in liver lipid. Muiruri et al. (46 ) showed that liver weights 
were greater in meal-fed chicks than in ad libitum-fed chicks. In 
addition, 1 hour after allowing meal-fed chicks access to food, there 
was a significant increase in liver weight, which these workers suggested 
was primarily the result of increases in water and glycogen content and, 
to a lesser extent, in lipid content ( 33 ' 46 ). The stimulation of 
hepatic lipogenesis by fructose is well-known (236 ' 276 ), and Pearce 
(277 ) has demonstrated that a diet rich in fructose causes a marked in-
crease in liver weight and liver lipid content in 7 to 8-week old female 
chicks. In some species, including the domestic fowl, the embryonic 
and newborn young have fatty livers, the lipid being derived from the 
yolk on which the embryo is nourished. However, this phenomenon is 
short-lived and the livers become normal a few days after hatching (278 , 
279) 
(d) Fatt liver and kidne s ndrome (FLKS) and fatt liver-
haemorrhagic syndrome FLHS) 
FLKS and FLHS are two non-infectious diseases afflicting young 
( 167) . 
chicks and laying hens respectively , and have been dlscussed in 
Chapter 1. The livers of affected birds are pale and enlarged as a 
result of fatty infiltration, of which most is triacylglycerol. The 
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accumulation of lipid in the liver in FLKS occurs despite a reduction 
in hepatic lipogenesis and appears to be due to reduced uptake of lipid 
b d . t. ( 169) h . . y a lpose lssue , w ereas evldence suggests that the accumulatlon 
of lipid in the liver in FLHS is the result of increased hepatic lipo-
( 167) genesis The internal structure of the liver of a victim of 
FLHS is disrupted greatly by the increased incidence of fat vacuoles 
in the cytoplasm of hepatocytes which often leads to rupture of the cells, 
and by lysis of the reticulin bands around the cells which results in 
structural weakness in the liver. In addition, there are diffuse 
capillary haemorrhages, bloodclots, vascular breakdown, and regions of 
fibrosis and necrosis (167 ' 280 ). In cases of FLHS and occasionally 
of FLKS, smalL haemorrhages are found on the periphery of the liver, and 
in FLHS death is usually caused by haemorrhage from the liver which 
ruptures the liver capsule. 
(e) Instances and causes of fatty livers in other species 
Fatty livers have been described in several species, including man, 
as a result of changes in physiological state, disease, poisoning or 
d . t d f t (275, 279, 280) F 1 f tt 1' . le ary e ec s or examp e, a a y lVer ls 
associated with conditions such as pregnancy (281 ), diabetes mellitus, 
pernicious anaemia, kwashiorkor, alcoholism and a variety of 
(275, 279) 
infections 
Dietary 
~~.deficiencies in choline and its precursors and in protein result in a 
fatty liver, as do many other dietary defects including an imbalance of 
amino acids or vitamins in the diet, too much dietary fat or cholesterol, 
excessive food intake, and the early stages of starvation. Several 
chemical substances also induce the formation of an enlarged fatty liver 
and these include carbon tetrafluoride, chloroform, ethionine, orotic 
(275) 
acid and the rare earth metals . 
Fatty livers can be the result of a variety of abnormal liver 
functions including accelerated lipid production and/or decreased lipid 
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degradation, or decreased apoprotein synthesis for the production of 
lipoproteins. In some cases the fatty liver is caused by an enhanced 
synthesis of triacylglycerols in the liver, and in these circumstances 
the plasma triacylglycerol level is either normal or elevated. On the 
other hand, decreased fatty acid oxidation and/or a decrease in lipo-
protein synthesis can also cause triacylglycerol accumulation in the 
liver. When lipoprotein production is interfered with the levels of 
triacylglycerol in the blood will be depressed, and this decrease in 
lipoprotein production may be the result of impaired lipid synthesis or 
. . d t . th . (275) 1mpa1re apopro e1n syn es1s . 
2. Effects of oestrogen on extra-hepatic organs 
It is well-known that oestrogens exert significant effects on the 
morphology and metabolic activity of organs other than the liver, notably 
th 'd t f . . (31' 166, 236, 246, 256, 282, 283) d th e ov1 uc o av1an spec1es , an e 
uterus (137 ' 284 - 288 ), vagina (288 ) and mammary gland (289 ) of mammals. 
Hawkins & Heald (236 ) observed an approximately 25-fold increase in the 
oviduct weight of 11-week old chickens after treating the animals with 
2 mg oestradiol benzoate on alternate days for 7 days. Similarly, 
Aprahamian et al. ( 31 ) obtained about a 23-fold increase in oviduct 
weight in 1-month old chickens after treating each bird with 4 mg oes-
tradiol benzoate/day for 6 days. Other research workers have observed 
similar increases in oviduct weight after treating immature pullets with 
oestrogen (166, 246 , 256 ), and in addition, have noticed that treatment 
with a mixture of oestrogen and testosterone causes a greater increase 
in oviduct weight than observed with oestrogen alone (166 ' 246 ). This 
increase in oviduct size is associated with cell expansion and division, 
is accompanied by an increase in metabolic activity and stimulation of 
ovalbumin synthesis, and is a prerequisite for the oviduct to respond to 
progesterone. 
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The uterus of mammals also responds to oestrogen treatment with an 
. . . d t b 1' t. . t ( 137 ' 285 ) d . t h b h 1ncrease 1n s1ze an me a o 1c ac lVl y ,an 1 as een sown 
that oestrogens dramatically increase the number and size of cells and 
the water content of the uterus (267 ' 284 , 290 ) The mammalian vagina 
responds to oestrogen with an increase in the thickness of the epithelium, 
as a result of an increase in the rate of proliferation of the cells of 
the basal layers. The cell layers of the vaginal epithelium increase 
in number and those on the surface stratify, then cornify and finally 
(288) desquamate • The development of the mammary gland during puberty 
and pregnancy appears to take place in response to several hormonal 
stimuli which occur in a prescribed sequence. Oestrogen, together with 
other hormones., is involved in the ductal growth which occurs during 
puberty, and lobuloalveolar growth which occurs during pregnancy. 
Ductal growth involves cellular proliferation giving rise to 'determined' 
but undifferentiated cells, and during pregnancy the interductal spaces 
are filled with lobuloalveolar structures as a result of cell replication 
and differentiation. In pregnancy, the epithelial cells assume a se-
cretory function and the gland becomes highly vascularized in preparation 
for the production of milk (289 ) 
3. Effects of oestrogen on the protein and lipid metabolism of 
avian liver 
In addition to the increase in liver size and weight, another 
visible effect of oestrogen treatment in the domestic fowl is the 
development of a yellow clouding of the plasma . This phenomenon 
is the result of accumulating lipid, and using the technique of func-
. ( 122) 
tional hepatectomy, Ranney & Cha1koff demonstrated that the liver 
was responsible for the development of this lipaemia in the oestrogenized 
cockerel. The lipid constituting the lipaemia is synthesized in the 
liver and is not of dietary origin, since the lipaemia still develops if 
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food is withheld (82 ). This oestrogen-induced hyperlipaemia is remin-
iscent of that observed in the mature hen approaching egg-laying, when 
the liver assumes the role of synthesizing the lipids and proteins re-
quired by the developing egg (5?, 236 ). The most marked elevations in 
the levels of lipid and egg yolk proteins in the plasma are observed 
during the 14 days immediately prior to the onset of laying, when the 
plasma lipid level can rise to 10 - 14 g/100 ml plasma, compared with 
0·2- 0·5 g/100 ml plasma in the immature female bird (55 ' 127). When 
the first egg is laid, the plasma lipids decrease sharply to a level of. 
1 • 5 - 3 g/1 DO ml ( 127 ' 291 ) 
The bulk of the plasma lipids constituting the lipaemia associated 
with egg-laying or oestrogen treatment of the domestic fowl are triacyl-
glycerols, existing predominantly in the form of VLDL (113 - 115 , 117 , 
118, 236, 242) VLDL are normal constituents of the blood and emanate 
from the ll·ver (120 , 121 ). S 1 k h h th t t evera wor ers ave s own a oes rogen 
treatment of the domestic fowl results in a dramatic increase in the 
plasma concentration of VLDL, with a lesser increase in LDL and a marked 
decrease in HDL (117 ' 118 ' 292 ) All the lipoprotein fractions are en-
riched in triacylglycerol, whilst the proportion of cholesterol is de-
creased in all the fractions. The remaining hyperlipaemia is 
attributable to phospholipids and to a lesser increase in cholesterol. 
The increase in triacylglycerol production by the liver is accompanied 
by a parallel increase in the production of the apoproteins of LDL and 
VLDL (115 - 119 , 293 ). Several investigators have demonstrated the en-
hanced production of VLDL by the liver of the oestrogen-treated domestic 
( 114 - 11 6, 11 8, 160, 206) d VLDL th · h b · t · d fowl · ,an syn esls as een maln alne 
in primary cell cultures isolated from the livers of oestrogen-treated 
chicks for at least 48 hours (160) However, only a small degree of 
success has been achieved in the in vitro stimulation of VLDL synthesis 
b t · 1· 1· from male chl. cks ( 1 59 ) y oes rogen ln lver s lces 
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The increase in VLDL apoprotein synthesis is the result of the in-
creased transcription of corresponding apoprotein genes (116 , 119 ). 
The apoprotein mRNAs are translated on membrane-bound ribosomes and the 
nascent proteins become associated with lipid, mainly triacylglycerol, 
during their passage through the endoplasmic reticulum to the cell sur-
face ( 294). This increased VLDL apoprotein synthesis is accompanied 
by similar increases in the syntheses of other secretory proteins such 
as vitellogenin, which also has lipid associated with it. In the hen, 
these proteins are destined for deposition in the egg yolk, but they are 
also manufactured by male and immature female birds in response to oes-
trogen. 
Xenopus laevis responds to oestrogen treatment in a similar way to 
the domestic fowl, but this species differs from the domestic fowl in 
that the plasma remains transparent after oestrogen treatment, giving no 
indication of enhanced VLDL synthesis (50, 81 ) However, an increase 
in hepatic lipid synthesis, primarily of cholesterol and fatty acids, 
has been detected in the oestrogenized male and female Xenopus laevis 
(138 - 140), and the bulk of this lipid is incorporated into intra-
cellular membranes, although some of it is associated with the egg yolk 
proteins. The peak production of lipid in the oestrogenized female 
Xenopus laevis occurs about 6 days after a single dose of oestrogen 
(1 mg 17 S-oestradiol) (138 ' 139 ), which precedes the peak in vitello-
genin content of the blood at about 9 - 21 days after hormone treatment. 
Similarly, in the oestrogenized cockerel, the increase in concentration 
of plasma VLDL after a single oestrogen injection occurs earlier and 
lasts longer than the increase in vitellogenin content of the blood (81 ) 
However, unlike the peak in plasma lipid in Xenopus laevis, that in the 
oestrogenized cockerel (25 mg oestradiol/kg body wt.) occurs after 2- 3 
days, and after 5 - 6 days begins to return towards normal levels. 
38 
Peak vitellogenin content of cockerel plasma is observed at about 2~ - 4 
days after such oestrogen treatment. 
In connection with the enhanced lipid synthesis associated with 
egg-laying in the hen and oestrogen treatment of male and immature fe-
male domestic fowl, it has been observed that increased levels of free 
fatty acids accompany the increased lipid content of the Ptasma (57 ' 113 ' 
114, 127) In laying hens, the highest plasma free fatty acid levels 
are observed during the 14 days before laying begins, when the concen-
tration can reach 4000 ~moles/litre compared with 250 - 500 ~moles/litre 
in the immature female bird (57 ). Similar increases in plasma free 
fatty acid levels are obtained when immature female chickens are treated 
with oestrogen· (57 ). Other oviparous vertebrate species also respond 
to endogenous or exogenous oestrogen with an increase in plasma free 
fatty acids (GO). 
In mammals, plasma free fatty acids are important precursors for 
plasma lipids which are manufactured in the liver (232 ), but contrary to 
the situation thought to exist in most mammals, the liver is a most 
active site of de novo fatty acid synthesis in the domestic fowl (20 -
22) Hence, the origin of the free fatty acids that appear in the 
plasma during the onset of laying and after oestrogen treatment of the 
domestic fowl is somewhat unclear. These fatty acids may have resulted 
from the lipolysis of triacylglycerol stores in the adipose tissue or 
have been derived from the lipolysis of VLOL by lipoprotein lipase in 
peripheral tissues, or they may have been synthesized de ~at extra-
hepatic sites. The fatty acids may, therefore, be in the process of 
being transported to the liver for incorporation into complex lipids. 
Alternatively, they may originate from the liver as a result of overpro-
duction. A detailed knowledge of the time sequence of the increased 
total lipid content and the free fatty acid content of the plasma of 
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laying hens and oestrogenized birds is lacking, but elucidation of this 
might help to provide information about the early events occurring in the 
elevated production of triacylglycerol. If the increase in total plasma 
lipids was secondary to the increase in plasma free fatty acids, this 
might imply that the fatty acids originated from extra-hepatic sources 
such as adipose tissue and were being utilized in the liver for complex 
lipid synthesis. On the other hand, if the plasma free fatty acids in-
creased after the hypertriacylglycerolaemia was evident, then this might 
imply that the liver was the site of origin of these fatty acids. 
Studies using liver slices and in vivo techniques have demonstrated 
that the liver of the oestrogenized chick has an enhanced capacity to 
th . 1" . d f 1" . d ( 11 3 ' 11 4) I dd . t . syn es1ze 1p1 s rom non- 1p1 precursors • n a 1 1on, 
in vivo and in vitro studies have also shown that the livers of the 
laying hen and oestrogenized male or immature female bird have an en-
( 114' hanced capacity to incorporate fatty acids into complex lipids 
236
, 
238 ) Kudzma et al. (113) reported that the increase in plasma 
free fatty acids in oestrogenized chicks did not occur until after the 
hypertriacylglycerolaemia was established, suggesting that the liver was 
not dependent on fatty acids arriving from extra-hepatic sources via the 
circulation. However, these workers did not explain a parallel in-
crease in plasma free fatty acid levels in control birds which 'masked' 
the increase in oestrogenized birds. The results presented by Pageaux 
et al. (235 ) showed that oestrogen treatment of 16-day old female quail 
(0·2 mg oestradiol benzoate/kg body wt.) resulted in a decrease in serum 
free fatty acids 1 hour after hormone administration, followed by in-
creased concentrations over the next 23 hours. This implies that, at 
least initially, the liver may have derived fatty acids from the cir-
culation. 
It is interesting to note that there is a substantial increase in 
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the percentage of palmitic acid in blood and liver fatty acids in oes-
trogenized pullets compared with the laying hen, implying that fatty 
acid metabolism in the oestrogenized immature bird does not completely 
resemble the situation in the mature hen (164). In addition to an in-
crease in the percentage of palmitic acid in liver fatty acids, oes-
trogen treatment of immature pullets causes other changes in the fatty 
acid composition of the liver. For example, increases have been re-
ported in the percentages of palmitoleic and oleic acids, and decreases 
in the percentages of stearic and linoleic acids (256 ' 295 ). The in-
crease in the percentage of mono-unsaturated fatty acids may be a re-
flection of the increased desaturation activity observed after oestrogen 
treatment ( 29~). 
Although it has been demonstrated that the oestrogen-induced hyper-
triacylglycerolaemia is, at least in part, the result of enhanced hepatic 
VLDL production and secretion, the possibility exists that decreased dis-
posal of plasma lipids via the lipoprotein lipase system may also con-
tribute. Kudzma et al. (114 ) clearly demonstrated, after the admini-
stration of [9,10-3H] palmitate, [1~4c] acetate and (u-14c] glucose in 
vivo, that oestrogen treatment of chicks leads to an enhanced capacity of 
the liver to incorporate fatty acids into triacylglycerol and to syn-
thesize fatty acids de ~· Increased production of plasma VLOL was 
confirmed by a kinetic study of VLDL metabolism, employing reinjected, 
endogenously prepared ~ 4q triacylglycerol-labelled VLOL, which showed that 
the fractional turnover rate of VLDL in oestrogen-treated birds was less 
than in untreated birds but that the total turnover rate was much greater. 
Several studies have reported decreased post-heparin lipolytic activity 
(PHLA) . b. t t d •'th t (183, 198, 211, 221 - 223) 1n women e1ng rea e Wl oes rogens 
in the female rat after oestrogen administration (224 ), and also in 
pregnant women and animals in which high levels of oestrogen and 
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hypertriacylglycerolaemia exist (225 , 226 ). Studies on the turkey have 
revealed that PHLA is reduced in laying females compared with non-laying 
birds, and that oestrogen treatment of male turkeys causes a similar 
decrease in PHLA (231 ) However, it has been suggested that the re-
duced PHLA after oestrogen treatment may be due to a certain amount of 
resistance of lipoprotein lipase to release from the surfaces of the 
endothelial cells of capillaries by heparin, and that, in fact, the 
total lipoprotein lipase activity is not depleted (228 ). 
In addition to the elevated levels of VLDL in the plasma of laying 
hens and oestrogen-treated male and immature female fowl, increased 
levels of other normally occurring proteins and of certain 'new' pro-
teins are also observed, notably the glycolipophosphoprotein vitello-
genin ( 81 ' 297 ), and several vitamin- and mineral-binding proteins (65 ' 
1 42' 298 - 304) Contrary to these increased protein concentrations, 
it has been shown that the plasma concentration of albumin, a normal 
plasma protein, is decreased in response to oestrogen in the domestic 
. t b t (58, 81' 116, 119, 242, 305, 306) fowl and other egg-lay1ng ver e ra es 
It has been suggested that this may be due to a decrease in albumin syn-
th . ft t t t t (152, 258, 266, 307) 'bl es1s a er oes rogen rea men , poss1 y as a 
result of decreased synthesis of plasma albumin mRNA by the liver (118 ' 
153, 307 - 311) However, other workers have implied that the decrease 
in plasma albumin concentration after oestrogen treatment may be due to 
an increase in plasma volume rather than to repression of albumin syn-
th . (81' 174, 175, 250) eslS This view is supported by reports of little 
difference existing between the absolute amounts of serum albumin and 
lb · RNA th · d by t t t d d t 1 an1'mals (118 ' a um1n m syn es1ze oes rogen- rea e an con ro 
306, 308, 312 - 314) 
The induction of vitellogenin synthesis in the oestrogenized male 
animal is a very interesting phenomenon, since it involves the activation 
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( 148, 150) 
of genes which are not normally expressed significantly 
This situation has, therefore, been widely exploited in the study of the 
early events involved in gene expression. In addition, the oestro-
genized male has proved useful in the study of vitellogenin itself, 
since, unlike the situation in the laying female where vitellogenin and 
the other egg yolk proteins are removed from the blood and inco~porated 
into the egg, no such export system exists in the male animal and the 
proteins accumulate to high levels in the blood. The synthesis of 
vitellogenin in response to oestrogens occurs in all oviparous verte-
brate species down to, but not including the cartilaginous fishes, but 
this protein has been studied in most detail in the domestic fowl and 
Xenopus laevis. That the liver is the site of vitellogenin synthesis 
has been confirmed by numerous studies including phosphate incorporation 
studies (67 ' 315 ), liver perfusion studies (243 ), tissue slice experi-
ments ( 71 ' 85' 1 01 ) t. lt . t ( 72) d h t t , 1ssue cu ure exper1men s an epa ec amy 
(73, 315) Vitellogenin synthesis has been induced in organ and 
primary cell monolayer cultures of Xenopus laevis liver by oestrogen 
in vitro, confirming that the action of oestrogen upon the liver is 
direct and that its continuous presence is required for the maintenance 
( 1 51 - 157) 
of vitellogenin synthesis The in vitro induction of 
vitellogenin synthesis by oestrogen has also been demonstrated in cell 
cultures of embryonic chick liver (158 ' 161 ), although such attempts 
have been unsuccessful when using liver cell cultures from older 
b . d (266, 316) 1r s . 
Structure of vitellogenin 
Vitellogenin is a complex glycolipophosphoprotein which is the 
plasma precursor of the egg yolk proteins phosvitin and a- and f3-
lipovitellin (61, 62, 64, 79, 81, 88, 90, 93, 94, 297) Chl.cken 
vitellogenin has a molecular weight of about 450,000 and is composed of 
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2 subunits, each having a molecular weight of 210,000 - 230,000 (93 , 317 ' 
318) Each vitellogenin subunit is proposed to comprise 2 phosvitin 
resl'dues and 1 1' 't 11' 'd (64 , 317 ) d C 2+ · 1pov1 e 1n res1 ue , an a 1ons are 
thought to play an important role in stabilizing the complex between 
the vitellogenin subunits in the blood of the domestic fowl. It has 
been suggested that there are at least 2 forms of phosvitin (93 , 319 ' 
320 ) with molecular weights of 28,000 and 34,000 (64 ' 93 ), whilst the 
molecular weight of the lipovitellins is about 170,000 (64 ). It is 
thought that there are 2 vitellogenins in chicken plasma differing in 
their phosvitin and lipovitellin compositions (320 ). One of the forms 
of vitellogenin gives rise to a- and S-lipovitellins, whilst the other 
form gives rise to a-lipovitellin only. In addition, neither form can 
give rise to both of the yolk phosvitins (320 ) In connection with 
this, at least 2 different species of vitellogenin mRNAs are thought to 
exist in the domestic fowl, with 1 species predominating during pri-
mary stimulation with oestrogen (321 ' 322 ). Moreover, diverse forms 
of vitellogenin have been recognized in the Japanese quail (323 ). It 
has been demonstrated that there are at least 4 different vitellogenin 
. (324 325) genes in Xenopus laev1s ' , and 4 distinct polypeptide products 
(348) The vitellogenins of Xenopus laevis are very similar to those 
of the chicken (325 ' 326 ), but contain only 1 type of lipovitellin 
which resembles the S-lipovitellin of the chicken (93 ). Xenopus 
vitellogenin also contains the bile pigment biliverdin, which gives it 
a green colour (327 ). 
In the laying hen, the vitellogenin molecule is split into its 
phosvitin and lipovitellin components within the oocyte (89 ) The 
major proteins in the egg yolk of the domestic fowl are phosvitin, 
a- and S-lipovitellins, and a-, S- and y-livetins (79 ). The a-, 
S- and y-livetins are normally occurring plasma proteins and have been 
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identified as plasma albumin, a 2-glycoprotein and y -globulins res-
t . 1 (243, 349) Th 1. t• t•t f pee 1ve y • ese 1ve 1ns cons 1 ute about hal of the egg 
yolk proteins and are present in the egg yolk in an approximate ratio of 
1:2:3. Phosvitin and the a- and (3 -lipovitellins make up most of the 
remaining egg yolk proteins and are 'new' proteins produced in response 
to oestrogen. The lipovitellins contribute about 30% and phosvitin 
. ( 243) 
about 7 - 8% to the yolk protein • 
The phosvitins are glycosylated phosphoproteins, and 56% of their 
. . d . ( 79) am1no ac1 s are ser1ne • Most of these serine residues and also 
some threonine residues are phosphorylated, which means that about 10% 
by weight of the phosvitins is phosphorus (B4, 328 ). The lipovitellins 
are also phosphoproteins but contain about 20% by weight of lipid (261 ). 
In addition, the lipovitellins are rich in methionine residues and 
about 4% of the amino acid residues are serine. The a - and (3 -
lipovitellins differ from each other in their phosphate content and in 
their ability to be dissociated into 2 subunits at alkaline pH (329 ). 
It is not altogether clear whether the presence of multiple forms of 
phosvitins and lipovitellins is the result of polypeptide heterogeneity 
or of different degrees of lipidation, glycosylation and phosphorylation. 
Characteristics of the induction of vitellogenin synthesis 
Vitellogenin is the only phosphoprotein present in significant 
amounts in the plasma of egg-laying vertebrate species, so determination 
of the amount of phosphorus covalently bound to plasma proteins repre-
(81, 250, 330) 
sents an estimate of the concentration of vitellogenin 
The synthesis of vitellogenin and the time course of the appearance of 
this complex protein in the blood of the oestrogenized male animal have 
been studied in detail in the domestic fowl and Xenopus laevis. In 
vivo and in vitro induction of hepatic vitellogenin synthesis by oes-
trogens is characterized by a lag period before vitellogenin is detectable. 
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In vivo studies in the cockerel have shown that after a single oestrogen 
injection, vitellogenin first becomes evident in the blood from about 
3 - 4 hours to about 20 hours later, depending on the sensitivity of the 
detection assay (141 ' 162 ' 163 ' 331 ), and increases in concentration to 
reach a peak after 3- 4 days (81 ' 141 ). The time course and magnitude 
of the response are affected by the hormone dose level (163 , 265 ), and 
the response of the cockerel is more rapid than that of the male Xenopus 
laevis, in which the response is slower and more extended (63 , 265 ). 
The lag phase is associated with the induced transcription and sub-
sequent translation on membrane-bound polysomes of mRNAs coding for 
't 11 . (163 ' 331 ' 332 ) f 11 db t t 1 t' 1 d'f' . Vl e ogen1n , o owe y pos - rans a 1ona mo 1 1cat1on 
of the nascent·protein in the endoplasmic reticulum and Golgi apparatus 
prior to its secretion (81 ' 99 - 106 ) It is generally considered that 
h h 1 t . after translatl'on (100, 101, 103, 104, 106) b t p osp ory a 10n occurs , u 
some workers have suggested that phosphoseryl tRNAs may be involved in 
the synthesis of vitellogenin (333 ' 334 ) In addition to increased 
synthesis of mRNA during this time, there is also increased production 
of rRNA and possibly tRNA (248 , 257 , 335 - 339 ). Conflicting views 
have been expressed as to whether DNA synthesis is required for the in-
duction of vitellogenin synthesis. Several workers have demonstrated 
enhanced DNA synthesis in the liver of the domestic fowl after oestrogen 
treatment (247 , 248 ' 257 ), whilst Green & Tata (152 ) have suggested that 
DNA synthesis and cell division are not required for the initial res-
ponse of the liver, but may be important for maintenance and amplifi-
cation of the response. Interestingly, the total DNA content of the 
livers of oestrogenized pullets has been shown to increase concomitantly 
with enhanced synthesis of vitellogenin (340 ). 
An interesting characteristic of the response of the livers of 
cockerels and male Xenopus laevis to oestrogen is the 'memory effect' 
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b d ft b t t t t t (81, 94, 100, 141, 163, o serve a er su sequen oes rogen rea men s 
247' 341) The 'memory effect' has a very long life-time and in the 
cockerel is undiminished even after 50 days ( 81 ) The lag phase before 
the appearance of vitellogenin in the blood is shortened with each 
successive injection, and an enhanced production of vitellogenin with 
successive injections has also been shown. This more rapid and enhanced 
vitellogenin synthesis has been ascribed to the persistence of the de-
methylated state of the vitellogenin genes (342 ' 343 ), to the more rapid 
and greater accumulation of vitellogenin mRNA with each successive in-
jection (148 , 265 ' 341 , 344), to a difference in the rate at which poly-
somes engaged in the synthesis of vitellogenin become functional (261 ), 
and to the pre~existence in subsequent inductions of initiation or elan-
gation factors (345 ) and special tRNAs (346 ) In Xenopus laevis it has 
been suggested that the more rapid and efficient expression of the 
vitellogenin genes during secondary oestrogen stimulation may be due to 
an alteration in the nuclear-cytoplasmic distribution of oestrogen re-
ceptor (265, 347). In addition, there may not be as great a necessity 
to synthesize endoplasmic reticulum and ribosomes for production of the 
protein during secondary oestrogen stimulation, as these structures may 
persist in the cell for some time after primary stimulation. 
Interestingly, the 'memory effect' has been found to be virtually 
absent in the duck (350), and although it is present in the oestro-
genized male Japanese quail it has been demonstrated that when male 
quail have been injected with successive injections of oestrogen 
(4·36 mg 17 S-oestradiol/100 g body wt./dose) an approximately equal 
amount of vitellogenin was synthesized each time (250 ) Gibbins & 
Robinson suggested that their lack of enhancement of vitellogenin pro-
duction with subsequent injections was because they had used a dose of 
oestrogen that stimulated vitellogenesis maximally in the quail, whilst 
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they suggested that other workers had used doses that caused sub-maximal 
stimulation of vitellogenesis in cockerels, and so successive injections 
were found to lead to cumulative effects (247 ). 
In the following account details are presented of changes in liver 
weight, liver DNA content, plasma triacylglycerol levels and protein-
bound phosphate levels of the plasma at various times after 17 13 -
oestradiol injection of male chicks. These observations were recorded 
primarily to ascertain that animals had responded to oestrogen treatment. 
The time courses of changes in these parameters were determined, so as 
to correlate these changes with the results of later investigations de-
signed to elucidate possible mechanisms involved in the oestrogen-
induced hypertriacylglycerolaemia. 
METHODS 
1. Animals 
* Day old male Hi-Sex chicks were obtained from a commercial hatchery 
and were reared to 2 - 6 weeks of age. The young birds were kept in a 
communal pen under constant illumination. From 2~ weeks of age, and 
throughout all experiments, birds were housed in groups of 3 - 6 in 
cages with raised wire floors. The environmental temperature was 19 -
21°C and a fixed photoperiod of artificial light was maintained. At 
the beginning of the study the photoperiod was 12 hours/day (7 am ~ 
7 pm), but under these conditions aggression became a problem. To re-
duce aggression, the photoperiod was decreased to 8 hours/day (9 am ~ 
5 pm) and dimmed red lighting was introduced in all reported work. 
Birds were fed ad libitum on standard chick crumbs (Dalgety 
** Spillers, Gold-Start Crumbs ACS) and were allowed free access to food 
* strain-cross White Leghorn ** see Appendix 
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and water until death. Whenever possible, birds were killed, by de-
capitation, around midday in order to minimize differences caused by 
diurnal effects and to ensure, as far as possible, a constant prandial 
state. 
Oestrogen-treated chicks were injected intramuscularly (pectoral 
muscle) with varying doses of 17 13-oestradiol dissolved in propane-1,2-
* dial. Control chicks received an equivalent volume of propane-1,2~diol 
* only. The inclusion of control, sham-injected birds was considered an 
important part of all experiments because of possible effects of handling 
and injection of propane-1,2-diol on metabolism. Goodridge (351 ) has 
described a significant stress response in sham-injected control chicks 
when compared with untreated controls, and lack of appropriate controls 
in experimental work can lead to speculative and perhaps incorrect con-
1 . (235) C USlOnS , 
A variety of plant oils have been used as the injection vehicles 
for oestrogens by a number of workers (114 , 139 , 231 , 235, 256, 295) 
The possible effects of these oils on lipid metabolism, even if only in 
the early stages following injection, favoured the use of non-lipid 
( 11 9 1 40' 296' 344) propane-1,2-diol as solvent in the present study ' 
particularly since the early events following oestrogenization were of 
major interest. 
All birds were weighed prior to sacrifice, and immediately after 
death livers were rapidly removed and weighed before proceeding with 
experiments. Portions of liver were weighed and stored frozen for 
future DNA estimation. Blood was collected from the severed necks of 
birds, and was mixed with tri-sodium citrate to prevent clotting (0·5 ml 
ice-cold 30% (w/v) tri-sodium citrate/3~- 4 ml blood collection). 
Plasma was collected by low-speed centrifugation at 4°C, and plasma 
samples were stored frozen for future triacylglycerol and protein-bound 
phosphate analyses. 
* 0·1 ml propane-1,2-diol / 100g body weight 
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2. Determination of DNA 
Liver samples were homogenized in 0·9% (w/v) NaCl (236 ). For each 
gram of liver, 10 ml of 0·9% (w/v) NaCl were added. From duplicate 
samples of this homogenate the DNA was precipitated, washed and extracted 
according to the procedure of Prashad & Cutler (352 ) The extracted DNA 
was assayed by the method of Burton (353 ) with slight modification. 
Acetaldehyde was omitted from the diphenylamine reagent and was added to 
the final assay as 0·2 ml of an aqueous solution (1 ·6 mg/ml) (354 ). 
A 2 ml aliquot of the DNA extract was mixed with 4 ml diphenylamine re-
agent and 0·2 ml aqueous acetaldehyde (1•6 mg/ml). Incubation was for 
18 hours at 30°C, after which the absorbance at 600 nm was measured in 
a Pye Unicam SPB-100 UV-vis spectrophotometer. Known amounts of stan-
dard DNA, and a blank containing 0·5 M-HC1D4 only, were treated in the 
same way. A calf thymus DNA preparation was used as standard. A 
stock solution of DNA was prepared by dissolving DNA in 0·5 M-HC1D4 to 
a concentration of 0·2 mg/ml. The DNA was solubilized by heating at 
70°C for 20 - 30 minutes, and standards of a variety of concentrations 
(0·025 - 0·2 mg/ml) were prepared by dilution with 0·5 M-HC104• 
3. Assay of plasma triacylglycerols 
Triacylglycerol levels in plasma samples were determined using the 
Sigma Diagnostic Kit procedure described in the Sigma Technical Bulletin 
No. 405 (355 ). The principle of the assay involves the extraction of 
triacylglycerols from plasma or serum samples into isopropanol, with re-
moval of interfering substances by a solid adsorbant. The triacyl-
glycerols are then subjected to the following reactions:-
(a) Triacylglycerol + KOH ~ Glycerol + Fatty acids 
(b) Glycerol + Periodate --7 Formaldehyde 
(c) Formaldehyde+ NH4+ + Acetylacetone --? Diacetyldihydrolutidine 
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Diacetyldihydrolutidine is yellow and exhibits maximum absorbance 
at 410 nm. Absorbance readings at 410 nm are proportional to the tri-
acy lgl ycerol concentration. 
The following solutions were made up and stored at 4aC:-
(1) 125 mg sodium m-periodate dissolved in 50 ml 2M-acetic acid 
(2) A chromogenic reagent prepared by mixing 2 M-ammonium acetate 
(20 ml), isopropanol (40 ml) and acetylacetone (0·15 ml). 
This reagent required ageing to obtain maximum colour in the 
final reaction and was kept for at least 18 hours before use. 
The solutions were replaced each month. 
Activated alumina (0·8 ± 0·2 g) was added to screw cap glass vials. 
Blank and standard assays were included along with duplicate test assays. 
Blank vials contained 5 ml isopropanol and 0·2 ml distilled water. 
Standard vials contained 4·8 ml isopropanol, 0·2 ml distilled water and 
0·2 ml triolein standard (300 mg triolein/100 ml anhydrous isopropanol). 
Test vials contained 5 ml isopropanol, and 0·2 ml plasma was added whilst 
gently swirling the vial contents. 
The vials were shaken manually for 5 minutes, and then the contents 
were centrifuged at low speed at 4ac to sediment the alumina. Aliquots 
of the clear supernatant (2 ml) were transferred to tubes, and 0·5 ml 
1 M-KOH was added to each with mixing. The tubes were incubated at 
Boac for 5 minutes and then cooled rapidly. Periodate solution (0·5 ml) 
was added to each tube with mixing. Exactly 10 minutes after the perio-
date addition, 3 ml chromogenic reagent were added with mixing. The 
tubes were capped with aluminium foil and incubated for 30 minutes at 
Boac. After rapidly cooling the tubes to room temperature, the absor-
bance of the solution at 410 nm was measured. Readings were completed 
within 20 minutes of the end of incubation. A standard curve was pre-
pared using a triolein standard of 300 mg/100 ml isopropanol. 
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Initially, plasma samples containing elevated triacylglycerol levels 
were diluted with 0·9% (w/v) NaCl, and 0·2 ml of the resulting diluted 
plasma was used for assay. However, when results for varying dilutions 
of a plasma sample were compared, it became apparent that increasing 
concentrations of plasma did not show corresponding increases in tri-
acylglycerol content, implying that triacylglycerols in the plasma were 
not being extracted quantitatively. With the enormous dilutions that 
were often needed when dealing with plasma from oestrogenized chicks, 
this posed a substantial problem. A more satisfactory approach was em-
played involving the extraction of total lipids from plasma samples 
using the method of Bligh & Oyer (356 ). Aliquots of the lipid extract 
were transferr~d to vials and were evaporated to dryness under a stream 
of nitrogen. Isopropanol (5 ml), water (0·2 ml) and activated alumina 
(0·8 ± 0·2 g) were added to each vial, and the assay procedure was con-
tinued as described above. 
4. Estimation of protein-bound phosphate in plasma 
The proteins in duplicate 0·1 ml aliquots of plasma were precipi-
tated with 2 ml ice-cold 10% (w/v) trichloroacetic acid (TCA). After 
centrifugation at 1550 g for 20 minutes at 4°C, lipid was removed from 
the protein precipitate by the following procedure (163 ). The precipi-
tate was washed with 2 ml ice-cold 10% (w/v) TCA, 2 ml acetone, twice 
with 2 ml ethanol/ether/chloroform (2:2:1, by val.), and then again with 
2 ml acetone. The phosphoprotein in the plasma was then assayed by 
measuring the alkali-labile phosphate content of the lipid-free protein 
precipitate. The protein precipitate was solubilized in 2 ml 1 M-NaOH 
and was heated at 100°C for 15 minutes. After cooling, the protein was 
re-precipitated with 2 ml ice-cold 20% (w/v) TCA and collected by centri-
fugation (100) The phosphate content of the resulting supernatant was 
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(357) determined by the inorganic phosphate method of Ames • Plasma 
sample~ were also taken through the procedure omitting the heating stage 
so as to give a measure of the inorganic phosphate content. Potassium 
dihydrogen orthophosphate was used as standard. 
RESULTS 
1. Changes in liver weight after oestrogen treatment 
The relationships between the body weight and the organ weights of 
an animal are affected by parameters such as the species, breed, sex and 
physiological ·state of the individual, and environmental and nutritional 
conditions. Nevertheless, it is generally observed that, at least in 
the normal young growing animal, an increase in body weight is accom-
panied by increases in internal organ weights. Matsuzawa (358 ) has ex-
tensively documented the changes in body weight and a variety of organ 
weights, including that of the liver, of growing male and female White 
Leghorn chicks during the first 20 weeks of life. 
The data presented in Fig. 1 illustrate the relationship between 
liver weight and total body weight for control (injected with propane-
1,2-diol) and untreated male Hi-Sex chicks aged 2- 6 weeks. The re-
gression equation for these data is:-
y = 0·029x + 2·081 
where y =liver weight (g) and x =total body weight (g). 
The correlation coefficient (r) of 0·928 is statistically significant 
(P < 0·001), indicating a very high degree of positive correlation 
between liver weight and body weight in these chicks. In Fig. 2 the 
data from Fig. 1 have been replotted to show the relationship between 
liver weight and body weight minus liver weight for control and untreated 
FIGURE 1 
The relationship between liver weight and total body weight of control 
and untreated male Hi-Sex chicks 
e values for control chicks 
• values for untreated chicks 
Control chicks had received a single intramuscular injection of 
propane-1,2-diol (0•1 ml/100 g body wt.) at varying times prior to 
sacrifice. 
Regression equation:-
y = 0·029x + 2·081 
where y = liver weight (g) and x = total body weight (g) 
Chicks were aged 2 - 6 weeks . 
Separate regression analyses for control and untreated birds showed that 
there was no significant difference between these groups . 
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FIGURE 2 
The relationship between liver weight and body weight minus liver weight 
for control and untreated male Hi-Sex chicks 
e values for control chicks 
~ values for untreated chicks 
Control chicks had received a single intramuscular injection of 
propane-1,2-diol (0·1 ml/100 g body wt.) at varying times prior to 
sacrifice. 
Regression equation:-
y = 0·030x + 2•194 
where y = liver weight (g) and x = body weight minus liver weight (g) 
Chicks were aged 2-6 weeks . 
Separate regression analyses for control and untreated birds showed that 
there was no significant difference between these groups , 
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chicks. In this case, the regression equation for the data is:-
y = 0•030x + 2·194 
where y = liver weight (g) and x =body weight minus liver weight (g). 
The high degree of positive correlation between liver weight and body 
weight minus liver weight is corroborated by the statistically signifi-
cant correlation coefficient of 0·923 (P < 0·001). 
A common way of expressing organ weights is as percentages of body 
weight rather than as absolute values. This method is particularly 
useful when comparing organ weights of animals with different body weights, 
since the differing body weights are taken into consideration. However, 
this procedure of comparison is not as simple as it might at first 
appear, since.organ weights are often not found to increase in direct 
proportion with total body weight. In the present study, this pheno-
menan has been observed with liver weight during the first few ·weeks of 
life of the male chick. The data presented in Fig. 3 illustrate the 
relationship between liver weight (as% of body wt.) and body weight for 
male Hi-Sex chicks aged 2 - 6 weeks. It is clear from this figure that, 
as the body weight increases, the liver weight comes to represent a 
lesser proportion of the total body weight. The regression equation 
for these data is:-
y = 4·324 - O·DD2x 
where y = liver weight (as% of body wt.) and x =total body weight (g). 
The correlation coefficient of -0·555 is statistically significant 
(P < 0·001), indicating a high degree of negative correlation between 
liver weight (as% of body wt.) and total body weight. A similar re-
(359) . lationship has been described by Raheja et al. 1n male White 
Leghorn chicks over the same age range. 
Several investigators have observed increases in liver weight after 
oestrogen treatment of chicks, and have expressed the liver weights as 
a percentage of body weight or as a proportion of body weight, withnut 
FIGURE 3 
The relationship between liver weight (as% of body wt.) and body weight 
of control and untreated male Hi-Sex chicks 
e values for control chicks 
A values for untreated chicks 
Control chicks had received a single intramuscular injection of 
propane-1,2-diol (0·1 ml/100 g body wt.) at varying times prior to 
sacrifice. 
Regression equation:-
y = 4•324 - 0·002x 
where y = liver weight (as% of body wt.) and x = total body weight (g) 
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taking into account the normal variation in these parameters during the 
. (166 256) growth.of ch1cks ' In the present study, birds were in-
jected with 1 mg 176-oestradiol/100 g body weight, and were sacrificed 
at varying times thereafter. Using the regression equation derived 
from the data presented in Fig. 2, the liver weight of an oestrogenized 
chick could be compared with the expected liver weight for a control or 
untreated bird of the same body minus liver weight. The results of 
such analyses are presented in Fig. 4, in which the percentage change in 
liver weight is plotted against the time after 176-oestradiol injection. 
These data clearly show increased liver weights with increasing time 
after hormone injection. A 50% increase in liver weight became evident 
after about 20 hours post-injection, and after about 40 hours some liver 
weights were found to be double those of equivalent control birds. 
Peak values were obtained at about 50 hours after injection, when liver 
weights were up to 2·4-fold greater than the weights expected if the 
chicks had not been treated with oestrogen. At times later than 50 
hours after injection the response appeared to be depressed. The 
livers of oestrogen-treated birds became noticeably larger, paler, 
fatty in appearance, and softer in texture with increasing time after 
176-oestradiol injection up to 50 hours. 
The data presented in Table 2 were obtained from an experiment in 
which each male chick received a single intramuscular injection of 176-
oestradiol (0·25- 1·25 mg/100 g body wt.) in propane-1,2-diol, and 
birds were sacrificed 48 hours after injection. Untreated birds, and 
control birds injected with an equivalent volume of propane-1,2-diol 
only, were also included. It can be clearly seen that there is a dose-
related increase in liver weight, as a percentage of body weight, over 
the dose range used. This trend is also evident when the varying body 
weights of the birds are taken into account and the results are expressed 
FIGURE 4 
The percentage change in liver weight of male Hi-Sex chicks at varying 
times after a single injection of 17 B-oestradiol (1 mg/100 g body wt.) 
Each chick received a single intramuscular injection of 1 mg 
17 S-oestradiol (in propane-1,2-diol)/100 g body weight. At the indi-
cated times after injection birds were sacrificed, and livers were 
removed and weighed. 
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TABLE 2 
The effect of varying doses of 17 S-oestradiol on the liver weights of male chicks sacrificed 2 days after injection 
Body weight (g) 
Liver weight (as % of 
body wt.) 
% increase in liver 
weight 
Age of chicks (days) 
17 S -oestradiol administered (mg/1 DO g body wt.) 
0 0 * 
Control Untreated 0·25 0·50 0·75 1 ·DO 
412 ± 15 395 ± 5 299 ± 7 348 ± 5 394 ± 17 396 ± 12 
3·51 ± 0·22 3·46 ± 0·05 3·97 ± 0·07 4·42 ± 0·12 5·00 ± 0·14 5·43 ± 0·12 
11 . 02 ± 1 . 85 27·65 ± 3·79 48·15 ± 4·99 62 ·01 ± 4 ·11 
37 36 31 32 33 34 
Values are the means (± S.E.M.) of 6 observations. 
*These values are the means (± S.E.M.) of 5 observations. 
1. 25 
390 ± 22 
6·09 ± 0·21 
82·10 ± 8·35 
35 
Ul 
ID 
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as the percentage increase in liver weight caused by oestrogenization. 
With a dose of 0·75 mg 17B-oestradiol/100 g body weight, liver weight 
increased by about 48% above that expected for untreated or control 
birds of the same size, whilst a dose of 1 ·25 mg hormone/100 g body 
weight resulted in an approximately 82% increase in liver weight. 
Subsequent experiments, in which male chicks were treated with a 
single intramuscular injection of 0·75 mg 17S-oestradiol/100 g body 
weight and sacrificed at varying times thereafter, illustrated a time-
related increase in liver weight as a percentage of body weight (Tables 
3 & 4). In the experiment presented in Table 3, birds were injected 
with 17 a-oestradiol in propane-1,2-diol and were killed between 3 and 
40 hours later. Untreated chicks were also included. An exception to 
the trend of a time-related increase in liver weight (as %of body wt.) 
is the mean value obtained at 14 hours after hormone injection which is 
lower than the value obtained at 6 hours. It should be noted that the 
chicks in this 14-hour group had the greatest body weights and, therefore, 
from the relationship between body weight and liver weight (as % of body 
wt.) presented in Fig. 3, it would be expected that the liver weights of 
untreated and control chicks of this size would represent a lesser pro-
portion of the total body weight than would be the case for smaller 
birds. Therefore, the response of the livers of these 14-hour birds 
may be camouflaged somewhat by presenting the liver weight data as a 
percentage of body weight. Consequently, the liver weight data were 
re-analyzed using the regression equation derived from the data illus-
trated in Fig. 2, and were presented as the percentage increase in liver 
weight after oestrogenization. A similar time-related trend was ob-
tained after this treatment of the liver weight data, with the mean 
value at 14 hours after injection being slightly lower than the value at 
6 hours. Comparison of the liver weight results of Table 3 with similar 
TABLE 3 
Liver weights and body weights of male chicks sacrificed at varying times after a single injection of 0·75 mg 
17 S-oestradiol in propane-1,2-diol/100 g body weight 
Time after 17 S-oestradiol injection (h) 
0 3 6 14 19 27 40 Unheated 
m 
--" 
Body weight (g) 380 ± 36 290 ± 10 316 ± 14 405 ± 20 340 ± 14 385 ± 25 295 ± 10 
Liver weight (as % 
of body wt.) 4·21 ± 0·47 4·23 ± 0·19 4·66 ± 0·17 4·43 ± 0·14 5 ·1 0 ± 0·27 5·23 ± 0·11 5·59 ± 0·30 
% increase in liver 
weight 
- 17·58 ± 5·24 32 ·13 ± 4·41 31 ·16 ± 4·63 47·45 ± 7·84 54·65 ± 3·95 57·93 ± 9·52 
Age of chicks (days) 34 28 30 35 32 33 29 
Values are the means (± S.E.M.) of 5 observations. 
TABLE 4 
Liver weights and body weights of male chicks sacrificed at varying times after a single injection of 0·75 mg 
17 S-oestradiol in propane-1,2-diol/100 g body weight or of propane-1,2-diol only 
Time after injection (h) 
* 3 6 14 26 
Untreated 
E c E c E c E c rn N 
Body weight (g) 396 ± 9 368 ± 31 393 ± 16 405 ± 22 400 ± 22 320 ± 15 323 ± 20 344 ± 18 358 ± 7 
Liver weight (as % 3·54 ± 4·00 ± 3·86 ± 4·01 ± 3·57 ± 4·54 ± 3·61 ± 5·03 ± 3·59 ± 
of body wt.) 0·06 0·22 0·13 0 ·1 0 0 ·11 0·18 0·06 0·26 0·17 
% increase in liver 15· 57 ± 18·26 ± 29·30 ± 45·89 ± 
weight - 5·67 - 3·05 - 5·49 - 9 ·12 
Age of chicks (days) 35 35 35 34 34 30 30 31 31 
E =values for chicks injected with 0·75 mg 17 S-oestradiol in propane-1,2-diol/100 g body weight. 
C =values for chicks injected with propane-1,2-diol only. 
Values are the means (± S.E.M.) of 5 observations. 
*These values are the means (± S.E.M.) of 4 observations. 
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results in Table 4 indicate that the abnormal value in Table 3 may, in 
fact, be the 6-hour value and not the 14-hour value. It should be noted 
at this stage that birds differed a great deal in the response of their 
liver weights to oestrogen treatment, as shown in Fig. 4. It can be 
seen that after oestrogen treatment some birds responded with a dramatic 
increase in liver weight, whilst some responded to a lesser extent and 
others appeared not to respond at all. The data presented in Table 3 
show that at 3 hours after 17 S-oestradiol injection the mean liver 
weight had increased by about 18% above that expected for untreated or 
control birds of the same size, whilst by 40 hours the increase was 
approximately 58%. 
The data·presented in Table 4 resulted from an experiment in which 
male chicks were given a single intramuscular injection of 0·75 mg 17 s-
oestradiol in propane-1,2-diol/100 g body weight, or of propane-1,2-diol 
only, and were sacrificed between 3 and 26 hours later. Untreated 
birds were also included. A time-related increase in liver weight (as 
%of body wt.) after oestrogenization was evident over this time range, 
although the mean value at 6 hours was virtually identical to the mean 
value at 3 hours after injection. At 14 and 26 hours after oestrogen 
treatment the mean liver weights (as% of body wt.) were progressively 
larger. The birds in the 6-hour oestrogen-treated group were heavier 
than the birds in the other oestrogen-treated groups, and therefore, as 
for the 14-hour group in Table 3, the response of the livers of these 
6-hour birds may be concealed to a certain extent by presenting the liver 
weight data as a percentage of body weight. This is confirmed by ex-
pressing the liver weight data as the percentage increase in liver weight 
after oestrogenization, since the mean value for the 6-hour oestrogenized 
group is then noticeably greater than the value for the 3-hour group. 
In this experiment, the mean liver weight had increased by about 18% at 
64 
6 hours after oestrogen injection and by almost 46% at 26 hours. A 
similar time-related increase in liver weight (as%of body wt.) was not 
observed for control birds, confirming that the phenomenon of increasing 
liver weight was the result of oestrogen treatment and was not caused by 
handling and/or injection of propane-1,2-diol. 
2. DNA content of the liver after oestrogen treatment 
The data presented in Fig. 5 illustrate the relationship between the 
liver weight and DNA content of the liver for control and untreated male 
Hi-Sex chicks. The regression equation for these data is:-
y = 3·837x - 7·604 
where y 2 DNA content of liver (mg) and x = liver weight (g). 
The correlation coefficient of 0·875 is statistically significant 
(P < 0·001), indicating a high degree of positive correlation between 
the DNA content of the liver and the liver weight. 
The increase in DNA content with increasing liver size 
represents DNA replication and cell division and a resulting increase in 
the number of liver cells, but may also reflect an increase in the number 
of polyploid cells. 
The increase in the liver weights of chicks after oestrogenization 
involves some cell division, but a substantial part of the increase in 
liver size and weight is considered to be due to the increase in volume 
of pre-existing cells as a result of water uptake and accumulation of 
lipid (242 ). The data presented in Fig. 6 show the DNA contents of the 
livers (mg DNA/g liver) of chicks sacrificed at varying times after a 
single intramuscular injection of 1 mg 17 S-oestradiol in propane-1,2-
FIGURE 5 
The relationship between liver weight and DNA content of the liver for 
control and untreated male Hi-Sex chicks 
e values for control chicks 
A values for untreated chicks 
Control chicks had received a single intramuscular injection of 
propane-1,2-diol (0·1 ml/100 g body wt.) at varying times prior to 
sacrifice. 
Regression equation:-
y = 3·837x - 7·604 
where y = DNA content of liver (mg) and x = liver weight (g) 
Chicks were aged 3- 6 weeks . 
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FIGURE 6 
The relationship between the liver DNA content (mg/g liver) of male Hi-
Sex chicks, injected with 17 B-oestradiol in propane-1,2-diol or with 
propane-1,2-diol only, and time after injection 
Oestrogen-treated·chicks received a single intramuscular in-
jection of 1 mg 17 B-oestradiol in propane-1,2-diol/100 g body weight 
at varying times prior to sacrifice. Control chicks received an 
equivalent volume of propane-1,2-diol only and were sacrificed at 
the times indicated. 
(a) values for untreated·chicks 
e values for control chicks 
(b) 0 values for oestrogen-treated chicks 
DNA was precipitated, washed and extracted from liver samples as 
described in the Methods section, and was assayed by a minor modifi-
cation of the method of Burton (353 ) 
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diol/100 g body weight, or of an equivalent volume of propane-1,2-diol 
only. A time-related decrease in the DNA content of a unit weight of 
wet liver is evident for chicks that had received 17S-oestradiol at 
varying times up to 50 hours before death. A time-related decrease in 
liver DNA content (mg/g liver) after injection was not evident for con-
trol birds, indicating that the decrease in DNA content of a unit 
weight of wet liver was the result of oestrogen treatment and not of 
handling and/or injection of propane-1,2-diol. The liver DNA content 
for control and untreated birds ranged from 2·35 to 4·66 mg/g liver, 
with a mean value of 3·16 ± 0·04 (S.E.M.). 
The data presented in Fig. 7 illustrate the relationship between 
the percentage change in the liver weights of chicks after oestrogen-
ization and the DNA content of the liver (mg/g liver). It is evident 
that as the liver weight increases after oestrogen treatment the DNA 
content of a unit weight of the wet liver decreases, confirming that 
cell expansion contributes substantially to the increase in liver weight. 
The regression equation for these data is:-
y = 124·909 - 34·951x 
where y = the percentage change in liver weight and x = the liver DNA 
content (mg/g liver). 
The correlation coefficient of -0·630 is statistically significant 
(P < 0·001), indicating a high degree of negative correlation between 
the percentage increase in liver weight and the DNA content of a unit 
weight of the liver. The lowest liver DNA content recorded was 1·79 
mg/g liver, which was the result for a chick injected with 1 mg 17S-
oestradiol/100 g body weight 27 hours before sacrifice. The liver 
weight of this chick was approximately 69% greater than that expected 
for an untreated or control chick of the same size, and represented 
5·68% of the total body weight. 
FIGURE 7 
The relationship between the percentage change in liver weight of male 
Hi-Sex chicks caused by oestrogen treatment and the DNA content of the 
liver (mg/g liver) 
Chicks received a single intramuscular injection of 1 mg 17S-
oestradiol in propane-1,2-diol/1DD g body weight at varying times 
before sacrifice. After killing, livers were removed, weighed and 
samples were taken for the assay of DNA. DNA was precipitated, 
washed and extracted from liver samples as described in the Methods 
section, and was assayed by a minor modification of the method of 
Burton (353 ) 
Regression equation:-
y = 124•909 - 34·951x 
where y = percentage change in liver weight after oestrogen treatment 
and x = liver DNA content (mg/g liver) 
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3. Plasma triacylglycerol levels after oestrogen treatment 
Besides the changes in liver size and weight resulting from oes-
trogen treatment of male chicks which are readily apparent to the inves-
tigator, another noticeable change occurring after oestrogenization is 
the development of a cream-coloured clouding of the plasma. This tur-
bidity is caused by accumulating lipid in the plasma, the bulk of which 
is triacylglycerol existing predominantly in the form of VLDL, which ori-
ginate from the liver and are the result of enhanced hepatic VLDL syn-
thesis (113 - 115, 118, 236, 242, 252) The data presented in Fig. 8 
show the plasma triacylglycerol concentrations of male chicks at varying 
times after a single intramuscular injection of 1 mg 17 s-oestradiol in 
propane-1,2-diol/100 g body weight or of an equivalent volume of propane-
1,2-diol only. The plasma triacylglycerol concentrations for control 
and untreated chicks ranged from 15 to 334 mg/100 ml plasma, with a mean 
value of 94·3 ± 4·7'(s.E.M.). These values are comparable with those 
presented for control and untreated chicks by other research workers 
(46, 113,117,174,254,360, 361) In the present study, the plasma 
concentrations of triacylglycerol for oestrogen-treated birds began to 
diverge noticeably from control values after about 10 hours post-
injection, and increased progressively up to 50 hours after 17 s-
oestradiol injection (Fig. 8). No such increase was evident for con-
trol birds. The values for oestrogenized chicks first became signifi-
cantly greater than control values at 5 - 7! hours post-injection 
( p < 0 ° 05) 0 The highest plasma triacylglycerol concentration was ob-
tained for a chick injected with 1 mg 17 s-oestradiol/100 g body weight 
at approximately 49 hours before sacrifice, in which the value reached 
3070 mg/100 ml plasma. This represents an approximately 33-fold in-
crease in the triacylglycerol concentration of the plasma as compared 
with the mean control value. 
FIGURE 8 
Concentration of triacylglycerol in the plasma (mg triacylglycerol/ 
100 ml plasma) of male Hi-Sex chicks at varying times after injection 
of 17 S-oestradiol in propane-1,2-diol or of propane-1,2-diol only 
Oestrogen-treated chicks received a single intramuscular in-
jection of 1 mg 17 S-oestradiol in propane-1 ,2-diol/100 g body weight 
at varying times prior. to sacrifice. Control chicks received an equi-
valent volume of propane-1,2-diol only and were sacrificed at the 
times indicated. 
A values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
Blood was collected and plasma was prepared as described in the 
Methods section. Total lipids were extracted from the plasma samples 
using the method of Bligh & Dyer (356 ). Triacylglycerol levels in the 
lipid extracts were determined as described in the text, using the 
Sigma Diagnostic Kit procedure detailed in the Sigma Technical Bulletin 
No. 405 (355 ) 
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4. Plasma protein-bound phosphate levels after oestrogen treatment 
Another plasma parameter that changes after oestrogen treatment of 
chicks is the concentration of protein-bound phosphate. The results 
presented in Fig. 9 clearly show that at about 17~ hours after 17 S-
oestradiol injection (1 mg hormone/100 g body wt.) the plasma concen-
tration of protein-bound phosphate begins to diverge from control values, 
and increases progressively up to about 42~ hours. Values remained 
high up to 55 hours post-injection, which was the longest time investi-
gated. Values for oestrogenized chicks first became significantly 
greater than control values at 14- 18 hours post-injection (P < 0·02). 
The only phosphoprotein present in any significant amount in the plasma 
of oviparous vertebrates is vitellogenin (81 ' 250 ' 330 ), and therefore, 
the concentration of phosphate covalently bound to plasma proteins can 
be used as an estimate of the concentration of vitellogenin in plasma. 
The plasma protein-bound phosphate concentrations for control and un-
treated chicks ranged from 0·17 to 0·43 ~moles/ml plasma, with a mean 
value of 0·26 ± 0·01 (S.E.M.). The highest plasma concentration of 
protein-bound phosphate was obtained for a chick injected with 1 mg 17S-
oestradiol/100 g body weight at approximately 42 hours before sacrifice, 
in which the value reached 2·10 ~moles/ml plasma. This represents an 
approximately 8-fold increase in the concentration of protein-bound 
phosphate in the plasma as compared with the mean control value. 
FIGURE 9 
Concentration of protein-bound phosphate in the plasma (wmol/ml plasma) 
of male Hi-Sex chicks at varying times after injection of 17 S-
oestradiol in propane-1,2-diol or of propane-1,2-diol only 
Oestrogen-treated·chicks received a single intramuscular in-
jection of 1 mg 17 S-oestradiol in propane-1,2-diol/100 g body weight 
at varying times prior to sacrifice. Control chicks received an equi-
~alent volume of propane-1,2-diol only and were sacrificed at the times 
indicated. 
~ values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
Blood was collected and plasma was prepared as described in the 
Methods section. Plasma protei~s were precipitated and lipid was 
removed from the protein precipitate as described in the text. The 
alkali-labile phosphate content of the lipid-free protein precipitate 
was determined by the method of Ames (357 ) 
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l . 
DISCUSSION 
1. Changes in liver weight during growth and after oestrogen treatment 
The positive correlation between the liver weights and total body 
weights of untreated and control chicks, illustrated in Fig. 1, is in 
agreement with the observations of Matsuzawa (358), who has described 
the changes in weights of a number of organs during the first 20 weeks 
of life of White Leghorn chicks. The body weights of male birds of 
this breed were very similar to the body weights recorded in the present 
study for male Hi-Sex chicks of the same age. Matsuzawa observed an 
increase in liver weight in both sexes concurrently with increased body 
weight during.the course of his study. The various organs differed 
somewhat in the time courses of their weight increases, with some in-
creasing in weight rapidly over the first few weeks and then increasing 
more slowly latterly, whilst others increased in weight until a certain 
age after which they remained constant or decreased in weight. Differ-
ences in the weight increments of organs were also observed between the 
sexes. For example, heart weight increased in both sexes over the 
first 18 weeks, but after 6 weeks the heart weights of male birds were 
about 1 ·5-fold greater than those of female birds. Although the body 
weights of female birds were less than those of male birds after 4 
weeks of age, the differences in body weight between the sexes were not 
as pronounced as the differences in heart weight. The brain weights of 
females were again less than those of males after 4 weeks of age, but in 
both sexes the brain weight increased up to 12 weeks and was constant 
thereafter. The weights of the pancreas and spleen increased rapidly 
during the first 10 weeks of life and increased more slowly after this. 
Two organs that increased in weight up to a certain age and then re-
gressed were the bursa Fabricii and the thymus gland. The most rapid 
74 
increase in liver weight for chicks of both sexes was between 2 and 10 
weeks of age. 
The examples presented above are just a few representative obser-
vations noted by Matsuzawa, and illustrate the variability of the 
growth patterns of different organs with increasing age and body weight 
in the domestic fowl. These data show that organ weights may increase 
in proportion with the weight of the whole body at certain stages of 
development, but that this relationship may not be upheld at other 
times. This leads to difficulties as to the best way of expressing 
organ weights of growing animals, with different body weights, for com-
parison. Many workers have expressed organ weights as percentages or 
proportions of total body weight after exposing animals to various con-
. . . ( 1 66 250 252 256 ditions which result 1n changes 1n organ we1ghts ' ' ' ' 
359, 360) Although the comparison of such values for animals of the 
same total body weight may be considered to be valid, the data presented 
in Fig. 3 show that liver weight, at least, declines as a percentage of 
total body weight as body weight increases in normal growing chicks. 
It is interesting at this point to note the similarity between these 
results and the results of Raheja et al. (359 ), who observed that in day 
old male White Leghorn chicks the liver weight represented a high pro-
portion of body weight. This proportion increased still further during 
the first week of life, and then declined steeply to about 4 weeks of 
age and more gradually thereafter to a constant level at the 14th week. 
It is well-known that oestrogen treatment of male and immature fe-
male birds results in increased liver weights some hours later (5B, 124 , 
162, 166, 174, 242- 248, 250 ), and similarly, endogenous oestrogens 
cause the livers of laying hens to be larger than those of non-laying 
hens and male birds (58 ' 125 ' 164 ) It would, therefore, be possible 
to treat a large chick with oestrogen and to observe an increase in 
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liver weight (as% of body wt.) compared with that of a control bird of 
the same body weight, but if compared with the liver weight (as % of body 
wt.) of a smaller control bird it might be assumed that no change had 
occurred if the relationship presented in Fig. 3 was not taken into 
account. It is, therefore, important to present data for body weights 
if expressing liver weights as a percentage or proportion of body weight. 
In the present study, chick liver weights after oestrogenization were ex-
pressed predominantly as percentage increases in liver weight as compared 
with the liver weights of control birds with the same body minus liver 
weight, since the body weights of the birds varied a great deal. 
The data illustrated in Fig. 4 were deduced using the regression 
equation derived from the data presented in Fig. 2, in which the liver 
weights of control and untreated chicks were plotted against the values 
of body weight minus liver weight. This regression equation enables a 
more accurate calculation of the liver weights that would have been ex-
pected for oestrogen-treated chicks had oestrogen not been administered 
than that derived from the data presented in Fig. 1. This is because 
the livers of oestrogenized birds can contribute substantially more to 
the total body weight than do the livers of control and untreated birds, 
and from Fig. 1 no allowance can be made for this phenomenon. This 
procedure is based, however, on the assumption that the injection of 
17S-oestradiol does not increase the weights of other organs in the male 
chick and lead to a general increase in body weight. This may not be 
the case, since some investigators have noted that oestrogenization in-
. . (82 174 246 362) 
creases the food 1ntake of the domest1c fowl ' ' ' • In 
addition, the large amounts of lipid produced by the liver of the oes-
trogenized male and immature female chicken accumulate in the blood, and 
some may be deposited in the adipose tissues which would consequently 
increase in weight. (254) On the other hand, Coleman et al. found no 
difference in the average body weight gain between control and oestro-
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genized chicks after treating 6 to 11-day old chicks with 2 mg diethyl-
stilbestrol in sesame oil, or with sesame oil only, each day for 5 days. 
A time-related increase in the liver weights of chicks up to 50 
hours after the injection of 1 mg 17 S-oestradiol/100 g body weight is 
shown in Fig. 4. A similar time-related increase in the liver weights 
of chicks was obtained up to 40 hours after the injection of 0·75 mg 
17 S-oestradiol/100 g body weight (Tables 3 & 4). Other workers have 
obtained comparable trends for liver weight, comb weight and oviduct 
weight of the immature female chicken after treatment with gonadal hor-
(166, 256, 363) (166) 
manes • For example, Balnave & Pearce injected 
4-week old pullets with 2 mg oestradiol dipropionate on alternate days 
for 9 days, and presented organ weights as proportions of body weight. 
These workers did not obtain any difference in liver weight between 
control and oestrogenized birds during the first 12 hours after hormone 
treatment. However, after 24 hours and up to 4 days after the beginning 
of hormone treatment, liver weight was found to progressively increase. 
The response was reduced considerably by the 9th day of oestrogen treat-
ment. Increases in liver weight were only observed for birds receiving 
oestrogen. Treatment of 4-week old pullets with 2 mg testosterone pro-
pionate on alternate days over a period of 9 days resulted in a time-
related increase in comb weight, as a proportion of body weight, from 
the 2nd day until the end of the experiment. Both treatment with oes-
tradiol as described above, and similar treatment of the immature pullets 
with 2 mg oestradiol dipropionate and 1 mg testosterone propionate to-
gether, produced a time-related increase in oviduct weight from 24 hours 
after hormone injection through to the 9th day of hormone treatment. 
On the 4th and 9th days of hormone treatment, the oviduct weights of 
the birds treated with oestradiol and testosterone were significantly 
greater than those of birds treated with oestradiol alone, illustrating 
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the enhancement of oestrogen-induced oviduct growth by testosterone. 
Pearce & Balnave (256 ) also noted time-related increases in oviduct 
weights and liver weights of 4-week old pullets treated with a variety 
of doses of oestradiol dipropionate (0·5- 4 mg hormone/bird). Organ 
weights were determined 2 days after a single injection of oestrogen, 
and 8 days after the commencement of hormone treatment, during which 
time oestrogen was administered on alternate days. At all dose levels, 
both oviduct weight and liver weight were greater after 8 days than 
after 2 days of hormone treatment. 
Time-related increases in liver weight have also been observed 
after oestrogen treatment of male birds of other species. For example, 
Gibbins & Robinson (250 ) injected 3 to 5-month old male Japanese quail 
with a single dose of 4·36 mg oestradiol/100 g body weight, and ob-
served a near doubling of liver weight by the 4th day after oestrogen 
treatment, but the response decreased at longer time intervals. 
Similarly, Dashti et al. (252 ) treated 19-day old male turkeys with a 
single injection of diethylstilbestrol (4 mg/100 g body wt.) and ob-
served a time-related increase in liver weight (as% of body wt.) up to 
48 hours after injection, followed by a decreased response at 72 hours. 
The data presented in Table 2 illustrate a dose-related increase 
in the liver weights of oestrogen-treated male chicks over the dose 
range 0·25- 1·25 mg 17S-oestradiol/100 g body weight. Birds were in-
jected with a single dose of hormone and were sacrificed 48 hours later. 
Similar dose-related trends in liver weight and oviduct weight were ob-
tained by Pearce&Balnave (256 ), who injected 4-week old pullets with 
varying doses of oestradiol dipropionate (0·5 - 4 mg/bird) and sacrificed 
the birds 48 hours after a single injection or 8 days after the commence-
ment of hormone treatment, during which time the birds received a 
hormone injection on alternate days. After 2 days of oestrogen 
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treatment, oviduct weight (as% of body wt.) increased up to a dose of 
1 mg oestradiol dipropionate, and with the higher doses the increase in 
weight was less. After 8 days of oestrogen treatment, oviduct weight 
increased progressively with increasing dose level. Liver weight (as 
%of body wt.) after 2 days of oestrogen treatment increased up to a 
dose of 2 mg oestradiol dipropionate and the response was depressed with 
a dose of 4 mg. A similar response pattern was observed after 8 days 
of hormone treatment. ( 164) As noted previously, Balnave observed an 
'over-reaction' of immature female chickens to exogenous oestrogen such 
that the liver weights were greater than those of mature laying hens. 
These observations suggest that large oestrogen doses and extended 
times of oestrogen treatment may lead to pharmacological effects rather 
than to a simulation of the situation existing in the laying hen. A 
decrease in liver weight after treatment with high oestradiol doses was 
not found in the present study, although a similar range of oestradiol 
dose levels was administered. The body weights of the birds used by 
Pearce & Balnave (256 ) for the 2-day hormone treatment experiment were 
approximately 250 g. Taking into account the different forms of oes-
tradiol used by these workers and used in the present study, Pearce & 
Balnave (256 ) injected oestradiol up to a dose of about 1·13 mg/100 g 
body weight. With this dose the liver weight response was depressed 
compared with that observed with a dose of approximately 0·57 mg 
oestradiol/100 g body weight. Contrary to this, in the present study 
oestradiol was administered up to a dose level of 1·25 mg/100 g body 
weight without any sign of a reduced response at the higher dose levels. 
The difference between the results of these two studies may be related 
to the sexes of the birds used, since Pearce & Balnave (256 ) used 
immature females, whilst male chicks were used in the present study. 
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2. DNA content of the liver during growth and after oestrogen treat-
ment 
The relationship between the total DNA content of the 
liver and the liver weights of control and untreated male chicks, illus-
trated in Fig. 5, represents another instance of a relationship that 
could be easily over-simplified in the absence of adequate information. 
From the data in Fig. 5, it would appear that cell division is more im-
portant in bringing about an increase in weight as livers get larger, 
and that the accumulation of materials such as water, lipid and glycogen 
may contribute substantially to the increase in weight in smaller livers. 
In addition, the development of blood vessels and connective tissue at 
this stage may lead to these structures representing a large proportion 
of the smaller livers. These components may not represent such a large 
proportion of the larger livers, in which dividing parenchymal cells 
may contribute more substantially to the liver weight. On the other 
hand, or in addition to the possibility of the above differences be-
tween small and large livers, there may be an increased incidence of 
polyploidy as the liver enlarges. Somatic polyploidy has been shown 
to be a common developmental feature of endocrine target tissues, in-
cluding vertebrate liver (364 ). 
The mean value (± S.E.M.) for the DNA content of the livers of 
control and untreated chicks was derived from the data presented in 
Fig. 6(a) and was found to be 3·16 ± 0·04 mg/g liver. This mean value 
is similar to the mean value of 3·46 mg DNA/g liver quoted by Hawkins 
& Heald (236 ) for the 9 to 16-week old immature hen. The decrease in 
DNA content of a unit weight of male chick liver after oestrogen treat-
ment (Fig. 6(b)) is in agreement with results obtained by Hawkins & 
Heald (236 ) for oestrogen-treated female chicks. These investigators 
injected 11-week old pullets with 2 mg oestradiol monobenzoate on al-
ternate days for 7 days, and on average obtained an approximately 33% 
80 
reduction in the DNA content of a unit weight of liver. The lowest 
DNA value reported for an oestrogenized pullet in their study was 
2·40 mg DNA/g liver, whereas the lowest in the present study was 
1 ·79 mg/g liver. The 'DNA-lowering' effect of oestrogen is also evi-
dent in the liver of the laying hen aged 23 - 32 weeks, for which Hawkins 
(236) & Heald reported a mean value of 2·50 mg DNA/g liver. These re-
sults indicate that uptake of water and accumulation of lipid contri-
bute substantially to the increase in liver size observed as the hen 
comes into lay and after oestrogen treatment of immature male and fe-
male birds. 
3. Plasma triacylglycerol and protein-bound phosphate levels after 
oestrogen treatment 
The development of turbidity in the plasma of oestrogen-treated 
chicks, resulting from the accumulation of lipid, first becomes evi-
dent about 12 hours after the injection of 1 mg 17 S-oestradiol/100 g 
It is I i kely that 
body weight (Fig. 8). A this lipid is of hepatic origin and comprises 
predominantly triacylglycerol in the form of VLDL (113 - 115 , 117, 118, 
122, 236, 242) The values for the plasma triacylglycerol concen-
tration of control and untreated chicks obtained in the present study 
(15- 334 mg/100 ml plasma) are similar to the levels observed by other 
research workers. ( 113) For example, Kudzma et al. presented a mean 
value of 27 mg triacylglycerol/100 ml plasma for chicks that had re-
ceived an injection of sesame oil each day for 18 days from the age of 
5 days. In another experiment, these workers injected chicks with 
sesame oil daily over 6 days, and observed plasma triacylglycerol levels 
ranging from 84 ± 6 to 236 ± 25 mg/100 ml plasma (means± S.E.M.). 
Plasma triacylglycerol levels of 39 - 168 mg/100 ml were obtained by 
Kudzma et al. (117 ) for untreated 9-week old female chickens. Coleman 
et al. (254) injected 6 to 11-day old chicks with a daily dose of sesame 
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oil for 5 days, and recorded a serum triacylglycerol concentration of 
151 ±51 mg/100 ml (mean± S.D.). Other workers have claimed sex 
differences in the levels of plasma triacylglycerol in chicks, and also 
differences with age. Pearson & Butler (174) injected male and female 
chicks aged 6 - 7 weeks with 5 doses of 0·5 ml 95% (v/v) ethanol given 
at 3-day intervals, and obtained mean plasma triacylglycerol levels 
(± S.E.M.) of 90 ± 7 mg/100 ml for female chicks, and 79 ± 10 mg/100 ml 
(360) for male chicks that were fed ad libitum. Raheja has reported 
plasma triacylglycerol levels for untreated chicks ranging from 85·7 ± 
7·98 to 104·8 ± 4•97 mg/100 ml (means± S.E.M.) for 5-week old chick_s, 
and somewhat lower values of 70·4 ± 3·29 to 75·2 ± 4·93 mg/100 ml (means 
± S.E.M.) for·14-week old chicks. 
The treatment of chicks with 1 mg 17 S-oestradiol/100 g body 
weight, and sacrifice of the birds up to 55 hours after hormone admini-
stration, resulted in increased plasma triacylglycerol levels up to 33-
fold greater than the mean level observed for control and untreated 
chicks, with the highest value reached being 3070 mg/100 ml plasma 
(Fig. 8). These increases are moderate compared with those obtained 
by other workers after chronic treatment of chickens with oestrogen. 
( 113) For example, Kudzma et al. demonstrated a dose-related increase 
in plasma triacylglycerol levels after treating 5-day old chicks with 
0·1, 1 ·0 or 5·0 mg diethylstilbestrol/day for 18 days. The mean level 
obtained with the 5 mg dose was 12,371 mg triacylglycerol/100 ml plasma, 
which represented an approximately 458-fold increase compared with the 
value for control chicks. However, other results obtained by these 
workers are lower than those obtained in the present study. For 
example, some chicks were injected with a daily dose of 0·5 mg diethyl-
stilbestrol over a period of 6 days, and groups of birds were sacrificed 
24 hours after each injection during this time. Plasma triacylglycerol 
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levels increased progressively with the duration of hormone treatment, 
and 24 hours after the 6th injection the mean triacylglycerol level 
(± S.E.M.) was 2288 ± 229 mg/100 ml plasma. This represented an 
approximately 27-fold increase above the mean value for control chicks. 
Pearson & Butler (174 ) also showed a dose-related increase in plasma 
triacylglycerol concentration for female chicks aged 6 - 7 weeks which 
were treated with oestrogen and fed ad libitum. These birds received 
an injection of 0•25, 0·5 or 1 mg 17S-oestradiol dipropionate/100 g 
body weight at 3-day intervals until a total of 5 injections had been 
administered, and birds were sacrificed 2 days after the last injection. 
The highest dose of 17S-oestradiol dipropionate (1 mg/100 g body wt.) 
caused a substantial increase in plasma triacylglycerol concentration to 
a value of 4350 ± 489 mg/100 ml plasma (mean± S.E.M.), which represents 
a 48-fold increase above the mean value for control chicks. The 
highest value obtained by these workers for the plasma triacylglycerol 
concentration of ad libitum-fed oestrogenized male chicks was 5870 ± 
914 mg/100 ml plasma (mean± S.E.M.), which was evident after the admini-
stration of 17S-oestradiol dipropionate (1 mg/100 g body wt.) at 3-day 
intervals on 4 occasions, and killing of the birds 2 days after the 
final dose. This represented an approximately 74-fold increase in the 
concentration of plasma ttiacylglycerol compared with the mean value for 
control male birds. 
Coleman et al. (254 ) injected 6 to 11-day old chicks with a daily 
dose of 2 mg diethylstilbestrol for 5 days, and recorded a serum tri-
acylglycerol level of 7313 ± 1769 mg/100 ml serum (mean± S.E.M.). 
This represented an approximately 48-fold increase compared with the 
mean value obtained for control birds. Dashti et al. (365 ) observed a 
similar increase (43-fold) in the plasma triacylglycerol concentration 
of 19-day old male turkeys after treatment with diethylstilbestrol for 
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2 days. In a later publication, Oashti et al. (252 ) reported a 30-
fold increase in the plasma triacylglycerol concentration of 19-day old 
male turkeys 24 hours after the injection of 4 mg diethylstilbestrol/ 
100 g body weight, and this was elevated to a 55-fold increase by 48 
hours. A 2·3-fold increase in plasma cholesterol was also observed by 
these workers at 48 hours after hormone treatment. It is interesting to 
note that the control plasma triacylglycerol concentrations of these 
turkeys were somewhat lower than values obtained by others for control 
domestic fowl chicks. 
The treatment of 3-week old male chicks with 1 mg 17S-oestradiol 
by Chan et al. (206 ) resulted in increased plasma triacylglycerol levels, 
which reached .a maximum of about 1400 mg/100 ml plasma at approximately 
48 hours after hormone injection. Treatment of male chicks of the same 
age with 5 mg 17S-oestradiol resulted in a mean level of 2780 mg tri-
( 116) 
acylglycerol/100 ml plasma after 48 hours • These authors also ob-
served an initial decrease in plasma triacylglycerol concentration over 
the first 2 or 3 hours after oestrogen administration (115 , 116 ). An 
interesting observation arising from the present study was the slight 
elevation in control plasma triacylglycerol concentrations up to about 
6~ hours after injection, which may have been caused by handling and/or 
injection of propane-1,2-diol. 
The administration of oestrogens to male and immature female birds 
is considered to cause physiological changes similar to those existing 
in the laying hen. ( 231) Kelley et al. have recorded a mean plasma 
triacylglycerol level for laying turkeys of 1974 mg/100 ml plasma, which 
is somewhat lower than many of the values mentioned above for oestro-
genized male and immature female chickens. Triacylglycerol levels, 
however, are undoubtedly higher than this in the hen just prior to the 
commencement of laying, when plasma lipids in general are at their 
h . h t 1 1 (55, 57, 127, 236) 19 es eve s 
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Increases in plasma triacylglycerol concentration are also observed 
(134 366) in mammalian species treated with oestrogens ' , and of parti-
cular interest are the elevations in plasma triacylglycerol levels ob-
d . . . t t t t ( 1 33' 1 82 - 1 84' 207' 21 8' serve 1n women rece1v1ng oes rogen rea men 
219, 229) Usually, contraceptive steroids cause only slight increases 
in fasting levels of plasma triacylglycerol, phospholipid and cholesterol, 
and the triacylglycerol concentration remains within the normal range, 
the upper limit of which is 150 mg triacylglycerol/100 ml plasma (184). 
(207) Gershberg et al. reported an increase in serum triacylglycerol 
levels of about 21% after premenopausal women had received oral contra-
ceptive treatment for 3 months. The effects of long-term oestrogen 
treatment of normal premenopausal women were recorded by Kekki & 
Nikkila (218 ), who observed that after 4 years of treatment, the mean 
plasma triacylglycerol concentration was increased from about 75 to 
125 mg triacylglycerol/100 ml plasma. Contrary to the situation in the 
majority of women, occasionally, ih women with a pre-existing endogenous 
hypertriacylglycerolaemia, a massive increase in plasma triacylglycerol 
concentration occurs after oestrogen treatment. For example, Glueck 
et al. (367 ) treated a woman with familial type V hyperlipoproteinaemia 
with 3 mg diethylstilbestrol/day, and the level of plasma triacylgly-
cerol rose to 5200 mg/100 ml plasma. A fortnight after finishing treat-
ment the triacylglycerol level had declined to 852 mg/100 ml plasma. 
In another patient with mild endogenous hypertriacylglycerolaemia, 
Zorrilla et al. (182 ) observed a plasma triacylglycerol concentration of 
221 mg/100 ml plasma, and after 6 months of combined oestrogen and pro-
gestagen treatment the level had reached 1948 mg triacylglycerol/100 ml 
plasma. Similar massive increases in plasma triacylglycerol levels 
have been observed in postmenopausal women on oestrogen supplementation, 
and Glueck et al. (219 ) have observed plasma triacylglycerol levels 
ranging from 222 to 3840 mg/100 ml plasma in such women. 
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The concentration of protein-bound phosphorus or phosphate in the 
plasma of birds has been used by many investigators as a measure of the 
concentration of vitellogenin, since this is the only phosphoprotein 
present in any significant amount in the plasma of oviparous vertebrates 
(81, 250, 330) The highly phosphorylated nature of the phosvitin 
moiety of the molecule provides a valuable marker for its detection and 
quantification. The data presented in Fig. 9 show a time-related in-
crease in plasma phosphoprotein concentration from approximately 17~ 
hours to 42~ hours after treating male chicks with a single injection 
of 17 S-oestradiol (1 mg/100 g body wt.). From this figure it is evi-
dent that a lag period of about 17~ hours exists between the time of 
oestrogen injection and the appearance of detectable changes in phos-
phoprotein concentration, which is due to vitellogenin, in the blood. 
Similar lag periods have been observed by other workers after primary 
oestrogenization of male birds ( 81 ' 368 ). For example, Gruber (368 ) 
reported that cockerels of 2 kg body weight injected with 12·5 mg oes-
tradiol exhibited a lag phase of 15 - 20 hours before the phosphoprotein 
content of the plasma was elevated. Jailkhani & Talwar (162 ) observed 
a lag phase of about 24 hours before the appearance of detectable 
amounts of vitellogenin in the circulation, after treating cockerels 
with 2 mg 17 S-oestradiol/100 g body weight. A similar lag period was 
observed by Maenpaa & Bernfield (335 ) after treating cockerels with a 
dose of 1 mg 17 S-oestradiol benzoate/100 g body weight. The length 
of the lag period obviously depends upon the sensitivity of the pro-
cedure used to determine the vitellogenin content of the blood. 
Gruber (243 ) injected oestrogen-treated cockerels with 32P-phosphate at 
various times after the hormone injection, and measured the incorpor-
ation of radioactivity into phosvitin. This method is more sensitive 
than the chemical assay of protein-bound phosphate, and elevated plasma 
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phosphoprotein levels were observed after 5 - 7 hours using this tech-
nique, although vitellogenin synthesis starts 3 - 4 hours after hormone 
. . t. ( 81 ) Th 1 h . . d lnJec 1on • e ag p ase 1s cons1dere to be associated with 
transcription and translation of mRNA sequences coding for vitellogenin, 
followed by post-translational modification of the protein prior to 
secretion into the blood. These post-translational modifications 
occur in the endoplasmic reticulum and Golgi apparatus during the 
passage of the protein towards the cell surface. It is generally con-
sidered that phosphorylation of phosvitin occurs after translation (100 ' 
1 01 ' 1 03' 1 04' 1 06) 
, although some workers have suggested that phosphate 
is incorporated into the vitellogenin molecule by means of phosphoserine 
tRNAs ( 333, 33.4) • 
Comparison of Figs. 8 and 9 shows that the increase in plasma tri-
acylglycerol concentration after oestrogen treatment of male chicks be-
comes evident several hours before an increase in protein-bound phos-
phate is detectable. This observation is in agreement with the reports 
of Bergink et al. (81 ) and Williams et al. (310 ), who observed that the 
rise in concentration of plasma VLDL in oestrogen-treated cockerels 
occurred earlier and lasted longer than the increase in vitellogenin 
concentration. The lag phase is independent of the oestrogen dose, 
but the duration of the rising phase, the maximum level of vitellogenin 
( 163) 
attained, and the descending phase are dose-dependent • Beuving 
& Gruber (163 ) have shown that the maximum plasma phosphoprotein levels 
attained for oestrogenized 3 to 6-month old cockerels are essentially 
linearly related to the oestrogen dose, at least up to a dose of 20 mg 
17 13 -oestradiol/ animal. 
The mean control level of protein-bound phosphate in the present 
study was 0·26 ~moles/ml plasma, which is equivalent to about 25 ~g 
protein-bound phosphate/ml plasma or to about 8 ~g protein-bound 
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phosphorus/ml plasma. It would seem likely that the phosphoprotein 
in control plasma is vitellogenin, since other workers have demonstrated 
the presence of vitellogenin at very low levels in the sera of non-
oestrogenizedccockerels, and have indicated that expression of the 
vitellogenin genes occurs at a basal rate prior to exogenous oestrogen 
treatment, (148 ' 150). The maximum level of protein-bound phosphate 
obtained in the plasma of an oestrogen-treated chick in the present 
study was 2·10 ~moles/ml plasma, which is equivalent to about 200 ~g 
protein-bound phosphate/ml plasma or to about 55 ~g protein-bound phos-
phorus/ml plasma. This concentration of protein-bound phosphate was 
obtained for a chick that had received an injection of 17S-oestradiol 
(1 mg/100 g body wt.) 42k hours before sacrifice. Vitellogenin has 
been shown to contain 3·4 ± 0·3% phosphorus by weight (54 ), and there-
fore, the concentration of vitellogenin in plasma from control chicks 
in the present study was approximately 215 - 258 ~g/ml plasma, whilst 
the highest concentration attained for an oestrogen-treated chick was 
about 1757 - 2097 ~g vitellogenin/ml plasma. 
Gruber (358 ) observed a similar protein-bound phosphate level of 
about 210 ~g protein-bound phosphate/ml plasma 100 hours after in-
jecting 2 kg cockerels with 12·5 mg 17 S-oestradiol. Other workers 
have, however, observed much higher levels after treating cockerels 
with larger and repetitive doses of oestrogen. For example, Goldstein 
& Hasty (100) treated 2 - 2·3 kg cockerels with repetitive doses of 
30 mg or 50 mg 17 S-oestradiol, and plasma levels of alkali-labile 
phosphorus were observed to reach approxim~tely 350 ~g/ml plasma. 
Similarly, Maenpaa & Bernfield (335 ) treated 1 ·8 - 2 kg cockerels with 
1 mg 17 S-oestradiol benzoate/100g bodyweight, and 5 days later the 
level of plasma protein-bound phosphorus was about 350 ~g/ml plasma, 
representing a 150-fold increase over their control values. The 
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maximum amount of protein-bound phosphorus that has been detected in 
chicken plasma after oestrogenization is 360- 420 ~g/ml plasma (250 ), 
which has been found in the plasma of chickens injected with 2 - 3 mg 
oestradiol/100 g body weight (81 ' 100 ' 163 ' 369 ) Even higher protein-
bound phosphorus levels have been observed in the plasma of oestro-
genized male and female quail that received 4·36 mg oestradiol/100 g 
body weight (250 ). Control levels of protein-bound phosphorus were 
about 4 ~g/ml plasma. The mean values for male and female quail 6 -
7 days after a single oestrogen dose were approximately 850 and 970 ~g 
protein-bound phosphorus/ml plasma respectively, although values as 
high as 1500 ~g/ml plasma were recorded. The vitellogenin of quail 
contains about half the amount of phosphorus/~g protein than does that 
of the chicken, showing that much higher levels of vitellogenin exist 
in the plasma of the quail than in the chicken after oestrogen treat-
ment. The mean level of protein-bound phosphorus in laying female 
quail plasma was about 120 ~g/ml plasma, which was raised to about 
970 ~g/ml plasma approximately 7 days after treatment with a single in-
jection of 17 s-oestradiol (4·36 mg oestradiol/100 g body wt.). These 
abnormal levels of vitellogenin in the plasma were associated with 
cessation of laying and considerable stress, and are highly unphysio-
logical. 
The changes in the liver and the constituents of the plasma of 
male chicks after 17S-oestradiol treatment described in this report 
were used to assay the response of the birds to the hormone. The re-
sults of subsequent experiments to elucidate the mechanisms of the in-
creased hepatic lipid synthesis could then be correlated with the 
magnitude of the birds' response to oestrogen treatment. 
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CHAPTER 3 
THE INCORPORATION OF [1-14c] ACETATE, 3H20 
AND [9,10-3H] PALMITATE INTO LIPIDS BY LIVER 
SLICES FROM CONTROL AND OESTROGEN-TREATED 
MALE CHICKS 
90 
INTRODUCTION 
1. Biochemical techniques for studying metabolic processes 
A variety of techniques have been developed to study metabolic 
pathways both in the intact living animal and in isolated tissue pre-
parations. The use of a combination of in vitro and in vivo techniques 
is important, since a detailed knowledge of a metabolic process cannot 
be obtained by the use of either type of technique alone, and each has 
its advantages and limitations. Possible mechanisms and enzyme systems 
can be best investigated with purified tissue preparations, but inter-
pretation of the results of experiments of this kind and extrapolation 
to the situation existing in the living animal involve a certain amount 
of speculation. The metabolic processes that take place within an 
animal are interrelated and are under complex homeostatic control, and 
this relationship is obviously disturbed when tissues are isolated. 
Consequently, although in vitro techniques are invaluable for deter-
mining possible metabolic mechanisms, only in vivo studies can provide 
information about the processes that actually occur in the living animal. 
In this report, various techniques that have been used in the study of 
liver metabolism will be reviewed, since this is the organ under in-
vestigation in the present study. 
Tissue preparations used in in vitro studies vary considerably 
in their degree of'deviation from the natural state. Preparations 
commonly used in the study of liver metabolism range from the intact 
perfused organ to tissue slices and fragments, cell suspensions, homo-
genates composed of broken cells, preparations of isolated organelles 
and pure enzyme preparations. The least disrupted preparation in-
valves the isolation of the intact liver, which can be perfused via the 
blood vessels with isotonic media containing oxygen and nutrients that 
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are able to sustain the metabolic activity of the organ (121 , 243 ). 
Using such preparations it is possible to study normal processes occurr-
ing in the liver, and the responses of the liver to a variety of agents 
that can be added to the perfusion medium. The advantages associated 
with this in vitro technique are that the cells remain intact and retain 
their natural positions and cell to cell contact within the organ. 
Nevertheless, the perfusion of the isolated liver is not an ideal repro-
duction of the situation existing in vivo since, as with other isolated 
tissue preparations, humoral and nervous influences are lacking. 
Another isolated tissue preparation which retains the cell to 
11 . t t" . th 1" 1" (30, 71' 113, 236, 238, 370) ce 1n erac 1ons 1s e 1ver s 1ce 
The advantage ·of using slices immersed in isotonic media containing 
necessary nutrients and oxygen, rather than the perfused liver, is that 
a variety of different experiments can be performed with tissue from the 
same liver, and both control and experimental determinations can often 
be carried out using samples from the same organ. The preparation of 
slices is also quick and easy once the technique of cutting is mastered. 
The disadvantages of using liver slices include the variability in sur-
face area and thickness of the slices, which affect the diffusion of 
oxygen and substrates into the cells and hence can limit the metabolic 
activity of the cells. The process of diffusion is better in the per-
fused liver, since the distance between the capillary wall and the liver 
cells is small compared with the distance between the cells in the centre 
of a liver slice and the medium in which it is suspended. Problems 
associated with liver slices also include the presence of cut cells on 
the surface and 'shocked' cells in the interior. Damage to cells in 
liver slices has been indicated by the leakage of small molecular weight 
constituents such as adenine nucleotides and, in extreme cases, intra-
cellular enzymes into the medium. 
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The problem of diffusion has been partly overcome by the use of 
'liver snips' ( 371 ), which have been shown to be less damaged and more 
active than liver slices, and to yield results with greater reproducib-
ility. Liver snips are prepared by manual snipping, and this has been 
reported to cause damage to less cells than is customary with a tissue 
slicer. Snips are also much smaller than liver slices and, therefore, 
samples taken for experiments are more homogeneous and diffusion dis-
tances are reduced. The preparation of snips is much easier than that 
of slices, which requires considerable practice before reasonable pre-
parations can be produced. Also, the preparation of slices from foetal, 
infant, fatty and other small or fragile livers can be extremely diffi-
cult, and the·preparation of snips is more practical in such cases. 
The problem of diffusion of substrates posed by the use of liver 
slices and liver snips has been solved by the use of isolated hepato-
cytes, prepared by enzymic digestion of the proteins and mucopoly-
saccharides holding cells together, which can be freely suspended in 
d · t . . t . t d . ( 276, 372 - 375) Th. me 1a con a1n1ng nu r1en s an oxygen · • 1s prepar-
ation has the advantage that samples taken for experimentation are more 
homogeneous than is the case with slices and snips, which contain a 
high proportion of ruptured cells and also connective tissue, blood 
vessels, and other cell types in addition to liver parenchymal cells. 
A disadvantage associated with the use of this type of tissue prepar-
ation, when compared with liver slices and liver snips, is that hepato-
cytes can take rather longer to prepare, and ageing of the cells may 
complicate experimentation. In addition, cell to cell contact is lost, 
and the preparation of hepatocytes involves enzymic digestion at cell 
surfaces, which may affect the plasma membranes and receptors situated 
(373) 
at the surface of the hepatocytes • Nevertheless, isolated hepa-
tocytes can be advantageous, since they avoid the complex interactions 
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imposed on cells in vivo and, therefore, are often more convenient for 
experimentation. 
A major problem with the use of the tissue preparations described 
above is that they are limited to acute studies of metabolism because 
they are viable for only a few hours. The development of cells in 
primary culture that are able to retain their differentiated functions 
are, therefore, more useful in extended studies (372 , 374 - 376 ), al-
though with longer periods the degree of deviation from the natural 
state becomes greater. 
The use of tissue homogenates, isolated organelles and purified 
enzyme preparations has proved extremely useful for the elucidation of 
possible metabolic pathways and enzyme systems. The separation of or-
ganelles by density gradient centrifugation allows the isolation, in 
good yield and purity, of most cellular components. However, the trans-
port of ions and compounds into isolated organelles may not be the same 
as in vivo, thus giving rise to an artificial situation. In addition, 
preparations of a particular organelle from a tissue may not necessarily 
be homogeneous, and may include organelles from different regions of the 
tissue which differ biochemically. In tissue homogenates and purified 
enzyme preparations, substrates can be presented directly to enzyme 
molecules without any problems of diffusion into cells, since the cell 
membranes are disrupted. In addition, homogenates of broken cells can 
be 'purified' to varying degrees. The disadvantages of using these 
preparations become evident when one tries to extrapolate from the re-
sults of experiments using such preparations to the situation existing 
in the living cell and in the animal as a whole. The process of cell 
disruption breaks up the structure of the cell, causing the mixing of 
components that might be separated in different cellular compartments 
in the living state. Hence, enzymes may be brought into contact with 
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a variety of activators, inhibitors, substrates and lysosomal enzymes 
from which they would be separated in the intact living cell. There-
fore, enzymes assayed in homogenates and subcellular preparations may be 
inhibited or activated compared with the activities they express in the 
living cell. Also, the addition of various cofactors and substrates 
to homogenates and purified enzyme preparations may give a false im-
pression of the activities of enzymes in the intact cell, where the con-
centrations of these components may be limited, or greater due to con-
centration in cellular compartments. Such studies, therefore, can pro-
vide information about the relative quantities of enzymes present in 
cells, but give no indication of the actual activities and their relat-
ive importance in the living state. 
One of the most useful in vivo experimental techniques for the 
study of metabolic pathways involves the employment of radioactive 
(20 25 67 114 252 377) tracers ' ' ' ' ' Labelled substances can be ad-
ministered orally or by injection into the bloodstream or any part of 
the body, and at specified times after administration body fluids can 
be withdrawn or tissues can be isolated and the fate of the radioisotope 
can be determined. This technique is particularly advantageous since 
natural conditions can be maintained in the living animal, and meta-
bolic pathways can be elucidated by isolating labelled intermediates 
at different times after administration of the radioactive substrate. 
The major problem arising from the use of this technique is the inter-
pretation of the results obtained. For example, the presence of a 
labelled product at a particular site in the body does not necessarily 
imply that the product is synthesized there, since the product may be 
manufactured elsewhere in the body and be translocated via the cir-
culation. Similarly, even though the product may be synthesized in a 
particular tissue or organ, the amount of product isolated from that 
95 
site may not be an accurate measure of the synthetic capacity at that 
location, since the product may be translocated from one organ or tissue 
to another via the bloodstream. 
2. Hepatic lipid metabolism of the domestic fowl 
Jn the present study, liver slices were used to investigate lipid 
metabolism in the livers of male chicks after they had been treated 
with 17 i3 -oestradiol. In Chapter 2, it was shown that such treatment 
causes elevations of plasma tri.acylglycerol levels, which are associated 
. 1 . (113- 115, 117, 118, 236, predom1nant y with 1ncreases in plasma VLDL 
242) Hepatic lipid metabolism in oestrogen-treated birds has received 
considerable ~ttention, since the liver is considered to be the major 
site of lipogenesis in avian species (20 - 27 ), and the domestic fowl 
does not develop hypertriacylglycerolaemia in response to oestrogens 
after functional hepatectomy (122 ) Extrapolation from these studies 
to the changes that occur in the hen approaching lay have also been 
attempted, since both situations involve similar changes in blood and 
liver lipids and proteins, and it is reasonable to believe that similar 
t b 1 . . 1 d (56' 58' 81 ' 82' 11 5' 242) me a o 1c processes are 1nvo ve 
A variety of in vivo and in vitro techniques have been employed to 
investigate hepatic lipid metabolism in the chick, the adult cockerel, 
male and immature female birds after oestrogen treatment, and in the 
laying hen, but some of the results have been confusing and conflicting, 
and we do not have a clear picture of the lipogenic changes that occur 
in birds after oestrogenization or at the onset of lay in the hen. 
Several investigators have employed liver slices, incubated with pre-
cursors of complex lipids, in order to detect increases in hepatic 
lipid synthesis and to determine the time courses of such changes. 
Various labelled non-lipid precursors and fatty acids have been used in 
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these liver slice studies, and the results of some of these investi-
gations will be outlined below. 
A number of research workers have tried to elucidate the differences 
in lipid metabolism that must occur between the immature female bird and 
the laying female, by virtue of the greater demand for lipid existing 
in the laying hen associated with egg production. Duncan (370 ) measured 
14 14 14 the incorporation of [1- C] glucose, [6- C] glucose and [U- C] glucose 
into total lipids by liver slices from 10 to 13-week old immature fe-
male fowl and from 26 to 32-week old laying hens, and observed higher 
incorporations by slices from the immature birds than from the laying 
birds when expressed on a wet tissue weight basis. However, the differ-
ences did not attain statistical significance at the 5% level using 
Student's 't' test, and when expressed on a cellular basis this differ-
ence was almost eliminated. Similar results have been reported by 
Weiss et al. (237 ) and Leveille (239 ), who studied the incorporation of 
[1-14c] acetate into lipids by liver slices from chicks and hens. 
Weiss et al. (237 ) observed levels of incorporation of [1-14c] acetate 
into lipids by mature hen liver slices which were about 2% of the levels 
observed by Leveille (33 ) for chicks. This observation led Leveille 
(239 ) to study the situation in the hen and chick simultaneously, and 
he showed that liver slices from male chicks and mature hens had similar 
capacities for fatty acid synthesis from [1-14c] acetate. 
Duncan (238 ) reported that liver slices from 9 to 15-week old 
immature female domestic fowl incorporated more [1-14c] acetate into 
fatty acids than did those of laying hens of 26 to 32 weeks of age, 
whereas no differences occurred in the conversion of [u-14c] glycerol, 
[2-14c] glutamate, [5-14c] glutamate and [3-14c] aspartate to fatty 
acids. When the incorporation results for liver slices from immature 
female birds were compared with those for mature male birds (35 to 40 
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weeks old), it was found that the immature female birds converted more 
14 14 14 [1- C) acetate, [2- C) glutamate and [5- C) glutamate into fatty 
acids, whilst the amounts of fatty acid synthesized from these sub-
strates by liver slices from cockerels and laying hens were not signifi-
cantly different. Similarly, Leveille et al. (20) studied lipogenesis 
of the domestic fowl in vivo using [u-14c] glucose and [1-14c] acetate, 
and observed rates of hepatic lipogenesis in the chick that were similar 
to those reported previously in the hen (3??), but considerably higher 
than those observed in the adult cockerel (3??) These observations 
suggest that hepatic fatty acid synthesis does not increase as the hen 
comes into lay. This conclusion is rather unexpected in view of the 
massive amounts of lipid that are produced by the laying hen, and con-
sidering the fact that the liver of the domestic fowl is extremely im-
(20- 22, 30, 31) portant in the de novo synthesis of fatty acids 
The conflicting results of some of the liver slice experiments 
presented above are of particular interest when viewed in conjunction 
with the results of }ipogenic enzyme activity studies. For example, 
Pearce (378 ) showed that the specific activities of ATP citrate lyase 
t ' )* (EC 4.1.3.8) and malic enzyme (EC 1.1.1 .40 were similar in the livers 
of laying hens and of 4 and ?-week old pullets. This is in agreement 
with the observations of Leveille (239 ) who showed, by studying the in-
corporation of [1-14c] acetate into lipids by liver slices, that the 
rate of hepatic lipogenesis was similar in the chick and the mature 
laying hen. Pearce (3?8) showed that the hepatic activities of ATP 
citrate lyase and malic enzyme in the female bird decreased sharply 
between 7 and 10 weeks of age, remained low until at least 22 weeks of 
age, and increased again at sexual maturity. Similar observations 
were made by Raheja et al. (359 ) for hepatic'malic enzyme activity in 
the cockerel during development, although in the cockerel the level of 
* malate dehydrogenase (decarboxylating; NADP+) 
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activity of this enzyme remains low throughout adulthood. In accordance 
. (125) (246) 
w1th these results, Pearce and Pearce & Brown observed 
greater hepatic specific activities of ATP citrate lyase and'malid en-
zyme in the laying hen than in the cockerel or non-laying mature female, 
while the hepatic enzyme specific activity levels observed in non-laying 
females and cockerels were similar. The general picture, therefore, 
resulting from these studies is that lipogenesis is high in the livers 
of young chicks, but decreases to a lower level with age. In the 
cockerel the rate of lipogenesis remains low, but at sexual maturity in 
the hen lipogenesis increases once again. 
Several workers have studied liver slices from oestrogen-treated 
birds in attempts to elucidate the mechanism of increased lipogenesis in 
these birds. Duncan (238 ) treated immature 9 to 15-week old female 
chickens with 1 mg 176-oestradiol/bird/day for 10 days, and observed 
increased fatty acid synthesis from [1-14c] acetate, but not from 
[u-14c] glucose, [2-14c] glutamate or [5-14c] glutamate, by liver slices 
from these birds compared with those from control pullets. Liver 
slices from control immature female birds were found to incorporate more 
[1-14c] acetate into fatty acids than did those from laying hens, and 
therefore, treatment with oestrogen increased the fatty acid synthetic 
capacity from [1-14c] acetate shown by the immature female bird still 
further. This stimulation of hepatic fatty acid synthesis by exogen-
ous oestrogen was, therefore, not comparable with the normal physio-
logical situation in the laying hen, in which metabolism is under the 
influence of endogenous oestrogens. A similar increase in the incor-
poration of [1-14c] acetate into lipids by liver slices from oestrogen-
treated birds was shown by Kudzma et al. (113 ) These investigators 
treated 5-day old male and female chicks with 0·1 mg diethylstilbestrol 
daily for 18 days, and 24 hours after the last injection chicks were 
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sacrificed and liver slices were prepared. Incorporation of [14c] 
acetate into total lipids by liver slices was found to be approximately 
3-fold greater for oestrogen-treated chicks than for control chicks. 
This increase in [14c] acetate incorporation after oestrogen treatment 
became a 4·5-fold increase when incorporation into triacylglycerol was 
presented in isolation. In addition, Kudzma et al. (114 ) reported that 
treatment of 1-week old chicks with a daily injection of 0·5 mg diethyl-
stilbestrol for 8 days increased the in vivo incorporation of [1-14c] 
acetate or [u-14c] glucose into blood and liver lipids, predominantly 
the triacylglycerol fraction of VLDL. Studies on young turkey hens, 
with body weights of 10 kg, have also shown that oestrogen treatment 
(a 25 mg dose of 17 S-oestradiol followed by a 75 mg dose 1 week later) 
causes an increase in de novo lipogenesis from [1-14c] acetate in liver 
slices (251 ) 
The activities of ATP citrate lyase and malic enzyme in the livers 
of oestrogen-treated pullets have been investigated and have yielded 
somewhat ambiguous results. Pearce & Brown (246 ) treated immature 
pullets with oestradiol dipropionate in the form of a subcutaneous 
pellet for a week, and observed no significant differences in the 
hepatic specific activities of ATP citrate lyase and malic enzyme be-
tween oestrogen-treated and control birds. However, Balnave & Pearce 
(166 , 256 ) treated 4-week old pullets with injections of oestradiol 
dipropionate (0·5 - 4 mg oestradiol dipropionate/injection) on alternate 
days, and observed maximum hepatic specific activities of ATP citrate 
lyase and malic' enzyme on the 2nd day, after just one dose of 2 mg and 
1 mg oestradiol dipropionate/bird respectively. The specific activities 
of these enzymes were decreased, and often depressed below control 
values, after longer times of oestrogen administration and/or after 
treatment with higher oestrogen doses. It would, therefore, appear 
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that short-term oestrogen treatment (s 2 days) at a carefully selected 
dose is more indicative of physiological effects and the situation in 
the laying hen than are high oestrogen doses and long-term treatment. 
One of the major problems associated with the use of radioisotop-
ically-labelled non-lipid precursors such as glucose and acetate for 
studying lipid metabolism, both in vivo and in vitro, is that interpre-
tation of the incorporation results remains speculative unless the cell-
ular pool sizes and specific radioactivities of the immediate precursors 
of the products are known. There is always the possibility that 14c-
labelled substrates underestimate de ~ lipogenesis, because the rate 
of entry of the substrates into cells and their metabolism to acetyl-CoA 
may be rate-limiting and because the specific radioactivity of the sub-
strate, or of acetyl-CoA generated from it, is diluted within the cell. 
Therefore, differences between oestrogen-treated and control birds in the 
hepatic incorporation of labelled substrates such as acetate into lipids 
may be obscured if the cellular pool sizes of acetyl-CoA differ in these 
birds. For example, the absence of increased incorporation of labelled 
acetate into fatty acids by oestrogenized chick liver may merely re-
fleet an oestrogen-induced increase in the cellular acetyl-CoA pool 
size, resulting in the dilution of labelled acetyl-CoA. Conversely, 
increased incorporation may merely reflect a decrease in acetyl-CoA 
pool size and concentration of labelled acetyl-CoA. In addition, 
there may be differences in the facility to activate acetate to acetyl-
CoA, and differences in permeability of the tissue to acetate. 
A means of avoiding problems of precursor pool sizes and specific 
radioactivities is to use 2H2D or 
3H2D as the labelled substrate for de 
novo lipogenesis (22, 30, 46, 139, 160, 252, 276, 365, 375, 379- 381) 
since the concentration of water in the incubation medium or body fluids 
and in the cells is very high, and the specific radioactivity of the 
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hydrogen being incorporated into lipids is relatively constant despite 
large variations in the rates of lipid synthesis and other metabolic 
(382) processes • Hydrogen from water is incorporated into fatty acids 
and cholesterol during their syntheses., but there is no incorporation of 
isotopic label into pre-formed lipids (383 ' 384 ). Hydrogen from water 
is incorporated into lipids regardless of the form of the carbon sub-
strate and, therefore, provides an accurate measure of total de ~ 
lipogenesis, as opposed to incorporation studies using a 14C-labelled 
substrate which measure fatty acid synthesis from that substrate alone. 
Fatty acids synthesized in the presence of 2H2o or 
3H2o have isotopic 
label incorporated into stable linkages at both odd- and even-numbered 
(383 384) . . 2 3 
carbon atoms · ' • A d1sadvantage of us1ng H2o or H2o for the 
measurement of metabolic processes is that the radioisotop~s have a 
larger mass than protium and may, therefore, react more slowly, and the 
rate of incorporation may not be a true reflection of the rate of the 
process under investigation. However, it is reasonable to assume that 
such an isotope effect would be the same in all animals and cells and, 
therefore, comparisons of incorporation results would be valid. 
Dashti et al. (252 ' 365 ) have applied the use of 3H2o to the 
measurement of de ~ lipogenesis in oestrogen-treated birds, and ad-
ministered 3H2o in vivo to immature male turkeys after treatment with 
diethylstilbestrol. These workers injected 19-day old male turkeys 
with diethylstilbestrol (40 mg/kg body wt.) in corn oil, or with corn 
oil only, and killed the birds immediately or 24, 48 or 72 hours later 
(252) One hour before death, birds were injected intraperitoneally 
with 20 mCi 3H2o, and the incorporation of 
3H20 into total liver and 
plasma lipids was determined. The incorporation of 3H2o into total 
lipid was approximately 3•9-fold greater for oestrogenized birds than 
for control birds at 24 hours after hormone and/or corn oil injection, 
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and this increased to a 5·5-fold difference at 48 hours. The increased 
3 incorporation of tritium from H2o was mainly into liver triacylglycerols 
which were secreted into the blood predominantly as VLOL. 
· The controversial results that have been obtained in the studies of 
de ~ fatty acid synthesis in chicks, cockerels, hens, and oestrogen-
ized male and immature female domestic fowl have occasionally suggested 
that at sexual maturity in the hen and after oestrogenization of birds 
the liver may not develop an enhanced capacity to synthesize fatty acids. 
Instead, fatty acids may, theoretically, be manufactured at extra-
hepatic sites or be mobilized from adipose tissue, and may be trans-
ported via the circulation to support an enhanced production of complex 
lipids by the.liver. This could possibly explain the lower level of 
14 fatty acid synthesis from [1- C] acetate registered for the livers of 
laying hens than for the livers of immature female birds (237 , 238 , 370 ) 
since hepatic fatty acid synthesis may be inhibited in the hen by fatty 
acids arriving from extra-hepatic sources. This process may also be 
operative in the oestrogenized bird. The mobilization of fatty acids 
from adipose tissue would be a rather wasteful way of obtaining fatty 
acids for hepatic lipogenesis, since the liver of avian species has a 
high capacity for de novo fatty acid synthesis, whereas that of adipose 
tissue is low. Consequently, the majority of the fatty acids in adi-
pose tissue are of hepatic origin. 
At the onset of lay in the hen, the amounts of complex lipids and 
f f tt "d . th 1 . . lt 1 (57, 234) ree a y acl s ln e p asma lncrease slmu aneous y • 
Similar increases are observed in oestrogen-treated birds (113 , 164 , 
235) 
, although it has been suggested that the increase in plasma free 
fatty acids does not occur until after the hypertriacylglycerolaemia 
develops, implying that the fatty acids may be of hepatic origin (113 ) 
Pageaux et al. (235 ) have demonstrated a significant decrease in serum 
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free fatty acids 1 hour after the administration of oestradiol ben-
zoate (0·2 mg/kg body wt.) to 16-day old female quail, although this 
was followed by increased concentrations over the following 23 hours. 
This implies that, at least in the early stages after oestrogen treat-
ment, the removal of fatty acids from the bloodstream may be stimulated. 
Oestrogen treatment of Xenopus laevis has also been shown to produce an 
increase in the level of free fatty acids in the plasma (5o). The 
origins of the plasma free fatty acids at the various times after oes-
trogen treatment of male and immature female domestic fowl, and during 
the development of sexual maturity in the hen, have not been determined. 
Consequently, it is not known if they are in a state of transport to the 
liver from extra-hepatic sites such as adipose tissue, if they have been 
released from circulating VLDL after lipolysis by lipoprotein lipase in 
peripheral tissues, or if they emanate from the liver as a result of 
overproduction. 
Several workers have demonstrated that the livers of the laying hen 
and oestrogenized domestic fowl have an increased capacity to incorporate 
f d f tt 'd . t 1 1' 'd (114, 236, 238) p pre- orme a y ac1 s 1n o camp ex 1p1 s • re-
formed fatty acids and fatty acids synthesized de ~ may be incor-
porated into complex lipids via the pathways illustrated in Fig. 10. 
Hawkins & Heald (236 ) showed that,on a dry weight basis, liver slices 
of the laying hen incorporated almost twice as much [1-14c] palmitate 
into neutral lipids than slices from immature female birds. On a 
cellular basis, using DNA as a standard for comparison, liver slices 
from the laying hen incorporated approximately 2·5-fold more [1-14c] 
palmitate into neutral lipids than did slices from immature female 
birds. Since the intracellular free fatty acid pool in the liver of 
the laying bird was shown to be twice that in the liver of the immature 
bird, liver cells of the laying hen would appear to possess a 5-fold 
FIGURE 10 
Schematic representation of the fates of fatty acids in the cell 
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greater capacity to incorporate fatty acids into neutral lipids than 
do liver cells of the immature female domestic fowl. Similarly, 
Duncan (238 ) demonstrated that liver slices from laying birds incorpor-
ated more [u-14c] glycerol into the glycerol moiety of triacylglycerols 
than did liver slices from immature female birds. In addition, there 
was no difference between laying and immature birds in the incorpor-
ation of [u-14c] glycerol, [2-14c] glutamate, [5-14c] glutamate and 
[3-14c] aspartate into fatty acids by liver slices, and the incorpor-
ation of [1-14c] acetate into fatty acids was lower in liver slices from 
the laying hen than in those from the immature female bird. These re-
sults suggest that additional fatty acids required for hepatic tri-
acylglycerol formation during egg production might be derived from extra-
hepatic sources. Kudzma et al. (114 ) showed that there was an increased 
incorporation of plasma free fatty acids into triacylglycerols by the 
livers of oestrogenized chicks compared with control chicks. These 
workers injected chicks (850- 1000 g body wt.) daily, for 4 days, with 
a dose of diethylstilbestrol (2 mg/day/bird) in sesame oil or with 
sesame oil only, and 24 hours after the last injection the birds were 
killed. Birds were given 25 ~Ci of plasma-bound sodium [9,10-3H] 
palmitate intravenously 5 - 7 minutes before death, and immediately 
after death the livers and plasma samples were rapidly removed, and the 
fraction of injected label converted to triacylglycerols was determined. 
The plasma free fatty acid pool size was increased 5-fold and the 
fractional conversion of [9,10-3H] palmitate increased 2-fold after oes-
trogen treatment, and hence it was calculated that the livers of oestro-
genized chicks converted 10-fold more free fatty acid to triacylgly-
cerol than did the livers of control chicks. It would appear, 
therefore, that the livers of laying hens and oestrogenized male and 
immature female domestic fowl possess an enhanced capacity to incor-
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porate fatty acids, whether they be of hepatic or extra-hepatic origin, 
into neutral lipids, predominantly into triacylglycerols. 
The aim of the present work was to study the relative importance of 
non-lipid precursors and pre-formed fatty acids in the biosynthesis of 
glycerolipid in the liver of the oestrogen-treated male chick at various 
times after hormone administration. The incorporation of [1-14c] ace-
tate or 3H2o into glycerolipid by liver slices from oestrogen-treated 
and control chicks was taken as a measure of lipogenesis via the de 
~ biosynthesis of fatty acids. On the other hand, the incorpor-
ation of [9,10- 3H] palmitate into glycerolipid by liver slices was taken 
as a measure of lipogenesis from pre-formed, exogenous fatty acid. It 
was hoped that.this work might help to resolve some of the anomalies 
that have appeared in the literature concerning the effect of oestrogen 
on lipid metabolism in avian liver. 
METHODS 
1. [1-14c] Acetate incorporation studies 
Preparation and storage of solutions 
A modified Krebs-Ringer bicarbonate buffer, pH 7·4, was used in 
these studies ( 385 ' 386 ) The compositions of the buffers employed 
were as follows:-
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Volume (ml) 
Component Buffer A Buffer B Buffer c 
4·5% (w/v) NaCl 20 20 18 
5•75% (w/v) KCl 4 4 4 
6·1% (w/v) CaC1 2 0·6 0·6 0·6 
3·82% (w/v) MgSD4.7H2D 1 1 
2·11% (w/v) KHlD4 1 1 
1 ·3% (w/v) NaHCD3 25 25 25 
0-glucose (0·572 M) 2·5 
+H 20 to total volume (ml) of:- 130 130 117 
Buffers were made up fresh each day by mixing of the components. 
Solutions of NaHC03 were made up fresh just before use. The other com-
ponent solutions were stored at 4°C, and fresh solutions were prepared 
every 7 - 14 days. The solutions were discarded sooner if there was 
obvious bacterial contamination. 
All buffers were gassed with o2:co2 (95%:5%) at 40°C for 30 - 40 
minutes before use, and the pH of each was adjusted to 7·4 with HCl 
after gassing. Most experiments ran for several hours and the buffers 
were gassed periodically throughout. 
Ice-cold buffer A was used for rinsing livers and storing liver 
cubes and slices before incubation. Prior to incubation, the liver 
slices were rinsed free of extraneous glucose by immersion in ice-cold 
buffer B. Buffer C was the buffer in which liver slices were in-
cubated, and was more concentrated than buffers A and B to allow for 
dilution following additions to incubations. Buffer C also contained 
+ less NaCl to compensate for Na ions added to incubations as sodium 
acetate. 
1 DB 
The buffer composition adopted is very close to that of the avian 
saline described by Sturkie (387 ) A comparison of mammalian Krebs-
Ringer bicarbonate buffer (386 ), the buffers used in the present study, 
and the avian saline of Sturkie (387 ) is as follows:-
Component 
NaCl 
KCl 
CaCl2 
MgSD4 .7H2D 
KH 2Po4 
NaHC03 
Concentration (mM) 
Mammalian Ringer Buffers A and B 
(Dawson (386 )) 
118·47 118·47 
4·75 23·73 
2·54 2·54 
1 ·19 1 ·19 
1 ·19 1 ·19 
25 29·76 
Avian saline 
(Sturkie (387 )) 
116.36 
23·20 
5·77 
1 ·01 
29•16 
The ionic concentrations of the 3 types of buffer are shown below:-
Ionic 
component 
Cl 
H2Po4-
so 2-
4 
HCO -
3 
Concentration (mequiv./litre) 
Mammalian Ringer Buffers A and B Avian saline 
(Dawson ( 386 ) ) (Sturkie ( 387 )) 
143·47 148·23 145·52 
5·94 24·92 23·2 
5·08 5·08 11·54 
2·38 2·38 2·02 
128·3 147·28 151·1 
1 ·19 1 ·19 
2·38 2·38 2·02 
25 29·76 29·16 
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The buffer used in the present study differs from that recommended 
by Sturkie ( 387 ) in that it contains approximately half the concentration 
of CaC1 2, and KH2Po4 is included at a concentration of 1 ·19 mM. The 
avian ringers differ from the mammalian ringer primarily by the in-
elusion of 5 times the concentration of KCl. This is to accommodate 
the fact that avian blood contains more potassium than does mammalian 
(388) blood , and to try to maintain normal intracellular potassium con-
centrations (389 ). The calcium and chloride concentrations of Sturkie's 
avian saline are high compared with the mammalian ringer. These con-
centrations were reduced towards those of the mammalian ringer in the 
buffer adopted for this study. The inclusion of less calcium reduced 
the possibility. of precipitation on mixing of the components. 
Liver slice preparation and incubation procedures 
Chicks were killed by decapitation and livers were rapidly removed, 
weighed, and immersed in ice-cold avian bicarbonate buffer containing 
11 mM-glucose (buffer A). Portions of liver were cut into small cubes 
(3 - 4 mm in dimension) and slices were prepared from these liver cubes 
with a Stadie-Riggs hand microtome. Weighed pieces of liver were 
frozen immediately for future DNA determinations. Liver cubes and 
slices were kept in ice-cold buffer A. Prior to incubation, slices 
were rinsed in avian bicarbonate puffer without glucose (buffer B), 
blotted on filter paper and weighed by means of a torsion balance. 
Incubations were routinely started within·10 minutes of killing the bird. 
Triplicate incubations were performed for each liver. The last incub-
ation was normally started within 16 - 18 minutes of the death of the 
bird. 
Incubations were carried out in 25 ml Erlenmeyer flasks fitted with 
rubber 'Suba-seal' stoppers through which gassing needles could be in-
serted. Flasks contained 2·7 ml buffer C and 0·3 ml sodium [1-14c] 
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acetate solution (1~ - 3 ~Ci/flask). Preliminary experiments were per-
formed to determine the optimum acetate concentration (10 mM) and a 
suitable incubation time (1 hour). Flasks were incubated at 40°C in a 
shaking water bath. After a 10 minute pre-incubation period, during 
which flasks were gassed with o2:co2 (95%:5%), liver slices (150 ± 10 mg, 
wet wt.) were added to each flask and the incubation time began. Flasks 
were gassed with o2:co2 (95%:5%) for the first 10 minutes of the incub-
ation time, after which the gassing needles were withdrawn. 
Reactions were stopped by the addition of either 0·24 ml cone. HCl 
(11 ·8 M) or 11·25 ml chloroform/methanol (1:2, v/v). The stoppered 
flasks were immediately packed in ice, prior to storage at -20°C until 
lipid extractions could be carried out. Lipid extractions were routinely 
performed within a week. 
Lipid extraction procedures 
In preparation for lipid extraction, the liver slices (150 ± 10 mg, 
wet wt.) and incubation medium (approx. 3 ml) from each flask were homo-
genized in 11 ·25 ml chloroform/methanol (1:2, v/v) and 0·24 ml cone. HCl 
with the aid of a Teflon-glass homogenizer. The tissue was disrupted 
with 10 'up and down' strokes of the rotating pestle. The homogenates 
were transferred to stoppered extraction tubes and lipid was extracted 
(390) by the method of Hajra et al. Chloroform (3·75 ml) was added to 
each tube and the contents were mixed thoroughly for 30 seconds, and 
then 3·75 ml 2 M-KCl in 0·2 M-H3Po4 were added and the contents were 
mixed for 30 seconds again. Subsequently, the tubes were left on ice 
until the phases separated. The upper aqueous phase from each ex-
traction was removed, and the bottom phase was washed thrice with 12·6 ml 
of 'synthetic top phase' containing 5 mM-sodium acetate as carrier. 
Aliquots of the lipid extracts were evaporated to dryness under 
nitrogen and were dissolved in 10 ml of xylene containing 4 g PPO and 
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0·1 g PoPoP/litre. Samples of the stock radioisotope solutions were 
made up to 1 ml with water and were mixed with 10 ml of xylene/Triton 
X-100 (2:1, v/v) containing 5·5 g PPO and 0·1 g PoPoP/litre to determine 
the amount of radioactivity added to each incubation. Radioactivity 
was measured by liquid scintillation counting in a Nuclear Enterprises 
8312 Automatic Spectrometer and a Packard 3DOC Tri-Carb Liquid Scin-
tillation Counter. 
Analysis of extracted lipid from liver slices by thin layer 
chromatography 
In some cases, samples of the lipid extracts were taken for analysis 
by thin layer chromatography (t.l.c.). An aliquot (1·5- 2 ml) of 
lipid extract was taken from each flask extraction, and aliquots from 
the same bird were pooled. The lipid extract was dried under nitrogen, 
dissolved in a small volume of chloroform, and aliquots were applied as 
2 em 'streaks' to activated plates of Kieselgel GOH. Aliquots were 
also taken, dried under nitrogen, and dissolved in 10 ml of xylene con-
taining 4 g PPO and 0·1 g PoPoP/litre, for estimation of the amount of 
radioactivity added to the plate. 
The solvent system employed to resolve lipid classes was light 
petroleum (b.p. 40- 60°C)/diethylether/acetic acid (60:40:1, by vol.). 
After separation, the lipid classes were visualized by exposing the 
dried plates to iodine vapour, followed by marking of the stained areas 
and decolourization in a stream of warm air. Authentic neutral lipid 
standards and oleic acid were run on the same plates to establish the 
identities of the lipid spots. The lipid classes separated by this 
solvent system, and the RF values obtained for these classes, are pre-
sented in Table 5. 
The lipid spots and the intermediate areas were scraped off the 
plates into scintillation vials and 10 ml of xylene containing 4 g PPO 
TABLE 5 
Lipid classes and their Rf values obtained after t.l.c. analysis of extracted lipid from liver slices 
Lipid class RF (mean± S.E.M.) 
Triacylglycerol 0·78 ± 0·005 (145) 
Free fatty acid 0·44 ± 0·004 (118) 
___,. 
___,. 
1,3-diacylglycerol 0·33 ± 0·005 (58) N 
1,2-diacylglycerol +cholesterol 0·26 ± 0·004 (58) 
Monoacylglycerol 0·04 ± 0·004 (4) 
Total phospholipid Origin 
The solvent system employed to resolve the lipid classes was light petroleum (b.p. 40 - 60°C)/diethyl ether/acetic 
acid (60:40:1, by vol.). 
The numbers in parentheses represent the number of values used in calculating the mean and S.E.M. in each case. 
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and 0·1 g PoPoP/litre were added to each. The vials were shaken to 
solubilize the lipid, and radioactivity was measured by liquid scin-
tillation counting. 
Saponification of lipids in lipid extracts from liver slices 
Samples (100 ~l) of the Hajra lipid extracts were evaporated to 
dryness under nitrogen in extraction tubes. NaOH (1 ml of 2 M in 50% 
(v/v) ethanol) was added to the lipid and the stoppered tubes were 
heated at 100°C for 2 hours. After cooling, water (3 ml) was added. 
Non-saponifiable lipids were removed by 2 successive extractions with 
3 ml light petroleum (b.p. 40- Boac). The pH of the aqueous phase was 
then adjusted to 1 - 2 with H2so4• Fatty acids derived from complex 
lipids were removed by 3 successive extractions with 3 ml light petroleum 
(b.p. 40- Boac). The light petroleum extracts were dried under 
nitrogen. Scintillation fluid (10 ml of xylene containing 4 g PPO and 
0·1 g PoPoP/litre) was added to each dried extract, and radioactivity 
was determined by liquid scintillation counting. 
2. 3H20 incorporation studies 
Procedures were as described for the [1-14c] acetate incorporation 
studies with minor modifications. Buffer C was made up as follows, to 
+ compensate for Na ions added to incubations as sodium acetate:-
Component 
4·5% (w/v) NaCl 
5·75% (w/v) KCl 
B·1% (w/v) CaCl2 
3·82% (w/v) MgS04 .7H20 
2·11% (w/v) KH 2Po4 
1 ·3% (w/v) NaHC03 
H20 
Volume (ml) 
19 
4 
O·B 
1 
1 
25 
BB·4 
Total volume:- 117 
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Incubation flasks contained 2·7 ml of the buffer C described above, 
100 ~l of a 300 mM-0-glucose solution (final concn. 10 mM) and 100 ~l of 
a 150 mM-sodium acetate solution (final concn. 5 mM), and were pre-
incubated and gassed with o2:co2 (95%:5%) for 10 minutes in a shaking 
water bath at 40°C. 3H20 (1 - 2 mCi/flask) was added as a 100 ~l ali-
quot at the time of adding the liver slices to the flask to minimize 
evaporation of the radioisotope, Initial experiments demonstrated a 
suitable incubation time of 1 hour. The 'synthetic top phase' used to 
wash the bottom phases of the lipid extractions did not contain sodium 
acetate. 14 All other procedures were as presented for the [1- C] ace-
tate incorporation studies. 
3. [9,10- 3H] Palmitate incorporation studies 
Preparation of [9,10-3H] palmitate-albumin complex 
A modified Krebs-Ringer phosphate buffer, pH 7·4, was made up as 
follows:-
Component Volume (ml) Final concn. (mM) 
4·5% (w/v) NaCl 20 123 ° 20 
5·75% (w/v) KCl 4 24·68 
2·11% (w/v) KH 2Po4 1 1 ·24 
3·82% (w/v) MgS04.7H2o 1 1 ·24 
0·1 M-sodium phosphate buffer, pH 7·4 25 20 
H20 74 
Total volume:- 125 
Bovine serum albumin (fatty acid poor) was dissolved in Krebs~ 
Ringer phosphate buffer, pH 7·4, to a concentration of 120 mg/ml. 
Palmitic acid (125 ~moles) was solubilized in chloroform and 
125 ~Ci [9,10-3H] palmitic acid (in toluene) were added. The mixture 
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was evaporated to dryness under nitrogen. This was followed by the 
addition of 0·2 M-NaOH (150 ~moles), and the mixture was heated at 60-
65°C with gentle mixing until the palmitic acid dissolved. The solution 
was cooled to approximately 45°C, and Krebs-Ringer phosphate buffer con-
taining bovine serum albumin (BSA) was added with mixing. The resulting 
solution was approximately 5 mM-[9,10- 3H] palmitate (5 ~Ci/ml) in Krebs-
Ringer phosphate buffer (pH 7·4) containing BSA (fatty acid poor) at 
120 mg/ml. 
Incubation procedures 
Incubation procedures were as described for the [1-14c] acetate 
incorporation studies with some modifications. Buffer C was made up as 
follows, since additional Na+ ions were not added to incubations:-
Component 
4·5% (w/v) NaCl 
5·75% (w/v) KCl 
6·1% (w/v) CaCl2 
3·82% (w/v) MgS04.7H2o 
2·11% (w/v) KH 2Po4 
1 ·3% (w/v) NaHC03 
H2o 
Total volume:-
Volume (ml) 
20 
4 
0·6 
1 
25 
74·1 
125·7 
Incubation flasks contained 2·5 ml of the buffer C described above, 
100 ~l of a 360 mM-S-0(-)-fructose solution (final concn. 12 mM) and 
400 ~l of tritiated palmitate-albumin solution, and were pre-incubated 
and gassed with o2:co2 (95%:5%) for 10 minutes in a shaking water bath 
at 40°C. Preliminary experiments were carried out to determine a 
suitable palmitate concentration (0·65 mM) and incubation time (1 hour). 
Thereafter, incubations were performed in triplicate for each liver. 
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Reactions were stopped by rapid filtration under suction using a 
Millipore filter fitted with filter paper discs to enable rapid and 
efficient removal of liver slices. The slices were immediately washed 
with 20 ml ice-cold 0·9% (w/v) NaCl, and rapidly placed into a pre-
weighed stoppered vial containing 7·5 ml chloroform/methanol (1:2, v/v). 
This operation lasted approximately 20 seconds. In initial experiments 
to determine future incubation conditions, the slices from each flask 
were put into an individual vial. Thereafter, the slices from tripli-
cate incubations were pooled. Vials were re-weighed after the addition 
of slices to determine the exact weight of tissue. Vials were stored 
for up to a week at -20°C until lipid extractions were carried out. 
Lipid extraction procedures 
The vial contents (liver slices (100- 350 mg, wet wt.) + 7·5 ml 
chloroform/methanol (1:2, v/v)) were homogenized with 0·16 ml cone. HCl 
and a variable volume of water (1·65- 1 ·9 ml) depending on the weight 
of slices. Lipid was extracted from the homogenates by the method of 
(390) Hajra et al. Chloroform (2·5 ml) was added to each homogenate 
in a stoppered extraction 
Then 
tube and the contents were mixed thoroughly 
for 30 seconds. A 2 M-KCl added and the 
tube contents were mixed for 30 seconds again. Subsequently, the tubes 
were left on ice until the phases separated. The bottom phase of the 
extraction was not washed with 'synthetic top phase', but was removed 
and evaporated to dryness under nitrogen. The dried lipid was dissolved 
in a small volume of chloroform, from which samples were taken for 
t.l.c. analysis. Procedures for t.l.c. analysis were as described 
previously. 
4. Statistical analysis 
Standard errors are provided to show the degree of variance in the 
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data. Data were analyzed statistically by Student's 't' test, and 
levels of statistical significance are indicated where appropriate. 
Probability values (P) of 0·05 or less were considered to be significant. 
RESULTS 
1. [1-14c] Acetate incorporation studies 
Preliminary experiments were performed to establish suitable con-
ditions for studying the incorporation of [1-14c] acetate into total 
lipid by liver slices from control and oestrogen-treated male chicks. 
Oestrogenized birds received a single intramuscular injection of 1 mg 
17 B-oestradiol in propane-1,2-diol/100 g body weight approximately 48 
hours before death. Control birds received an equivalent volume of 
propane-1,2-diol only. 
Initially, a suitable incubation time was determined using an ace-
tate concentration of 10 mM, since Leveille ( 23~) and Goodridge (276 ) 
reported maximum rates of incorporation of acetate into fatty acids by 
liver slices and hepatocytes, respectively, using this concentration. 
The effect of incubation time (0 - 90 min) on the incorporation of 10 mM-
sodium [1-14c] acetate into total lipid by liver slices from control and 
oestrogen-treated chicks is shown in Fig. 11. The data show that, after 
a lag period of about 15 minutes, chick liver slices synthesized lipid 
from [1-14c] acetate in a linear fashion until at least 60 minutes. 
Liver slices from control chicks continued to synthesize lipid from 
[1-14c] acetate in a linear fashion until 90 minutes, but the results for 
liver slices from oestrogen-treated chicks indicated that linearity was 
lost with incubation periods of 75 and 90 minutes. 
As a result of these observations,an incubation period of 60 minutes 
FIGURE 11 
14 The effect of incubation time on the incorporation of 10 mM-[1- C) 
acetate into total lipid by liver slices from control and oestrogen-
treated chicks 
Each oestrogen-treated chick received a single intramuscular in-
jection of 1 mg 178 -oestradiol in propane-1,2-diol/100 g body weight 
48 hours before death. Control chicks received an equivalent volume 
of propane-1,2-diol only 48 hours before death. 
Chick liver slices (150 ± 10 mg, wet wt.) were incubated at 40°C 
in 3 ml avian bicarbonate buffer, pH 7·4, containing 10 mM-sodium 
[1-14c] acetate (1 ·5 ~Ci). Total lipid was extracted at the times 
indicated. 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the average of single determinations for 
4 birds. 
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was adopted during the study of the effect of acetate concentration on 
the incorporation of [1-14c] acetate into total lipid by chick liver 
slices. Liver slices were incubated in the presence of [1-14c] acetate 
concentrations ranging from 1 to 20 mM, and maximum incorporation was 
obtained with an acetate concentration of 10 mM (Fig. 12). All sub-
sequent incubations involving the incorporation of [1-14c] acetate into 
total lipid by liver slices from control and oestrogen-treated chicks 
were performed for 1 hour in the presence of 10 mM-sodium [1-14c] ace-
tate. 
Experiments were performed to investigate the incorporation of 
14 10 mM-[1- C] acetate into total lipid by liver slices from male chicks 
treated with a single intramuscular injection of 1 mg 17S-oestradiol in 
propane-1,2-diol/100 g body weight, or with an equivalent volume of 
propane-1,2-diol only. Birds were sacrificed at varying times after 
injection, and liver slice incubations were conducted as described in 
the Methods section. Chicks were also included that had received mul-
tiple injections over several days, and which were sacrificed 24 hours 
after the last injection. Incubations were performed in triplicate for 
each liver. The results of these experiments are presented in Figs. 
13 - 15 and in Tables 6 and 7. In Tables 6 and 7, the chicks have been 
allocated to groups dependent upon the time of death (3~ - 73~ h) after 
a single injection, or upon the number of injections received (3- 11). 
Wherever possible, the results for each group of oestrogen-treated 
chicks have been compared with the results for the corresponding group 
of control chicks. The data were analyzed statistically by Student's 
't' test, and levels of statistical significance are indicated in the 
tables and text where appropriate. 
In Fig. 13 and Tables 6 and 7, the results of the experiments have 
been expressed as nmoles acetate incorporated/100 mg liver/hour. The 
FIGURE 12 
The effect of acetate concentration on the incorporation of [1-14c] 
acetate into total lipid by chick liver slices 
Each oestrogen-treated chick received a single intramuscular in-
jection of 1 mg 17S-oestradiol in propane-1,2-diol/100 g body weight 
48 hours before death. Control chicks received an equivalent volume 
of propane-1,2-diol only 48 hours before death. 
Chick liver slices (150 ± 10 mg, wet wt.) were incubated in 3 ml 
avian bicarbonate buffer, pH 7·4, containing varying concentrations 
(1 - 20 mM) of sodium [1-14c] acetate (1·5 ~Ci/incubation). Total 
lipid was extracted after a 60 minute incubation at 40°C. 
Each value represents the average of single determinations for 
4 control chicks and 3 oestrogen-treated chicks. 
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FIGURE 13 
The incorporation of 10 mM-[1-14c] acetate into total lipid by liver 
slices (nmol acetate incorporated/100 mg liver/h) from control and 
oestrogen-treated male chicks at varying times after injection 
Oestrogen-treated chicks received a single intramuscular in-
jection of 1 mg 17S-oestradiol in propane-1,2-diol/100 g body weight. 
Control chicks received an equivalent volume of propane-1,2-diol only. 
At the indicated times after injection, birds were sacrificed and liver 
slices were prepared. Chicks receiving multiple injections were in-
jected every day for variable periods of time (3 - 11 days), and were 
sacrificed 24 hours after the last injection. The chicks that re-
ceived 4 injections were an exception, since these birds received in-
jections on alternate days over 7 days, and were killed 24 hours after 
the last injection. 
Liver slices (150 ± 10 mg, wet wt.) were incubated in 3 ml avian 
bicarbonate buffer, pH 7·4, containing 10 mM-sodium [1-14c] acetate 
(1·5- 3 ~Ci/incubation). 
incubation at 40°C. 
Total lipid was extracted after a 60 minute 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the average of 3 determinations for a single 
bird. 
Chicks were aged 2 - 5 weeks • 
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FIGURE 14 
The incorporation of 10 mM-[1-14c] acetate into total lipid by liver 
slices (nmol acetate incorporated/liver/min) from control and 
oestrogen-treated male chicks at varying times after injection 
See legend of Fig. 13 for experimental details. 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the average of 3 determinations for a 
single bird. 
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FIGURE 15 
The incorporation of 10 mM-[1-14c] acetate into total lipid by liver 
slices (nmol acetate incorporated/0·1 mg liver DNA/h) from control and 
oestrogen-treated male chicks at varying times after injection 
See legend of Fig. 13 for experimental details. 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the average of 3 determinations for a 
single bird. 
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TABLE 6 
The incorQoration of 10 mM-[1-14c] acetate into total liQid bt liver slices from male chicks at various times after a 
single injection of 17 B-oestradiol (1 mg/100 g bodt wt.) in propane-1,2-diol, or of an equivalent volume of propane-
1,2-diol onl.t 
Incorporation of Time after injection (h) 
14 [1- C] acetate 3~ - 7~ 12t - 14t 17 - 21 ~ 24~ - 27 30 - 31 48~ - 55~ 72~ - 73~ 
tt 
E 1266 ± 60 849 ± 122 2458 ± 243 944 ± 111 1623 ± 186 1327 ± 178 969 ± 352 
nmol acetate/ (5) (3) (7) (4) (3) ( 14) (3) 
100 mg liver/h 
c 1324 ± 99 734 ± 251 1186 ± 231 1288 ± 260 N.D. 1586 ± 116 N.D. 
(2) (3) (4) (4) ( 15) 
/:). 
E 2035 ± 470 2047 ± 177 7133 ± 740 2259 ± 519 6772 ± 1070 3533 ± 820 4876 ± 2012 
nmol acetate/ (5) (3) (7) (4) (3) ( 14) (3) 
liver/min 
c 688 ± 106 1881 ± 585 2348 ± 555 2647 ± 997 N.D. 2393 ± 404 N.D. 
(2) (3) (4) (4) ( 15) 
tt t 
E 323 ± 10 254 ± 36 1103 ± 124 367 ± 66 799 ± 108 750 ± 105 409 ± 170 
nmol acetate/ (3) (3) (7) (3) (3) (3) (3) 
0·1 mg DNA/h 
c N.D. 208 ± 85 399 ± 80 390 ± 129 N.D. 372 ± 51 N.D. 
(3) (4) (3) (3) 
E 4·06:!: 0·35 3·80:!: 0·29 4·60 :!: 0·16 4·69 :!: 0·16 5·47:!: 0·07 5·04:!: 0·22 5·38:!: 0·57 
Liver wt. (as (5) (3) (?) (4) (3) (14) (3) 
1o of · body wt.) 
c 4·47:!: 0·40 3·70:!: 0·02 3·45:!: 0·16 3·69:!: 0·29 N.D. 3·78 :!: 0·13 N.D. 
(2) (3) (4) (4) (15) 
-
" 
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./ 
See legend of Fig. 13 for experimental details. 
Incubations were performed in triplicate, and the results are the means (± S.E.M.) of the average values 
obtained from 2 - 15 chicks. The number of birds involved in each group is given in parentheses. 
E = values for oestrogen-treated chicks 
C = values for control chicks 
N.D. = not determined 
Data were analyzed statistically by Student's 't' test, and levels of statistical significance are pre-
sented with respect to values for corresponding control chicks. 
t significant at P < 0·05 
tt significant at P < 0·01 
6 significant at P < 0·002 
---' 
N 
Ul 
TABLE 7 
The effect of multiple injections on the incorporation of 10 mM-[1-14c] acetate into total lipid by liver slices from 
control and oestrogen-treated male chicks 
Incorporation of number of injections 
14 [1- C] acetate 3 4 6 7 9 11 
t 
E 1773 ± 542 (2) 2408 ± 272 (4) 790 ± 46 (3) 1409 ( 1) 1551 ± 269 (2) 1036 ( 1) 
nmol acetate/ 
1 DO mg liver/h 
c 953 ± 422 (2) 2896 ± 332 (4) 1031 ± 61 (3) 2376 (1) 941 ± 308 (2) 1434 ( 1) 
tt 
E 1772 ± 396 (2) 11683 "± 1370 (4) 1298 ± 21 (3) 1951 ( 1 ) 2468 ± 438 (2) 2085 (1) 
nmol acetate/ 
liver/min 
c 715 ± 366 (2) 771 8 ± 1 560 ( 4) 1007 ± 59 (3) 2325 ( 1 ) 996 ± 259 (2) 1793 ( 1) 
E 5·70 :!: 0·18 (2) 7·02 ± 0·31 (4) 4·66 :!: 0·25 (3) 6·14 (1) 5·71 :!: 0·42 (2) 5·86 (1) 
Liver wt. (as 
1o of body wt.) 
c 4·24 :!: 0·15 (2) 3·71 :!: 0·18 (4) 3·03 ± 0·19 (3) 4·26 (1) 3·62 :!: 0·08 (2) 3·95 (1) 
. .~.~:" 
"..-J 
~~·. ,......,. __ ..~ ' ~ 
.....:. 
See legend of Fig. 13 for experimental details. 
Incubations were performed in triplicate, and the results are the average values for a single bird or the means 
(± S.E.M.) of the average values obtained from 2 - 4 birds. The number of birds involved in each group is given 
in parentheses. 
E = values for oestrogen-treated chicks 
C = values for control chicks 
Data were analyzed statistically by Student's 't' test, and levels of statistical significance are presented 
with respect to values for corresponding control birds. 
t significant at P < 0·05 
tt significant at P < 0·01 
--" 
N 
-,J 
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data illustrated in Fig. 13 clearly show the enormous variability among 
birds, which makes any differences between control and oestrogen-treated 
chicks difficult to detect. The values obtained at 17- 21i hours after 
a single injection of 1 mg 17 S-oestradiol/100 g body weight were sig-
nificantly greater (P < 0·01) than the values for the corresponding 
control group (Table 6). The mean value for this group of oestrogen-
treated chicks was more than double that for the corresponding group of 
control birds. Since there were no control groups to compare directly 
with the 30 - 31 h and 72~ - 73~ h oestrogen-treated groups, comparisons 
were made with all the other control groups. The results for the 30 -
31 h oestrogen-treated group were significantly greater (P < 0·05) than 
the results for the 12k - 14k h control group, but did not attain sig-
nificance with respect to the other control groups. The results for 
the 72~ - 73~ h oestrogen-treated group failed to attain significance 
with respect to any of the control groups, and the values for the re-
maining oestrogen-treated groups were not significantly different from 
those of their corresponding control groups. ~he results obtained for 
chicks treated with a daily injection of 1 mg 17S-oestradiol/100 g 
body weight for 6 days, qnd sacrificed on the 7th day, were significantly 
lower (P < 0·05) than the results for the corresponding group of control 
birds (Table 7). However, the results for the other multiply-injected 
groups of oestrogen-treated birds were not significantly different from 
the results for the corresponding control chicks. 
In Fig. 14 and Tables 6 and 7, the results of the experiments have 
been expressed as nmoles acetate incorporated/liver/minute. Again, 
quite a lot of variability was evident, but from about 17 hours after a 
single oestrogen injection the acetate incorporation values had a ten-
dency to be greater than control values (Fig. 14). The values ob-
tained at 17- 21i hours after a single injection of 17 S-oestradiol 
_-(::, 
'-.--" 
TABLE 8 
The incorporation of [1-14c] acetate and 3H2o into the fatty acids of complex lipids and into non-saponifiable lipids 
by liver slices from control and oestrogen-treated male chicks 
Radioisotope 
and labelled 
compound 
14 [1- C] acetate 
3H 0 2 
'-.{ 
Percentage recovery Treatment 
of radioactivity 
of chicks in the procedure 
Control 90·47 ± 2·64 (10) 
Oestrogenized 91·57 ± 0·79 (15) 
Control 80·10 ± 1·24 (3) 
Oestrogenized 78 ·1 3 ± 1 ·1 2 . ( 3) 
s~ 
"" 
Percentage of the Percentage of the 
recovered radioactivity recovered radioactivity 
in non-saponifiable in fatty acids derived 
lipids from complex lipids 
9·92 ± 0·98 (10) 90·08 ± 0·98 (10) 
t t 
1 5 • 91 ± 2 ·DO ( 1 5) 84·09 ± 2·00 (15) 
4 ·1 8 ± 0 • 62 ( 3) 95·82 ± 0·62 (3) 
6·53 ± 1·78 (3) 93·47 ± 1·78 (3) 
Values are the means (± S.E.M.) of the results for 3- 15 chicks. 
The number of observations involved in each group is given in parentheses. 
Oestrogen-treated chicks received a single intramuscular injection of 1 mg 176-oestradiol in propane-1,2-diol/ 
100 g body weight. Control chicks received an equivalent volume of propane-1,2-diol only. 
At various times after injection, chicks were sacrificed and liver slices were prepared. Liver slices 
(150 ± 10 mg, wet wt.) were incubated in 3 ml avian bicarbonate buffer, pH 7·4, containing 10 mM-sodium [1-14c] 
acetate (1·5- 3 ~Ci/incubation), or in 3 ml avian bicarbonate buffer, pH 7·4, containing 10 mM-0-glucose, 5 mM-
sodium acetate and 3H2D (1 - 2 mCi/incubation). Total lipid was extracted after a 60 minute incubation at 40°C. 
The saponification procedure and extractions were performed as described in the Methods section. 
Data were analyzed statistically by Student's 't' test, and levels of statistical significance are presented for 
results from oestrogen-treated birds with respect to values for corresponding control birds. 
t significant at P < 0·05 
--> 
(J.J 
1\..l 
TABLE 9 
The incorporation of [1-14c] acetate and 3H20 into lipid classes, as separated by thin layer chromatography, by liver 
slices from control and oestrogen-treated male chicks 
Radioisotope Percentage recovery Percentage of recovered radioactivity in:-Treatment 
and labelled 
of chicks of radioactivity Monoacyl- Diacylglycerol Free fatty 
compound on t.l.c. plates Phospholipid glycerol + cholesterol acid Triacylglycerol 
Control 1 04 ·1 9 ± 4. 60 16·41 ±1·19 1·70 ± 0·70 8·64 ± 1·06 0·48 ± 0·15 66·46 ± 3·73 
(8) (8) (8) (8) (8) (8) 
14 [1- C) acetate 
:j: 
Oestrogenized 1 06. 50 ± 2. 34 13·02 ± 0· 72 1·83 ± 0·44 7·52 ± 1·05 0·90 ± 0·27 69·50 ± 2 ·01 
( 12) ( 12) ( 12) ( 12) ( 12) ( 12) 
Control 65·41 ±1·90 6·09 ± 0·47 0·19 ± 0· 04 4·36 ± 0·61 0·38 ± 0·04 86·91 ± 0·93 
(3) (3) (3) (3) (3) (3) 
3H 0 2 
Oestrogenized 64·50 ± 1·35 6·04 ± 0·39 0·18 ± 0·02 4·11 ± 0·23 0·44 ± 0·03 87·19 ± 0·75 
(3) (3) (2) (3) (3) (3) 
(, ~/ ~; -"' t.__/ v 
Values are the means (± S.E.M.) of the results for 2- 12 chicks. 
The number of observations involved in each group is given in parentheses. 
See legend of Table 8 for experimental details. 
Liver slice incubations, lipid extractions and t.l.c. analyses were performed as described in the Methods 
section. 
Data were analyzed statistically by Student's 't' test, and levels of statistical significance are presented 
for results from oestrogen-treated birds with respect to values for corresponding control birds. 
* significant at P < 0·02 
__,. 
t.N 
.c-
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the label was located in triacylglycerol, with about 16·4% being located 
at the origin (phospholipid), 1 ·7% in monoacylglycerol, 8·6% in diacyl-
glycerol and cholesterol, and about 0·5% in free fatty acids. A 
similar distribution of the label in the lipid classes was observed for 
lipid extracts from liver slices of oestrogenized chicks, with about 
69·5% of the label being located in triacylglycerol, 13% at the origin 
(phospholipid), 1·8% in monoacylglycerol, 7·5% in diacylglycerol and 
cholesterol, and about 0·9% in free fatty acids. A significantly 
greater percentage of the recovered radioactivity was located in phos-
pholipid after t.l.c. analysis of lipid extracts from control chick liver 
slices than was obtained for lipid extracts from oestrogen-treated chick 
liver slices (P < 0·02). There were no significant differences be-
tween control and oestrogen-treated liver lipid extracts in the per-
centages of the recovered radioactivity located in the other lipid 
classes. 
2. 3H2o incorporation studies 
De novo lipogenesis by liver slices from untreated, control and oes-
trogen-treated male chicks was also assayed by measuring the incorpor-
ation of tritium 3 from H20 into total lipid. An advantage of using 
3 H2o rather than [1-
14c] acetate is that hydrogen from water is incor-
porated into lipids regardless of the nature of the carbon substrate, 
and consequently the incorporation of tritium from 3H20 provides a 
14 
measure of total de~ lipogenesis, whereas the use of [1- C] acetate 
measures lipogenesis from that substrate alone. A further advantage of 
using 3H2o is that substrate pool size problems are minimized. Such 
problems may arise with the use of [1-14c] acetate, and possible differ-
ences in pool size were not considered in the present study, since the 
cellular pool size of acetyl-CoA was not determined. 
136 
Initial experiments were performed to establish a suitable incub-
ation period for studying the incorporation of tritium from 3H20 into 
total lipid by liver slices from control and oestrogen-treated male 
chicks. The effect of incubation time (0 - 60 min) on the incorpor-
ation of tritium from 3H2o into total lipid by chick liver slices is 
shown in Fig. 16. The data show that liver slices from control and 
oestrogen-treated chicks exhibit a lag period of about 10 minutes, after 
which incorporation of tritium from 3H2o into lipid is linear until at 
least 60 minutes. An incubation period of 60 minutes was, therefore, 
adopted for all subsequent incubations involving the incorporation of 
tritium from 3H2o into total lipid by chick liver slices. 
Experiments were carried out to investigate the incorporation of 
tritium from 3H2o into total lipid by liver slices from untreated chicks, 
chicks treated with a single intramuscular injection of 1 mg 17B-
oestradiol in propane-1,2-diol/100 g body weight, and chicks treated 
with an equivalent volume of propane-1,2-diol only. Birds were sacri-
ficed at varying times after injection and liveD slice incubations were 
performed as described in the Methods section. Chicks were also in-
eluded that had received an injection every day for 7 or 11 days and 
which were sacrificed 24 hours after the last injection. Incubations 
were performed in triplicate for each liver. The results of these 
experiments are presented in Figs. 17 - 19 and in Table 10. In Table 
10, the chicks have been allocated to groups dependent upon treatment 
and upon the time of death after a single injection (3~ - 43k h), or 
upon the number of injections received (7 or 11). Wherever possible, 
the results for each group of oestrogen-treated chicks have been com-
pared with the results for the corresponding group of control chicks. 
The data were analyzed statistically by Student's 't' test, and levels 
of statistical significance are indicated where appropriate. 
FIGURE 16 
The effect of incubation time on the incorporation of tritium from 
3H2D into total lipid by liver slices from control and oestrogen-
treated chicks 
Oestrogen-treated chicks received a single intramuscular injection 
of 17 S-oestradiol in propane-1,2-diol (1 mg hormone/100 g body wt.) 
24 hours before death, or daily for 7 days prior to sacrifice. 
Control chicks received an equivalent volume of propane-1,2-diol daily 
for 7 days or 11 days prior to sacrifice. 
Chick liver slices (150 ± 10 mg, wet wt.) were incubated at 40°C 
in 3 ml avian bicarbonate buffer, pH 7·4, containing 5 mM-sodium ace-
3 tate, 10 mM-0-glucose and 2 mCi H2o. Total lipid was extracted at 
the times indicated. 
(a) values for control chicks 
(b) values for oestrogen-treated chicks 
Each value represents the average of single or duplicate deter-
minations for 2 chicks. 
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FIGURE 17 
The incorporation of tritium from 3H2D into total lipid by liver slices 
(wg atoms H incorporated/100 mg liver/h) from control and oestrogen-
treated male chicks at varying times after injection 
Oestrogen-treated chicks received a single intramuscular injection 
of 1 mg 17 S-oestradiol in propane-1,2-diol/100 g body weight. Control 
chicks received an equivalent volume of propane-1,2-diol only. Un-
treated chicks were also included in the experiments. At the indicated 
times after injection, birds were sacrificed and liver slices were pre-
pared. Chicks receiving multiple injections were injected every day 
for 7 or 11 days, and were sacrificed 24 hours after the last injection. 
Liver slices (150 ± 10 mg, wet wt.) were incubated at 40°C in 3 ml 
avian bicarbonate buffer, pH 7·4, containing 5 mM-sodium acetate, 10 mM-
3 0-glucose and 1 - 2 mCi H20. Total lipid was extracted after a 60 
minute incubation. 
A values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the average of 3 determinations for a single 
bird. 
Chicks were aged 2- 5 weeks . 
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FIGURE 18 
The incorporation of tritium from 3H20 into total lipid by liver 
slices (wg atoms H incorporated/liver/min) from control and oestrogen-
treated male chicks at varying times after injection 
See legend of Fig. 17 for experimental details. 
A values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the average of 3 determinations for a 
single bird. 
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FIGURE 19 
The incorporation of tritium from 3H2D into total lipid by liver slices 
(ug atoms H incorporated/0·1 mg liver DNA/h) from control and oestrogen-
treated male chicks at varying times after injection 
See legend of Fig. 17 for experimental details. 
A values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the average of 3 determinations for a single 
bird. 
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TABLE 10 
The incorporation of tritium from 3H2o into total lipid by liver slices from control and oestrogen-treated male chicks 
at varying times after injection 
Incorporation of Time after a single injection (h) Multiple 
tritium from 3H20 
Untreated injections 
3~ - 7! 14 - 17 19 - 21 ~ 25! - 28~ 29! - 31~ 40! - 43! X 7 X 11 
E 17·6±1·5 20·8 ± 2·7 15·9±1·5 20·6 ± 2·4 11.8 ± 1 • 2 18·8 ± 3·2 8·6 7·0 
(6) (6) (6) (7) (2) (6) ( 1 ) ( 1 ) 
).19 atoms H/ 9·6 ± 1·4 
100 mg liver/h (8) 
c 16·3 ± 2·B 15·7 ± 2·1 11·7 ± 2·0 15·8 ± 3·3 7·7 12·1 ± 1·5 12· 2 11 . 0 
(6) (6) (6) (7) ( 1 ) (6) (1) ( 1 ) 
tt b. tt tt 
E 28·3 ± 1·5 46.5 ± 5 ·1 40·0 ± 3·9 48·4 ± 3·7 23·3 ± 12·2 53·5 ± 9·0 12 ·0 13· 7 
].19 atoms H/ (6) (6) (6) (7) (2) (6) ( 1 ) ( 1 ) 
liver/min 16·5 ± 2·2 
(B) 
c 26·8 ± 4·2 26·6 ± 2·9 20·3 ± 2·6 25·5 ± 5·7 5·0 22.3 ± 2 ·1 12 ·1 15 ·1 
(6) (6) (6) (7) ( 1 ) (6) (1) ( 1 ) 
tt &. t :j: 
E 6·2 ± 0·3 9·3±.1·0 6·4 ± 0·3 9·6 ± 1·2 5·3 B·1 ± 1 ·4 N.D. N.D. 
].19 atoms H/ (6) (6) (6) (7) ( 1 ) (6) 
0·1 mg DNA/h 3·3 ± 0·4 
(B) 
c 5·7 ± 1 ·0 5·3 ± 0·6 3·6 ± 0·5 5·0 ± 1 ·3 N.D. 4·0 ± 0·3 N.D. N.D. 
(6) (6) (6) (6) (6) 
~:·'_-._., 
J 
See legend of Fig. 17 for experimental details. 
Incubations were performed in triplicate, and the results are the average values for a single chick or the 
means (± S.E.M.) of the average values obtained from 2- 8 chicks. The number of birds involved in each group is 
given in parentheses. 
E = values for oestrogen-treated chicks 
C = values for control chicks 
N.D. = not determined 
Data were analyzed statistically by Student's 't' test, and levels of statistical significance are presented 
with respect to values for corresponding control chicks. 
·t significant at P < 0·05 
* 
significant at P < 0·02 
tt significant at P < 0·01 
6 significant at P < 0·002 
£ significant at P < 0·001 
---" 
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In Fig. 17 and Table 10, the results of the experiments have been 
expressed as ~g atoms H incorporated/100 mg liver/hour. As was found 
in the acetate incorporation studies, there was a lot of variability 
among birds. Statistical analysis of the results showed that none of 
the values for the oestrogen-treated groups of chicks differed signifi-
cantly from the values for their corresponding control groups (Table 10). 
However, for all groups receiving a single injection, the mean value for 
the oestrogen-treated chicks was greater than the mean value for the con-
trol chicks in each time group. In addition, it is of interest to note 
that the results for the untreated chicks were found to be significantly 
lower than the results for the 3~ - 7* hand 14- 17 h control groups 
(P < 0·05). The mean values for the 3~ - 7k h and 14 - 17 h control 
groups were approximately 70% and 64% higher, respectively, than the 
mean value for the untreated group of chicks. Insufficient data pre-
vented any sort of statistical analysis or deductions being made about 
the effect of multiple injections on tritium incorporation from 3H 0 2 
into total lipid by liver slices. 
In Fig. 18 and Table 10, the results of the experiments have been 
expressed as ~g atoms H incorporated/liver/minute. Between approxi-
mately 14 and 43 hours after a single oestrogen injection, the values 
for the incorporation of tritium from 3H2o into total lipid appeared to 
be generally greater than the values for untreated and control chicks 
(Fig. 18). Statistical analysis of the results showed that the values 
for the oestrogen-treated chicks in the 14 - 17 h, 19 - 21~ h, 25k -
28~ h and 40k - 43k h groups were significantly greater than the values 
for their corresponding control chicks with probabilities (P) of less 
than 0·01, 0·002, 0·01 and 0·01 respectively. The mean values for these 
oestrogen-treated groups of birds were approximately 1 ·75-fold, 1·97-fold, 
1 ·90-fold and 2·40-fold greater, respectively, than the mean values for 
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their corresponding control groups. The results for the untreated 
chicks were found to be significantly lower than the results for the 
3~ - 7! h control group (P < 0·05) and the 14 - 17 h control group 
(P < 0 · 02). The mean values for the 3~ - 7! h and 14 - 17 h control 
groups were approximately 1·62-fold and 1·61-fold higher, respectively, 
than the mean value for the untreated group of chicks. Insufficient 
data prevented any analysis of the results from the birds that had re-
ceived multiple injections. 
In Fig. 19 and Table 10, the results of the experiments have been 
expressed as ~g atoms H incorporated/0·1 mg liver DNA/hour. Between 
approximately 14 and 43 hours after a single oestrogen injection, the 
values for the incorporation of tritium from 3H2o into total lipid had 
a tendency to be greater than the values for untreated and control 
chicks (Fig. 19). Statistical analysis of the results showed that the 
values for the oestrogen-treated chicks in the 14 - 17 h, 19 - 21~ h, 
25! - 28~ h and 40! - 43! h groups were significantly greater than the 
results for their corresponding control groups with probabilities (P) 
of less than 0·01, 0·001, 0·05 and 0·02 respectively. The mean values 
for these oestrogen-treated groups of chicks were approximately 1·76-
fold, 1·78-fold, 1·92-fold and 2·03-fold greater, respectively, than the 
mean values for their corresponding control groups. The results for 
the group of untreated chicks were significantly lower than the re-
sults for the 3~ - 7! h control group (P < 0·05) and the 14 - 17 h con-
trol group (P < 0·01), the mean values for these control groups being 
1·73-fold and 1·61-fold higher, respectively, than the mean value for 
untreated chicks. 
The results of the saponification and t.l.c. analyses of lipid ex-
tracts from control and oestrogenized chick liver slices, after incub-
ation with 3H20, are presented in Tables 8 and 9. The recovery of 
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radioactivity in the saponification procedure was routinely about 80% 
(Table 8). On average, for samples from control chicks, about 4% of 
this was attributable to non-saponifiable lipids and about 96% to fatty 
acids derived from complex lipids. For samples from oestrogen-treated 
chicks, on average about 6·5% of the recovered radioactivity was attri-
butable to non-saponifiable lipids and about 93·5% to fatty acids de-
rived from complex lipids. These percentages of the recovered 
radioactivity in non-saponifiable lipids and fatty acids of complex 
lipids were not found to differ significantly for control and oestrogen-
treated chicks. 
The recovery of radioactivity from t.l.c. plates in the 3H2o in-
corporation studies was routinely about 65% (Table 9). For lipid ex-
tracts from control chick liver slices, about 86·9% of the label was 
located in triacylglycerol, with about 6·1% being located at the origin 
(phospholipid), 0·2% in monoacylglycerol, 4·4% in diacylglycerol and 
cholesterol, and about 0·4% in free fatty acids. A similar distri-
bution of the label in the lipid classes was observed for lipid extracts 
from liver slices of oestrogenized chicks, with about 87·2% of the label 
being located in triacylglycerol, 6·0% at the origin (phospholipid), 
0·2% in monoacylglycerol, 4·1% in diacylglycerol and cholesterol, and 
0·4% in free fatty acids. There were no significant differences be-
tween control and oestrogen-treated liver lipid extracts in the percen-
tages of the recovered radioactivity in the lipid classes. 
3. [9,10-3H] Palmitate incorporation studies 
The capacity of liver slices from untreated, oestrogen-treated and 
control chicks to incorporate pre-formed fatty acids into complex lipids 
was investigated by measuring the incorporation of [9,10-3H] palmitate 
into neutral lipids. From the incorporation studies using [1-14c] 
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acetate and 3H2o it was evident that the main product of lipogenesis was 
triacylglycerol, since t.l.c. analyses showed that the majority of the 
label was recovered in the triacylglycerol fraction in each case. The 
lipid extracts from [9,10-3H] palmitate incubations were, therefore, 
subjected to t.l.c. analysis, and the triacylglycerol fractions were 
isolated for counting. Initial experiments were carried out to es-
tablish a suitable incubation time and palmitate concentration for 
studying the incorporation of [9,10- 3H] palmitate into triacylglycerol 
by liver slices from control and oestrogen-treated chicks. Oestro-
genized chicks received a single intramuscular injection of 1 mg 17S-
oestradiol in propane~1,2-diol/100 g body weight approximately 48 hours 
before death. Control chicks received an equivalent volume of propane-
1,2-diol only. 
The effect of incubation time on the incorporation of [9,10-3H] 
palmitate into triacylglycerol was studied using a palmitate concen-
tration of 0·65 mM, since Hawkins & Heald (236 ) adopted a similar con-
centration in their studies. The results of th~s investigation are 
presented in Fig. 20. The data do not show the existence of an initial 
lag phase, and the results for liver slices from both control and 
oestrogen-treated chicks suggested that the incorporation of [9,10-3H] 
palmitate was linear for at least 90 minutes. A 60 minute incubation 
period was adopted in all subsequent incubations since this incubation 
time had been used for the [1-14c] acetate and 3H2o incorporation studies 
and it seemed adequate. 
The effect of palmitate concentration on the incorporation of 
[9,10-3H] palmitate into triacylglycerol by chick liver slices, during 
a 60 minute incubation, was investigated over a palmitate concentration 
range of 0·162 to 1·293 mM. The results of this investigation are pre-
sented in Fig. 21, from which it can be seen that incorporation increased 
FIGURE 20 
The effect of incubation time on the incorporation of 0·65 mM-
[9,10-3H] palmitate into triacylglycerol by liver slices from control 
and oestrogen-treated chicks 
Each oestrogen-treated chick received a single intramuscular in-
jection of 1 mg 17S-oestradiol in propane-1,2-diol/100 g body weight 
48 hours before death. Control birds received an equivalent volume 
of propane-1,2-diol only. 
Chick liver slices (150 ± 10 mg, wet wt.) were incubated at 40°C 
in 3 ml avian bicarbonate buffer, pH 7·4, containing 12 mM-S-0(-)-
fructose and 0·65 mM-[9,10- 3H] palmitate (1·95 wei). Total lipid was 
extracted at the times indicated, and lipid classes were separated by 
t.l.c. as described in the text. 
(a) values for control chicks 
(b) values for oestrogen-treated chicks 
Each value represents the average of single determinations for 
2 birds. 
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FIGURE 21 
The effect of palmitate concentration on the incorporation of 
[9,10-3H] palmitate into triacylglycerol by liver slices from control 
and oestrogen-treated chicks 
Each oestrogen-treated chick received a single intramuscular in-
jection of 1 mg 17 S-oestradiol in propane-1,2-diol/100 g body weight 
48 hours before death~ Control chicks received an equivalent volume 
of propane-1,2-diol only. 
Chick liver slices (150 ± 10 mg, wet wt.) were incubated at 40°C 
in 3 ml avian bicarbonate buffer, pH 7·4, containing 12 mM-S-0(-)-
fructose and 0·162 to 1·293 mM-[9,10- 3H] palmitate (3 ~Ci/~mole). 
Total lipid was extracted after a 60 minute incubation, and lipid 
classes were separated by t.l.c. as described in the text. 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the average of single determinations for 
2 birds. 
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FIGURE 22 
The incorporation of 0·65 mM-[9,10- 3H] palmitate into triacylglycerol 
by liver slices (nmol palmitate incorporated/100 mg liver/h) from 
control and oestrogen-treated male chicks at varying times after in-
jection 
Oestrogen-treated chicks received an intramuscular injection of 
1 mg 17 8-oestradiol in propane-1,2-diol/100 g body weight. Control 
chicks received an equivalent volume of propane-1,2-diol only. Un-
treated chicks were also included in the experiments. At the indicated 
times after injection birds were sacrificed and liver slices were pre-
pared. 
Liver slices (150 ± 10 mg, wet wt.) were incubated at 40°C in 3 ml 
avian bicarbonate buffer, pH 7·4, containing 12 mM-8-D(-)-fructose and 
0·65 mM-[9,10- 3H] palmitate (1·95 ~Ci). Total lipid was extracted 
after a 60 minute incubation, and lipid classes were separated by 
t.l.c. as described in the text. 
A values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the mean result from 3 incubations for a 
single bird. 
Chicks were aged 4- 4t weeks. 
149 
with increasing palmitate concentration in a curvilinear fashion. 
A palmitate concentration of approximately 0·65 mM was chosen for use in 
all subsequent incubations, since very high palmitate concentrations 
would have been needed to completely saturate the system, and such high 
concentrations would have been very difficult, if not impossible, to 
prepare. Plasma free fatty acid levels have been presented in the 
literature, ranging from 0·2 to 0·5 mM in the immature domestic fowl to 
1 to 3 mM in the mature laying hen, whilst at the point of lay levels 
can reach 4·5 mM (S?, 127 ' 236 ) Hawkins & Heald (236 ) injected 11-
week old pullets with 2 mg oestradiol monobenzoate on alternate days for 
7 days, and obtained plasma free fatty acid levels on the Bth day of 
7·2 - 7·7 mM, compared with 0·5 - 0·9 mM for untreated pullets. These 
workers also showed that the incorporation of palmitate into neutral 
lipids by liver slices from immature and laying domestic fowl increased 
linearly with increasing palmitate concentration to at least 2·13 mM. 
Experiments were ~arried out to investigate the incorporation of 
[9,10-3H] palmitate into triacylglycerol by liver slices from untreated 
chicks, chicks treated with a single intramuscular injection of 1 mg 
17 S-oestradiol in propane-1,2-diol/100 g body weight, and chicks in-
jected with an equivalent volume of propane-1,2-diol only. Birds were 
sacrificed at varying times after injection, and liver slice incubations 
were performed as described in the Methods section. The results of 
these experiments are presented in Figs. 22 - 24 and in Table 11. In 
Table 11, the chicks have been allocated to groups dependent upon treat-
ment and upon the time of death after a single injection (3i- 51i h). 
The results for each group of oestrogen-treated chicks have been compared 
with the results for the corresponding group of control chicks. The 
data were analyzed statistically by Student's 't' test, and levels of 
statistical significance are presented in the table and text where 
appropriate. 
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FIGURE 23 
The incorporation of 0·65 mM-[9,10-3H] palmitate into triacylgly-
cerol by liver slices (nmol palmitate incorporated/liver/min) from 
control and oestrogen-treated male chicks at varying times after 
injection 
See legend of Fig. 22 for experimental details. 
A values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
Each value represents the mean result from 3 incubations for 
a single bird. 
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TABLE 11 
The incorporation of 0·65 mM-[9,10- 3H] palmitate into triacylglycerol by liver slices from control and oestrogen-
treated male chicks at varting times after injection 
Incorporation of Untreated 
Time after injection (h) 
[9,10-3H] palmitate 3~ - 8 14~ - 18~ 19 - 22! 28 - 31~ 40~ - 44 45~ - 51~ 
t t :j: 
E 113 ··2 ± 8·0 108·8 ± 4·5 108·8 ± 5·6 122·3 ± 8·6 117·1 ± 8·3 101.6 ± 7·5 
nmol palmitate/ (6) (6) (6) (6) (6) (4) 
100 mg liver/h 106.2 ± 11 . 6 (6) 
c 111 ·2 ± 6·9 95·5 ± 5·9 91 ·6 ± 4·7 96·4 ± 6·4 90·8 ± 4·4 109.2 ± 8·3 
(6) (6) (6) (5) (6) (4) 
tt ! b:. ! 
E 197.6 ± 15.8 229 ·8 ± 20·1 277·6 ± 16·1 381 ·8 ± 39·6 389·9 ± 45·5 341 ·9 ± 54·0 
nmol palmitate/ (6) (6) (6) (6) (6) (4) 
liver/min 189.7 ± 1 g. 2 (6) 
c 201 . 6 ± 11 . 6 142.6 ± 14.6 171 • 4 ± 15 ·1 168· 7 ± 20·0 157 ·7 ± 13 ·4 212·0 ± 20·2 
(6) (6) (6) (5) (6) (4) 
! ! tt ! 
E 41 ·1 ± 4·0 40·6 ± 1 • 2 43·9 ± 2·3 50·8 ± 4·4 52·1 ± 4·6 N.D. 
nmol palmitate/ (6) (6) (6) (6) (6) 35·2 ± 4·7 
0·1 mg DNA/h (6) 
c 38·4 ± 2·7 30·0 ± 1 • 6 28·5 ± 1 . 9 29·5 ± 2·9 27·8 ± 1 ·1 N.D. 
(6) (6) (6) (5) (6) 
See legend of Fig. 22 for experimental details. 
Incubations were performed in triplicate and the incubation products from a bird were combined to give a single 
value. The results are the means (± S.E.M.) of values obtained from 4- 6 chicks. The number of birds involved in 
each group is given in parentheses. 
E = values for oestrogen-treated chicks 
C = values for control chicks 
N.D. = not determined 
Data were analyzed statistically by Student's 't' test, and levels of statistical significance are presented with 
respect to values for corresponding control chicks. 
t significant at P < 0·05 
* 
significant at P < 0·02 
tt significant at P < 0·01 
~ significant at P < 0·002 
£ significant at P < 0·001 
__, 
U1 
+::-
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In Fig. 22 and Table 11, the results of the experiments have been 
expressed as nmoles palmitate incorporated into triacylglycerol/100 mg 
liver/hour. From Fig. 22 it is difficult to detect differences be-
tween the results for the untreated, control and oestrogen-treated 
chicks, although at times later than 15 hours after injection the values 
for the oestrogen-treated chicks showed a tendency to be greater than 
corresponding control values. Statistical analysis of the results 
showed that the values for the oestrogen-treated chicks in the 19 -
22! h, 28 - 31~ h and 40~ - 44 h groups were significantly greater than 
the results for the corresponding control chicks with probabilities (P) 
of less than 0·05, 0·05 and 0·02 respectively. The mean values for 
the oestrogen-treated chicks in the 19 - 22! h, 28 - 31~h and 40~ - 44 h 
groups were approximately 19%, 27% and 29% higher, respectively, than 
the mean values for their corresponding control groups. The values 
for the untreated chicks did not differ significantly from any of the 
values for control chicks. 
In Fig. 23 and Table 11, the results of th~ experiments have been 
expressed as nmoles palmitate incorporated into triacylglycerol/liver/ 
minute. From Fig. 23 it is evident that between approximately 17 and 
49~ hours after a single oestrogen injection the palmitate incorporation 
values were generally greater than values for control and untreated 
chicks. The results for the oestrogen-treated chicks in the 14~ -
18~ h, 19 - 22! h, 28 - 31~ h and 40~ - 44 h groups were significantly 
greater than the results for the corresponding control chicks with pro-
babilities (P) of less than 0•01, 0·001, 0·002 and 0·001 respectively. 
The mean values for the oestrogen-treated chicks in the 14~ - 18~ h, 
19- 22! h, 28- 31~ hand 40~- 44 h groups were approximately 1·61-
fold, 1·62-fold, 2·26-fold and 2•47-fold greater, respectively, than the 
mean values for their corresponding control groups. The values for the 
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untreated birds were not significantly different from any of the values 
for control birds. 
In Fig. 24 and Table 11, the results of the experiments have been 
expressed as nmoles palmitate incorporated into triacylglycerol/0·1 mg 
liver DNA/hour. Between approximately 15 and 44 hours after a single 
oestrogen injection, the palmitate incorporation values were generally 
greater than corresponding control values (Fig. 24). Statistical 
analysis of the data showed that the results for the oestrogen-treated 
chicks in the 14~ - 18~ h, 19 - 22k h, 28 - 31~ h and 40~ - 44 h groups 
were significantly greater than the results for the corresponding con-
trol birds with probabilities (P) of less than 0·001, 0·001, 0·01 and 
0·001 respectively. The mean values for the oestrogen-treated chicks 
in the 14~ - 18~ h, 19 - 22k h, 28 - 31~ h and 40~ - 44 h groups were 
approximately 35%, 54%, 72% and 87% greater, respectively, than the 
mean values for their corresponding control groups. The values for 
the untreated chicks did not differ significantly from any of the values 
for control chicks. 
In these [9,10-3H] palmitate incorporation studies only the iodine-
staining areas on the t.l.c. plates were removed and counted, and the 
recovery of radioactivity was generally about 70%. The distribution 
of the label in the lipid classes is presented in Table 12. For lipid 
extracts from control and untreated chick liver slices, about 92·3% of 
the recovered radioactivity was attributable to triacylglycerol, with 
approximately 3·3% of the label being located as free fatty acid, 2·7% 
at the origin (phospholipid) and 1 ·3% in diacylglycerol and cholesterol. 
A similar distribution of the label in the lipid classes was observed 
for lipid extracts from liver slices of oestrogen-treated chicks, with 
about 92·9% of the label being located in triacylglycerol, about 2·8% 
as free fatty acid, 2·6% at the origin (phospholipid) and about 1·3% in 
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Values are the means(± S.E.M.) of the results for 34- 65 chicks. 
The number of observations involved in each group is given in parentheses. 
Oestrogen-treated chicks received a single intramuscular injection of 1 mg 17S-oestradiol in propane-1,2-diol/ 
100 g body weight. Control chicks received an equivalent volume of propane-1,2-diol only. 
At various times after injection, chicks were sacrificed and liver slices were prepared. Liver slices 
(150 ± 10 mg, wet wt.) were incubated in 3 ml avian bicarbonate buffer, pH 7·4, containing 12 mM-S-0(-)-fructose and 
0·65 mM-[9,10-3H] palmitate (1·95 ~Ci). Total lipid was extracted after a 60 minute incubation at 40°C, and lipid 
classes were separated by t.l.c. as described in the text. 
Data were analyzed statistically by Student's 1 t 1 test, and levels of statistical significance are presented where 
appropriate. 
tt significant at P < 0·01 
__. 
Ul 
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diacylglycerol and cholesterol. A significantly greater percentage 
of the recovered radioactivity was located in free fatty acid after 
t.l.c. analysis of lipid extracts from control and untreated chick 
liver slices than was obtained for lipid extracts from oestrogen-
treated chick liver slices (P < 0·01). In addition, a significantly 
greater percentage of the recovered radioactivity was located in tri-
acylglycerol in lipid extracts from oestrogen-treated chick liver 
slices than in lipid extracts from control and untreated chick liver 
slices (P < 0·01). 
DISCUSSION 
1. [1-14c] Acetate incorporation studies 
* Acetate thiokinase (EC 6.2.1.1) is responsible for the conversion 
of [1-14c] acetate to labelled acetyl-CoA, and the activity and location 
of this enzyme are, therefore, extremely important when acetate is being 
used as a precursor for lipids. The 14c-labelled acetyl-CoA can enter 
the Krebs cycle, or be converted to fatty acids via the actions of 
acetyl-CoA carboxylase (EC 6.4.1.2) and fatty acid synthetase. 
The incorporation of labelled acetyl-CoA into fatty acids 
will, therefore, be dependent upon the rate of entry of labelled 
acetyl-CoA into the Krebs cycle. In addition to the acetyl-CoA formed 
from acetate, acetyl-CoA can also be formed from other precursors such 
as pyruvate, and by the degradation of fatty acids and amino acids. 
Hence, the labelled acetyl-CoA pool formed from [1-14c] acetate will be 
diluted by unlabelled acetyl-CoA formed from these other precursors. 
Acetate is a poor physiological substrate for the production bf 
acetyl-CoA in chick liver, but it was chosen for use in the present 
* Acetyl- Co A synthetase 
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studies of de ~ lipogenesis because its conversion to acetyl-CoA in-
valves only one metabolic step, and it does not readily enter other 
metabolic pathways. 
De novo lipogenesis from [1-14c] acetate by livers of control and 
oestrogen-treated male chicks was studied by incubating liver slices in 
avian bicarbonate buffer for 1 hour at 40°C, in the presence of 10 mM-
14 . 
sodium [1- C] acetate. These conditions resemble those adopted by 
other workers in similar studies with chick liver preparations. All 
incubations were performed at 40°C, since this temperature closely 
approximates chick body temperature and 
of chick metabolism by Goodridge (34 ). 
and Kudzma et al. (113 ) and Weiss et al. 
has been widely 
Leveille (33 ) 
(237) 
employed 
used in studies 
emp~oyed 38°C, 
37°C as the in-
cubation temperature during chick liver slice studies. On the other 
hand, Hawkins & Heald (236 ) and Duncan ( 238 ) adopted temperatures of 
41 ·3°C and 41 ·5°C, respectively, which are within the actual range of 
body temperature of the domestic fowl (391 ). The concentration of 
sodium [1-14c] acetate found to produce maximum.incorporation into lipid 
in the present study was 10 mM, which is the same as that reported by 
Leveille (239 ) and suggested by Goodridge (276 ). The data presented 
in Fig. 12 show that inhibition of incorporation occurs with acetate 
concentrations greater than 10 mM. In the present investigation, liver 
slices synthesized lipids from 10 mM-sodium [1-14c] acetate in a linear 
fashion for 1 hour. This is a somewhat shorter period than observed 
by several other workers, who have reported linear incorporation of 
labelled acetate into lipid by liver slices for up to 3 hours (33 , 113 ' 
237 - 239, 276, 392) The initial lag phase was undoubtedly the re-
sult of delays in the diffusion of the labelled substrate into the cells 
and in the equilibration of the labelled acetyl-CoA with the unlabelled 
pool of acetyl-CoA, and also of the time taken by the tissue to attain 
the correct temperature. 
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The results of the acetate incorporation studies were expressed as 
nmoles acetate incorporated into lipid/100 mg liver/hour, as nmoles 
acetate incorporated into lipid/liver/minute and as nmoles acetate 
incorporated into lipid/0·1 mg liver DNA/hour (Figs. 13 - 15, Tables 6 
and 7). Treating male chicks with oestrogen results in an increase in 
the size and weight of the liver, as shown in Chapter 2. It was, there-
fore, considered important to determine the total hepatic capacity for 
lipogenesis in each case, so as to ascertain whether variations in lipo-
genic capacity were the result of different liver sizes. This liver 
enlargement associated with oestrogen treatment is considered to be 
predominantly caused by cell expansion, as a result of water uptake and 
1 t . f 1. . d . th 11 d. . . ( 242 ) c tl accumu a 1on o 1p1 , Wl some ce 1V1s1on • onsequen y, a 
unit wet weight of liver from an oestrogen-treated chick would un-
doubtedly contain fewer cells than an equivalent unit wet weight of 
liver from a control or untreated chick. It was considered important, 
therefore, to express incorporation results on a cellular basis, which 
was accomplished by determining the DNA content.of the liver in each 
case, and by expressing the results as rates of incorporation per unit 
weight of DNA. By presenting the data in these various ways, it was 
hoped that any differences in the capacities of the livers to incorporate 
[1-14c] acetate into total lipid, either at the cellular level or on the 
level of the whole organ, would become apparent. 
When acetate incorporation into total lipid was expressed as nmoles 
acetate/100 mg liver/hour (Fig. 13, Table 6), a significant difference 
between the results for oestrogen-treated and control birds was obtained 
at 17- 21~ hours after injection (P < 0·01). The mean value for the 
oestrogen-treated chicks in this group was approximately 2-fold greater 
than the mean value for the control chicks. In the absence of an 
appropriate control group, the results for the oestrogen-treated birds 
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in the 30 - 31 h group were compared with those for the control birds 
in the other groups and were found to be significantly greater than the 
results for the 12k - 14k h control group (P < 0·05). However, these 
control groups are not directly comparable with the 30 - 31 h oestrogen-
treated group and, therefore, such comparisons cannot be considered to 
be valid It should be noted at this stage that the 1 DO mg samples 
of liver from the oestrogen-treated chicks would be expected to contain 
fewer cells than the 100 mg samples of liver from the control chicks. 
When the acetate incorporation results were expressed as nmoles 
acetate incorporated/liver/minute (Fig. 14, Table 6), the results for 
the oestrogen-treated chicks in the 17 - 21i h group were, once again, 
significantly greater than the results for the corresponding control 
chicks (P < 0·002). In this case, the mean value for the oestrogen-
treated chicks was more than 3-fold greater than the mean value for the 
control group. Hence, expressing the results on a total organ basis 
increased the difference between oestrogenized and control values that 
had been revealed when the results were expressed per 100 mg liver. 
Therefore, at this time after injection the lipogenic capacity of a unit 
weight of oestrogen-treated liver appears to be greater than that of an 
equivalent weight of control liver, and in addition, the lipogenic 
capacity of the oestrogenized liver is increased still further by virtue 
of an increase in liver size. Expression of the acetate incorporation 
data as nmoles acetate incorporated/liver/minute (Fig. 14) clearly shows 
a greater divergence between the oestrogenized and control values after 
about 17 hours post-injection than is evident from Fig. 13 in which in-
corporation was expressed per 100 mg liver. The results obtained for 
the oestrogenized chicks in the 30 - 31 h group were found to be signifi-
cantly greater than the control values in all the other groups. Had 
control birds been included in the 30 - 31 h group, it would seem likely 
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that the results for the oestrogenized birds would have been signifi-
cantly greater than these too, but this has not been shown. Expressing 
the data as total organ incorporation increased the differences between 
the oestrogenized birds in the 30 - 31 h group and control birds that 
had been evident when the results were expressed per 100 mg liver. 
Rosebrough et al. (251 ) .have also observed a greater difference 
between the livers of oestrogen-treated and control birds in their lipo-
genic capacity from acetate when results were expressed on a whole liver 
basis rather than a unit liver weight basis. These workers injected 
Large White turkey hens with 100 mg 17 S-oestradiol (a 25 mg dose 
followed by a 75 mg dose one week later) in corn oil, or with corn oil 
only. One week after the last dose hens were killed, livers were 
isolated and liver slices were prepared. The liver slices were in-
cubated with sodium [1-14c] acetate and incorporation of [1-14c] acetate 
into the fatty acids of complex lipids was determined. When results 
were expressed as nmoles acetate incorporated/100 mg liver/2 hours, hens 
treated with 17 S-oestradiol synthesized fatty acids at a 1·5-fold 
greater rate than the control hens. When results were expressed on a 
whole liver basis, hens treated with 17 S-oestradiol synthesized fatty 
acids at a 2·5-fold greater rate than the control hens. 
Expression of the acetate incorporation data on a cellular basis 
also reveals divergence between values for oestrogenized and control 
chicks (Fig. 15). From Table 6, it can be seen that the results for 
oestrogen-treated chicks were significantly greater than those for con-
trol chicks at 17 - 21i and 4Bi - 55~ hours after injection, with the 
greatest difference being observed in the 17- 21i h group (P < 0·01). 
The mean value for this group of oestrogen-treated chicks was about 
2·76-fold greater than the control value, indicating that the liver 
cells of the oestrogen-treated birds had a greater capacity to incor-
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porate [1-14c] acetate into lipids than did those of control birds. 
The fact that the difference is increased to 3-fold when results are 
compared on a total organ basis implies that not only do the cells of 
the oestrogen-treated livers have an enhanced capacity to synthesize 
lipids from [1-14c] acetate, but that there may be more cells present 
in the livers of the oestrogen-treated chicks. Once again, the re-
sults for the 30 - 31 h oestrogen-treated group were significantly 
greater than the control values at 12! - 14!, 17 - 21i and 4Bi - 55~ 
hours. 
The results presented in Tables 6 and 7 show that expression of 
the incorporation data on a total liver basis or a cellular basis re-
veals or increases differences between values for oestrogen-treated and 
control chicks that are not obvious, or are smaller, when results are 
expressed per unit weight of liver. The values for the 4Bi - 55~ h 
group are particularly interesting in this respect. Expression of 
these results as nmoles acetate incorporated/100 mg liver/hour revealed 
a mean value for the oestrogen-treated chicks w~ich was slightly- lower 
than the mean value for the control chicks, but the difference was not 
significant. On the other hand, when the results were expressed as 
nmoles acetate incorporated/liver/minute, the difference between the 
mean values was reversed. In other words, the mean value for the oes-
trogen-treated birds was greater than the mean value for the control 
birds, although the difference was not significant. These observations 
are perhaps not surprising, since 100 mg of an oestrogen-treated liver, 
at this time after injection, would be expected to contain fewer cells 
than 100 mg of a control liver and, therefore, the same numbers of cells 
are not being compared in the two cases. On the other hand, the livers 
of oestrogen-treated birds at this time are larger than control livers 
and possibly contain more cells and, therefore, the increased incorpor-
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ation of [1-14c] acetate by the livers of oestrogen-treated birds is not 
unexpected. Similar results were obtained for chicks that had received 
6 injections prior to sacrifice (Table 7). Expression of the results 
on a cellular basis (nmoles acetate incorporated/0·1 mg DNA/h) revealed 
a significantly greater incorporation of [1-14c] acetate into lipid by 
oestrogen-treated liver cells than by control liver cells at 4Bi - 55! 
hours after a single injection (Table 6). 
From the results presented in Figs. 13- 15 and Table 6, it would 
appear that the greatest differences between values for oestrogen-
treated and control birds were obtained at 17 - 21i hours after injection. 
Significantly greater [1-14c] acetate incorporation values were ob-
tained for oestrogen-treated chicks, compared with control chicks, at 
17 - 21i hours after injection when results were expressed on a unit 
liver weight, a total liver weight, and a cellular basis, despite the 
fact that 100 mg of the oestrogen-treated livers probably contained 
fewer cells than 100 mg of the control livers. The results indicate 
that the oestrogen-treated cells have a far greater lipogenic capacity 
than the control cells, and that the increased total lipogenic capacity 
of the oestrogen-treated liver is primarily the result of this and, to 
a lesser extent, of a greater number of cells. 
The results obtained for the distribution of radioactivity in the 
lipid classes separated by t.l.c., in the [1-14c] acetate incorporation 
studies, showed that about 66·5 - 69·5% of the recovered radioisotope 
was in the triacylglycerol fraction, with phospholipids accounting for 
the next highest recovery of 13·0- 16·4% (Table 9). These results are 
( 113) 
similar to those reported by Kudzma et al. , who also showed that 
[14c] acetate was incorporated predominantly into triacylglycerol by 
chick liver slices, with phospholipid being the next important fraction. 
Kudzma et al. (113 ) treated 5-day old chicks with 0·1 mg diethylstil-
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bestrol in sesame oil/day for 18 days and, after incubating liver slices 
with [14c] acetate, reported that a greater proportion of the radio-
isotope was recovered in triacylglycerol and a lesser proportion in 
phospholipid for liver slices of the oestrogen-treated chicks (75% and 
17% respectively) than for those of control chicks injected with sesame 
oil only (51% and 29% respectively). These results are in agreement 
with observations made in the present study. Similar distributions of 
14
c-label from non-lipid precursors, such as acetate and glucose, in 
the lipid fractions of liver slices and hepatocytes from the domestic 
fowl, have been reported by Weiss et al. (237 ), Goodridge et al. (372 ) 
. (375) (24) 
and Watk1ns et al. , and for the duck by Evans • The in vivo 
experiments performed by O'Hea & Leveille (21 ), to study lipogenesis in 
the chick, showed that after saponification, most of the 14c-label from 
[1-14c] acetate was recovered in fatty acid residues derived from com-
plex lipids, as was found in the present study. These workers also 
showed similar distributions of the label in the triacylglycerol and 
phospholipid fractions as were found in the cur~ent study. 
When the [14c] acetate incorporation results were expressed /g wet 
weight of liver, Kudzma et al. (113 ) showed that livers from chicks 
treated with diethylstilbestrol (0·1 mg hormone each day for 18 days) 
incorporated 3-fold more acetate into total lipid than livers from con-
trol chicks. If the triacylglycerol fraction was considered alone, the 
difference was increased to 4·5-fold. Assuming that liver samples from 
the oestrogen-treated chicks contained fewer cells than samples from 
control chicks, and that oestrogen-treated livers were larger than con-
trol livers, the difference would probably be even greater if the results 
were expressed on a total liver or a cellular basis. The differences 
obtained in the present study (Fig. 13, Table 6) are not as obvious, 
which may have something to do with the use of 17 (3 -oestradiol instead 
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of diethylstilbestrol, the duration and mode of oestrogen treatment, 
and the age and sex of the chicks. Nevertheless, it is of interest to 
note that after the publication of the data in Metab. Clin. ~· in 
1973, Kudzma and his co-workers made several attempts to repeat this 
work and failed to demonstrate increased lipogenesis by liver slices 
from oestrogen-treated chicks using [14c] acetate (personal communi-
cation, 1980). Kudzma et al. (114) did, however, demonstrate that 
[1-14c] acetate, administered in vivo to chicks, was incorporated to a 
greater extent into lipid by livers of chicks (850- 1000 g body wt.) 
treated with a daily dose of diethylstilbestrol (2 mg/day) for 4 days 
than by livers of control chicks. These workers also measured the 
hepatic acetyl-CoA pool sizes for oestrogen-treated and control chicks, 
and found that the concentration of acetyl-CoA was the same in both 
cases. Therefore, on the basis of this result, it is probable that 
the differences in acetate incorporation between control and oestrogen-
treated chicks observed in the present study and in the studies of 
(113 114) . Kudzma et al. ' actually represent d1fferences in lipogenic 
capacity rather than differences in the intracellular pool size and 
specific radioactivity of the acetyl-CoA. 
It is of interest at this point to note similar work that has been 
done using Xenopus laevis. Smith et al. (139 ) used [14c] acetate to 
register a 120 to 160-fold increase in cholesterol and fatty acid syn-
thesis in liver slices from female Xenopus laevis 6 days after they had 
been exposed to oestrogen treatment in vivo (1 mg 17 S-oestradiol/ 
animal). Philipp & Shapiro (140) used [14c] acetate to measure 
cholesterol and fatty acid synthesis in vitro in liver cubes from male 
Xenopus laevis at various times after the administration of 17 S-
oestradiol in vivo ( 0·4 mg/100 g body wt.). These workers observed 
increased hepatic syntheses of cholesterol and fatty acids in these 
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animals compared with control animals, with peak values being obtained 
at 6 days after oestrogen treatment. 
2. 3H2o incorporation studies 
Since acetyl-CoA pool sizes were not determined in the present 
study, it is perhaps rather presumptuous to assume that the pool sizes 
determined by Kudzma et al. (114 ) can be adopted, particularly as the 
chicks were of different strains, age and perhaps sex, and were treated 
for different periods with different oestrogens. To minimize possible 
difficulties imposed by uncertainties about the pool size and specific 
radioactivity of acetyl-CoA leading to equivocal conclusions being 
drawn from the data, and to support the results obtained using [1-14c] 
acetate, de ~ lipogenesis by chick liver slices was also investi-
gated using 3H2o. The use of a 
14C-labelled substrate underestimates 
hepatic fatty acid synthesis, since it does not take into account acetyl-
CoA formed from other substrates, whereas 3H2D is incorporated into fatty 
acids regardless of the nature of the acetyl-CoA. precursor. It would, 
however, seem that the use of 3H20 to measure de novo lipogenesis in the 
livers of chicks after oestrogen treatment may not be ideal, since the 
increase in cell size (and cell water 'pool') caused by oestrogen treat-
ment might be expected to lead to a decrease in the specific radio-
activity of water in the cell and, therefore, to an underestimate of 
hydrogen incorporation into lipid. 
De ~ lipogenesis by livers of untreated, control and oestrogen-
treated chicks was studied by incubating liver slices in avian bicarb-
onate buffer, pH 7·4, containing 3H2o, for 1 hour at 40°C. Adoption of 
an incubation period of 1 hour was based on the data presented in Fig. 
16, and the initial lag period was undoubtedly a result of the delay in 
the diffusion of 3H2o into the cells and equilibration with the unlabelled 
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cellular water, and of the time required for thermoequilibration of the 
tissue in the incubation medium. The reasons for using an incubation 
temperature of 40°C have been explained previously. The results of 
the 3H20 incorporation studies were presented as wg atoms H incorporated 
into lipid/100 mg liver/hour, as wg atoms H incorporated into lipid/ 
liver/minute and as wg atoms H incorporated into lipid/0·1 mg liver DNA/ 
hour (Figs. 17 - 19, Table 10), for reasons explained earlier for the 
[1-14c] acetate incorporation studies. 
When the rate of incorporation of 3H2o into total lipid was ex-
pressed on the basis of a unit wet weight of liver (wg atoms H incor-
porated/100 mg liver/h), it became clear that none of the results for 
the oestrogen-treated groups differed significantly from the results 
for their corresponding control groups, although the mean value for the 
oestrogen-treated chicks was greater than the mean value for the control 
chicks in each post-injection time group. This picture of the data 
was altered, however, when the results were expressed on the basis of 
total hepatic lipogenic capacity (wg atoms H incorporated/liver/min) as 
shown in Fig. 18 and Table 10. In this case, the values for the 
oestrogen-treated birds in the 14 - 17 h, 19 - 21~h, 25! - 28~ h and 
40i - 43! h groups were significantly greater than their corresponding 
control values. Insufficient data prevented statistical analysis of 
the results in the 29! - 31~ h group. These results reflect those ob-
tained in the [1-14c] acetate incorporation studies, since, although 
the lipogenic capacity of a unit weight of oestrogen-treated liver was 
not significantly greater than that of control liver in the time groups 
mentioned above, the total lipogenic capacities of the oestrogen-
treated livers were significantly greater by virtue of an increase in 
liver size. Expression of the 3H2o incorporation data on a cellular 
basis (wg atoms H incorporated/0·1 mg DNA/h) also revealed significantly 
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greater values for oestrogen-treated chicks than for control chicks in 
the 14 - 17 h, 19 - 21~ h, 25~ - 28~ h and 40~ - 43~ h post-injection 
time groups. Therefore, in these time groups, the oestrogen-treated 
cells had a greater lipogenic capacity than the control cells. Com-
parison of the 3H2o incorporation data expressed as the total organ 
lipogenic capacity with that expressed on a cellular basis (Table 10) 
suggests that the oestrogen-dependent stimulation of lipogenesis is 
mainly caused by an enhanced rate of lipogenesis per cell and, to a 
lesser extent, by an increase in cell number. Significant differences 
were not obtained for the chicks in the 3~ - 7~ h group, regardless of 
how the data were expressed. An interesting observation resulting 
from these experiments was that, in whatever way the results were pre-
sented, the values for the untreated chicks were significantly lower 
than the results for the control chicks in the 3~ - 7~ h and 14 - 17 h 
groups, suggesting that fatty acid synthesis may be stimulated at these 
times by handling and/or the injection of propane-1,2-diol. From Figs. 
17 - 19 and Table 10, it would appear that the greatest differences in 
3H20 incorporation into lipid between oestrogen-treated and control 
birds were in the 40~ - 43~ h group, although the differences appear to 
be, at least partly, the result of low control values. The distri-
bution of the 3H-label in the lipid classes separated by t.l.c. was 
similar to that obtained in the [1-14c] acetate studies, and to the 
results obtained by other workers which have been mentioned previously. 
However, in these 3H2o experiments, no significant differences were 
obtained between control and oestrogen-treated chicks in the distribution 
of the radioisotope in the lipid classes. 
In contrast to the many studies that have been carried out using 
14 c -labelled non-lipid precursors of fatty acids to study hepatic lipo-
genesis in oestrogen-treated and control chicks, the use of 3H20 has 
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been rare. . (365) 3 Dasht1 et al. used H20 to measure hepatic lipo-
genesis in vivo in 19-day old male turkeys treated with diethylstil-
bestrol, and reported a 3·4-fold increase in the incorporation of 
tritium from 3H20 into liver triacylglycerol when compared with control 
birds. In a later report, these workers treated 19-day old male tur-
keys with a single dose of diethylstilbestrol (40 mg/kg body wt.), and 
injected birds with 3H20 1 hour prior to sacrifice (
252 ). Total 
hepatic triacylglycerol synthesis, 24 - 48 hours after oestrogen treat-
ment, was found to be increased 8 to 12-fold compared with control 
values. 
3. 3 [9,10- H) Palmitate incorporation studies 
Since the results of the [1-14c] acetate and 3H20 studies did not 
reveal dramatic differences in the capacities of oestrogen-treated and 
control chick livers for de novo lipogenesis in vitro, a final study was 
performed using [9,10-3H] palmitate to measure the capacities of the 
livers for incorporating pre-formed fatty acids.into complex lipids in 
vitro. The results of the previous 
3 tate and H2o, and those of a number 
14 experiments employing [1- C) ace-
of other workers (21 ' 113 ' 237 ' 372 ' 
375) h 
, ave shown that triacylglycerols are the major product of lipo-
genesis in chick liver and, therefore, the incorporation of [9,10-3H] 
palmitate into triacylglycerol by chick liver slices was measured. 
Liver slices from untreated, control and oestrogen-treated chicks 
were incubated in avian bicarbonate buffer, pH 7·4, for 1 hour at 40°C, 
in the presence of 12 mM-S-0(-)-fructose and 0·65 mM-[9,10-3H] palmitate. 
The incubation period of 1 hour was adopted after obtaining the data 
presented in Fig. 20, and the incubation temperature was 40°C as used 
previously. The lack of an initial lag phase implies that the labelled 
fatty acid enters the cell rapidly and that the intracellular pool size 
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must be very small, or have a quick turnover, to enable rapid equili-
bration of the labelled palmitate with unlabelled fatty acids. The 
concentration of palmitate employed (0·65 mM) was adopted after ob-
taining the data presented in Fig. 21 and for the reasons outlined in 
the Results section. Hawkins & Heald (236 ) used a similar palmitate 
concentration, and the inclusion of 12 mM-S-0(-)-fructose in incubations 
was adopted from their studies, since they showed that this enhanced 
the incorporation of 0·62 mM-[1-14c] palmitate into the neutral lipid 
fractions of liver slices from the domestic fowl. 
Results of studies on the incorporation of palmitate into triacyl-
glycerol were presented (Figs. 22- 24, Table 11) on the basis of a unit 
wet weight of liver (nmoles incorporated/100 mg liver/h), as the total 
hepatic capacity (nmoles incorporated/liver/min) and on a cellular basis 
(nmoles incorporated/0·1 mg liver DNA/h). Hence, any differences that 
might exist in the capacities of the livers to incorporate [9,10-3H] 
palmitate into triacylglycerol, either at the cellular level or on the 
level of the whole organ, would become apparent~ 
When the data were presented on the basis of a unit wet weight of 
liver (nmoles palmitate incorporated/100 mg liver/h), it was found that 
the results for oestrogen-treated chicks were significantly greater than 
corresponding control values in the 19 - 22k h, 28 - 31i h and 40~ - 44 h 
groups. In these groups, the mean incorporation values for hormone-
treated birds were 1•19-fold, 1·27-fold and 1·29-fold higher, respectively, 
than the corresponding control values. Expression of the results as 
total hepatic capacity (nmoles palmitate incorporated/liver/min) re-
vealed significant differences between oestrogen-treated and control 
chicks at 14~ - 18~, 19 - 22k, 28 - 31i and 40~- 44 hours, when the 
mean incorporation values for the hormone-treated chicks were 1·61-fold, 
1·62-fold, 2·26-fold and 2·47-fold higher, respectively, than the 
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corresponding control values. Thus, expression of the results as 
total hepatic capacity increased the differences between oestrogen-
treated and control birds, indicating that the increased capacity to 
incorporate palmitate into triacylglycerol was, at least in part, the 
result of an increase in liver size in the oestrogen-treated chick. 
Oestrogen-treated birds in the 3~ - 8 h and 45~ - 51~ h groups showed no 
significant differences in palmitate incorporation compared with corres-
ponding control birds when the results were expressed either on the 
basis of a unit wet weight of liver or as total hepatic capacity, al-
though the mean value for the total hepatic capacity of the 45~ - 51~ h 
oestrogen-treated group was 1·61-fold greater than that of the corres-
ponding control group. 
In Fig. 24 and Table 11, the results were expressed on a cellular 
basis, and the values for the oestrogen-treated chicks in the 14~ -
18~ h, 19 - 22k h, 28 - 31~ h and 40~ - 44 h groups were significantly 
greater than the corresponding control values, although the differences 
between the oestrogen-treated and control value~ appear to be, at least 
partly, due to low control values. The mean incorporation values for 
these groups of hormone-treated chicks were 1 ·35-fold, 1 ·54-fold, 1·72-
fold and 1·87-fold higher, respectively, than the corresponding control 
values. The DNA contents of the livers in the 45~ - 51~ h group were 
not determined, but the results expressed on a cellular basis for the 
oestrogen-treated chicks in the 3~ - 8 h group were not significantly 
greater than the corresponding control values. Consequently, in the 
14~ - 18~ h, 19 - 22k h, 28 - 31~ h and 40~ - 44 h groups, the cells of 
the oestrogen-treated livers had a greater capacity than those of the 
control livers for incorporating palmitate into triacylglycerol. In 
whatever way the results were expressed, the values for the untreated 
chicks were not significantly different from any of the control values. 
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This would indicate, therefore, that the incorporation of fatty acid 
into triacylglycerol is not stimulated by handling and/or the injection 
of propane-1,2-diol. In contrast, the 3H2o incorporation studies indi-
cated that fatty acid synthesis was stimulated at early times (~ 17 h) 
after the injection of propane-1,2-diol. 
Hawkins & Heald (236 ) demonstrated that liver slices from laying 
hens and from oestrogen-treated 11-week old female chickens (2 mg oes-
tradiol benzoate/bird on alternate days for 7 days) incorporated more 
palmitate into neutral lipids than did liver slices from untreated imma-
ture female birds when results were expressed on both a dry weight basis 
and a cellular basis. These workers also measured the hepatic free 
fatty acid pool sizes for immature female birds and laying hens, and 
found a greater pool size in the laying birds. In connection with this, 
the specific radioactivity of the liver free fatty acid was lower in the 
laying birds than in the immature birds. Therefore, the greater in-
corporation of palmitate into neutral lipids by the laying birds was 
'real', and not due to a smaller free fatty acid pool and a higher 
specific radioactivity. In addition, Balnave (164 ) observed higher 
liver free fatty acid levels for oestrogen-treated immature pullets 
than for control birds. The free fatty acid pool sizes of the livers 
were not measured in the present study, and so the results obtained can-
not be considered to be the true relative rates of triacylglycerol syn-
thesis from palmitate for the livers of untreated, control and oestrogen-
treated chicks. However, it would seem likely that oestrogen treatment 
of the male chick would cause similar changes to those observed after 
oestrogen treatment of the immature pullet, and in the mature hen in 
response to endogenous oestrogen. Consequently, it might be expected 
that the hepatic fatty acid pool size would be larger, and the specific 
radioactivity of the fatty acid lower, for oestrogenized male chicks 
than for control and untreated male chicks. 
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In the [1-14c] acetate studies, the greatest differences in incor-
poration, on a total organ basis and a cellular basis, between oestrogen-
treated and control male chicks were in the 17 - 21~ h group. In the 
3H2D and [9,1D-
3H] palmitate studies, significant differences became 
apparent at, or after, 14 and 14~ hours post-injection, respectively, 
with the greatest differences being observed at about 40 - 44 hours, 
although some of this difference appeared to be due to a decrease in 
control values. In none of the studies were significant differences 
observed between oestrogen-treated and control chicks from 3 to 8 hours 
after injection, and significant differences only became evident at, or 
after, 14 hours post-injection. The results of these experiments 
demonstrated that the livers of oestrogenized male chicks developed en-
hanced capacities to incorporate non-lipid precursors into fatty acids 
and to incorporate fatty acids into triacylglycerol. However, the ex-
tent to which the fatty acids that are incorporated into triacylglycerol 
are of hepatic origin or are derived from other sources, such as adipose 
tissue, cannot be deduced from the results of t~e present study. The 
possible importance of extra-hepatic sources of fatty acids cannot be 
ruled out, particularly since it is suggested that such sites may contri-
bute up to 50% of the total fatty acids synthesized by the chick (3, 4) 
Nevertheless, this lack of knowledge does not detract from the con-
elusions drawn from the incorporation studies, that the livers of oes-
trogenized chicks develop an increased capacity to produce triacylgly-
cerol from both non-lipid precursors and free fatty acids. 
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CHAPTER 4 
THE EFFECT OF 17S-OESTRADIOL INJECTION ON 
HEPATIC FATTY ACID SYNTHETASE ACTIVITY OF 
THE MALE CHICK 
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INTRODUCTION 
1. De novo lipogenesis and associated lipogenic enzymes 
The rate of lipogenesis and the activities of several lipogenic 
enzymes have been extensively studied in a variety of animals during 
development and subsequent maturity. In many cases, changes in the 
nutritional or hormonal status of the animal promote changes in the rate 
of lipogenesis, often accompanied by corresponding changes in the activ-
ities of key lipogenic enzymes, especially in the liver ( 6, 44 , 393 -
396) The most popular experimental animals for this work have been 
mammals where, usually, the liver and adipose tissue are the major sites 
of lipogenesis. However, birds are particularly useful experimental 
animals for the study of hepatic lipogenic enzymes, since the liver is 
th . . t f d 1" . . . . ( 21 ' 23 - 27' 34) e maJor Sl e o ~ novo lpogenesls ln avlan specles . • 
The de novo biosynthesis of long-chain saturated fatty acids from 
acetyl-CoA is catalysed by the two cytosolic enzyme systems, acetyl-CoA 
carboxylase (EC 6.4.1.2) and fatty acid synthetase (393, 
396) These two enzyme systems catalyse the following sequence of re-
actions:-
Acetyl-CoA + ATP + HC03 
acetyl-CoA > malonyl-CoA + AOP + P. 
carboxylase l 
Acetyl-CoA + 7 malonyl-CoA + 14 NADPH + 14 H+ 
palmitate + 14 NAOP+ + 7 C02 + 8 CoASH + 5· H20 (C16:0) 
fatty acid > 
synthetase 
(a) 
(b) 
The formation of malonyl-CoA from acetyl-CoA is the first committed 
step in the fatty acid synthetic sequence, and is regarded as the rate-
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limiting step in de novo fatty acid synthesis for a number of tissues 
( 1 9' 397 - 402) In short-term regulation of fatty acid synthesis, 
the activity of a constant quantity of acetyl-CoA carboxylase is pos-
tulated to be controlled by the phosphorylation state of the enzyme 
(403 ' 404 ), the concentrations of allosteric effectors such as citrate 
and long-chain acyl-CoA derivatives (405 , 406 ), and the availability of 
substrates for lipogenesis (375 , 394, 400, 404, 407) However, long-
term regulation has been found to involve changes in the concentrations 
of acetyl-CoA carboxylase and other lipogenic enzymes, brought about by 
lt t . . th . t f h . d d t. ( 408 - 411 ) a era 1ons 1n e1r ra es o synt es1s and egra a 1on • 
The NAOPH required for the reductive stages of fatty acid synthesis 
is usually provided by the action of malic enzyme (EC 1.1.1.40) and/or 
the pentose phosphate pathway dehydrogenases, glucose 6-phosphate 
dehydrogenase (EC 1.1.1.49) and 6-phosphogluconate dehydrogenase (EC 
1.1.1.44) as follows:-
+ L-Malate + NAOP 
t , 
malic > 
enzyme t + Co N~DPH + H+ pyruva e 2 + (c) 
a-D-Glucose 6-phosphate 
+ NADP+ 
glucose 6-phosphate > 
dehydrogenase 6-phosphogluconolactone 
+ NADPH + H+ (d) 
6-Phosphogluconate 
+ NADP+ 
6-phosphogluconate > 
dehydrogenase ribulose 5-phosphate + C02 
+ NADPH + H+ (e) 
Several workers have suggested that the pentose phosphate pathway 
is of little importance in providing reducing power for fatty acid syn-
thesis in birds (32, 49, 269, 412 - 414) The pathway has been shown 
to be active in the chick embryo, but its activity declines as incub-
ation progresses, until at hatching it is virtually inactive as in the 
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adult bird (415 ). In contrast, the pentose phosphate pathway is an 
important source of NAOPH for the reductive reactions of lipogenesis in 
1 (393, 416) mamma s • 
The acetyl-CoA required for reaction (a) may be provided by the 
cleavage of citrate in the cytoplasm, catalysed by ATP citrate lyase 
(EC 4.1.3.8):-
Citrate + ATP + CoASH __ AT_P~c_i_t_r_a_t_e __ ~> 
lyase acetyl-CoA + oxaloacetate 
+ ADP + P. 
l 
(f) 
The saturated long-chain fatty acids produced as a result of re-
actions (a) and (b) may be converted to unsaturated fatty acids by the 
action of desaturation enzyme systems (417 ) Fatty acids may be in-
corporated into complex lipids by the pathways shown in Fig. 10. 
2. The effects of the pattern of food intake and the composition of 
the diet on hepatic lipogenesis and lipogenic enzyme activities 
The rate of hepatic lipogenesis is closely ·related to nutritional 
state, and to the composition of the diet given to an animal (6, 8 ' 44 , 
47, 393) For example, starvation or feeding a high fat diet have 
been shown to be accompanied by depressed hepatic lipogenesis and corres-
ponding decreases in lipogenic enzyme activities in several animal species. 
Conversely, refeeding after starvation or feeding a low fat, high car-
bohydrate diet are accompanied by increased hepatic lipogenesis and in-
creases in lipogenic enzyme activities. Such effects are observed in 
birds (1, 32, 45, 48- 50, 237, 410, 418- 422) In the rat, refeeding 
after starvation produces elevated liver lipogenesis and lipogenic en-
zyme activities to levels far greater than in ad libitum-fed animals 
(1, 6, 47) Under similar circumstances, increased hepatic lipogenesis 
is observed in birds (45 ' 46 ), but the enormous 'overshoot' in lipogenic 
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enzyme activities is not found, and recovery is to normal or slightly 
elevated levels (1 , 32, 45, 46, 48- 51) This may have something to 
do with the higher lipogenic enzyme activities in avian liver, and 
implies that lipogenesis may be more strictly regulated in bird liver 
than in rat liver. 
3. Changes in hepatic lipogenesis and lipogenic enzyme activities 
during development 
The development of birds and mammals is accompanied by major changes 
in nutritional and hormonal status, which promote changes in hepatic 
1 . . (423) 1pogenes1s • Developmental studies in birds have been facil-
itated by the accessibility and independence of the developing avian 
(351~ 372, 413, 424 - 426) 
embryo In chicks, hatching results in a 
dietary change from a high fat, low carbohydrate food source (egg yolk) 
to a low fat, high carbohydrate food intake (cereal-based mash), and is 
accompanied by a large increase in hepatic lipogenesis (3D) and the 
activities of certain lipogenic enzymes. Under these circumstances, 
increases in the activities of acetyl-CoA carboxylase, fatty acid syn-
thetase, ATP citrate lyase and mali2 enzyme have been demonstrated (413 ' 
424, 427 - 430) It is generally considered that enzyme activity 
changes during development are the result of protein synthesis rather 
than the activation of latent proteins (410 ' 422 ' 424 ). However, some 
evidence has been presented which suggests the presence of some pre-
existing inactive enzyme proteins in embryonic and neonatal chick liver 
(381, 431, 432) 
That the emergence of enzyme activity on hatching is not prompted 
solely by the dietary change is shown by the fact that significant 
levels of certain hepatic lipogenic enzymes appear even if the newly 
hatched chicks are not fed. Increases in the activities of acetyl-CoA 
carboxylase, fatty acid synthetase and ATP citrate lyase occur during 
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the hatching period before feeding begins, but an increase in ~ali~ 
enzyme activity is not seen at this time (413 , 424 , 429 , 433 ) After 
hatching, hepatic ATP citrate lyase and fatty acid synthetase activities 
continue to increase when the chicks are not fed, but the activities of 
'malid enzyme and acetyl-CoA. carboxylase do not change. On feeding, 
'malic enzyme and acetyl-CoA carboxylase activities increase, and the 
activities of ATP citrate lyase and fatty acid synthetase increase at a 
much faster rate than in the absence of food intake (49 , 424 , 433 ) 
Some of the effects of feeding a mash diet have been shown to be 
mimicked in unfed neonatal chicks by the injection of glucose or 
. ( 351 381 41 0 424 432' 434) fructose, or by glucose feed1ng ' ' ' ' Some 
controversy exists as to whether glucose or fructose injection evokes 
similar effects in chick embryo liver ( 351 ' 424 ' 435 ). Goodridge (424 ) 
has shown that hepatic fatty acid synthetase activity can be increased 
by exposing chick embryos to an atmosphere of 100% oxygen for 24 hours, 
implying that environmental factors other than diet may be involved in 
lipogenic enzyme development. 
In contrast, in the rat, birth results in a dietary change from a 
low fat, high carbohydrate nutrient supply provided via the placental-
maternal circulation, to a high fat, low carbohydrate supply of milk. 
This dietary change is accompanied by a substantial reduction in hepatic 
(436, 437) lipogenesis and the activities of certain lipogenic enzymes 
Later, weaning represents a second dietary transition, from the high 
fat, low carbohydrate maternal milk to a low fat, high carbohydrate 
cereal-based feed, and this is accompanied by an increase in hepatic 
lipogenesis and the activities of key lipogenic enzymes (436 , 437 ) 
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4. The effects of hormones on hepatic lipogenesis and lipogenic 
enzyme activities 
(a) Effects of insulin, glucagon, catecholamines, thyroid hormones 
and prolactin 
Nutritional changes, such as those described above, often promote 
changes in the levels of certain hormones, notably insulin and glucagon, 
whose actions at the cellular level provide a molecular explanatiori for 
the observed changes in lipogenesis and lipogenic enzyme activity. 
Birds and mammals differ considerably in the endpcrine control of car-
bohydrate and lipid metabolism (416 ' 438 ' 439 ). Insulin inhibits 
lipolysis in rat adipose tissue (440 ), but in the chicken insulin is not 
anti-lipolytic (441 ), and the plasma free fatty acid level increases in 
. (441 442) 
response to th1s hormone ' . In addition, unlike rat adipose 
tissue, aviah adipose tissue responds poorly, if at all, to the lipogenic 
action of insulin (32 ' 443 ' 444 ) In mammals, hepatic lipogenesis is 
stimulated by insulin, and, in the chicken, hepatic lipogenesis (276 ) and 
(444) lipogenic enzyme activities have been stimulated using high doses 
of insulin. Glucagon appears to be the major lipolytic hormone in 
(441 445 - 448) birds ' , and fatty acid synthesis in cultured chicken 
hepatocytes has been shown to be inhibited by glucagon (375 ). In birds, 
insulin potentiates the stimulation of lipolysis brought about by 
glucagon (449 ), whereas, in rat adipose tissue, insulin is antagonistic 
to glucagon-stimulated lipolysis ( 440 ). 
Catecholamines are activators of lipolysis in mammalian adipose 
tissue (450 ), but have been shown to be relatively insignificant in 
(445, 449) fatty acid mobilization in birds The comparative lack of 
response of avian adipose tissue to insulin and catecholamines may be 
associated with the minor role that adipose tissue plays in lipogenesis 
in these species. Thyroid hormones stimulate fatty acid synthesis and 
lipogenic enzyme activities in animals that have free access to food and 
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t ( 451 - 454) wa er • The action of thyroxine on lipogenic enzyme activity 
has been studied in chickens, with the conclusion that thyroxine in-
creases basal metabolism and, if food and water are restricted, reduces 
the energy available for fatty acid synthesis. When food and water 
were supplied ad libitum, hypophysectomy was shown to depress hepatic 
'malid enzyme activity, and thyroxine injection to increase hepatic ~alid 
enzyme activity in intact and hypophysectomized birds (455 ). If birds 
were maintained on equalized food and water intakes, thyroxine reduced 
rather than increased hepatic ~alic enzyme activity in normal male 
chicks (456 ) 
The emergence of hepatic lipogenic enzyme activities during the 
development of birds has been extensively studied with respect to possible 
hormonal influences. Thyroid hormones have been shown to increase the 
activities of acetyl-CoA carboxylase (433 ), ATP citrate lyase (372 ), 
( 372 433) ' . • ( 372, 374) fatty acid synthetase ' and mal1c enzyme in cul-
tured chick embryo hepatocytes. After the in vivo administration of 
insulin, glucagon, and cyclic AMP, insulin was implicated as being the 
active hormone in stimulating chick embryo hepatic fatty acid synthetase 
t . 't (426) ac lVl y • The in vitro treatment of chick embryo hepatocytes 
and liver explants with insulin alone, or in combination with thyroid 
hormones, has been reported to stimulate acetyl-CoA carboxylase, fatty 
acid synthetase and ~alic enzyme activities (374 ' 433 ' 457 ). Contra-
dietary observations have been reported as regards glucagon, since 
Ryder & Campos (458 ) found that this hormone stimulated acetyl-CoA car-
boxylase activity in chick embryo hepatocytes, whilst other workers have 
. f 1' . d 1' . t. . t. ( 372 ' reported inhibit1on o 1pogenes1s an 1pogen1c enzyme ac lVl 1es 
374) It is apparent, therefore, that studies on the role of hormonal 
influences in the emergence of lipogenic enzyme activities during avian 
development are both incomplete and controversial. 
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Prolactin has been implicated to play an important role in the 
stimulation of hepatic lipogenesis and fat storage in migratory species 
(459, 460) Goodridge & Ball (268 ' 269 ) studied the effects of pro-
lactin and growth hormone on lipogenesis, and showed that prolactin 
was responsible for the induction of a food-dependent increase in 
hepatic lipogenesis and associated enzyme activities in the pigeon. 
Similar metabolic changes were observed with growth hormone, although 
the increase in size of the crop sac, seen with prolactin, was not ob-
tained. 
(b) Effects of gonadal hormones 
The effects of gonadal hormones on avian lipid metabolism have been 
widely studied, with special emphasis being placed on oestrogens, which 
have major involvement in the physiological changes observed when the 
hen comes into lay (82 ). However, androgens and progestagens have been 
shown to be involved in these physiological changes (166 ), and androgens 
exert significant influences on hepatic lipid metabolism and lipogenic 
t . ·t· . h" k (165, 166, 245, 253, 295, 363, 461) For enzyme ac lVl 1es 1n c 1c ens 
example, testosterone treatment of 4-week old pullets (2 mg testosterone 
propionate/bird) has resulted in increases in the specific activities of 
hepatic ATP citrate lyase and mali2 enzyme after 1 day of hormone treat-
ment, but after longer periods, with hormone administration on alternate 
days, variable effects were obtained (166 , 363 ) Pearce (253 ) injected 
laying hens with a daily dose of testosterone propionate (1 mg/kg body 
wt.) for 4 days and, 24 hours after the last injection, observed signif-
icantly reduced specific activities of hepatic ATP citrate lyase and 
~alid enzyme in these birds. These reports clearly indicate the impor-
tance of considering age of animal, hormone dose level and duration of 
treatment when attempting to elucidate hormonal effects on metabolism. 
In addition, testosterone treatment significantly affects l~ver lipid 
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metabolism by increasing the oxidation of lipids (245 , 461 ), an effect 
not found with oestrogen treatment. The involvement of progestagens in 
the regulation of lipogenesis is unclear, as administration of proges-
terone has not been found to have marked effects on hepatic lipid meta-
bolism or enzyme activities in the domestic fowl (165 , 166 , 295) 
Studies on the development of sexual maturity in the domestic 
fowl have shown that the laying hen has greater hepatic specific activ-
ities of ATP citrate lyase and malic enzyme than does the non-laying 
hen or cockerel, but has similar specific activities to those found in 
. ( 125 246 378) . young blrds aged 4 - 7 weeks ' ' • These observatlons are 
in agreement with the work of Leveille (239 ), who found similar levels 
of hepatic lipogenesis in the laying hen and the young bird. 
The administration of oestrogen to immature female birds results 
in biochemical and physiological changes similar to those found when the 
female comes into lay (82 ) For example, short-term oestrogen treat-
ment ( ~ 2 days, 1 - 2 mg oestradiol dipropionate /bird) leads to in-
creased specific activities of ATP citrate lyase and ~alid enzyme in the 
. (126 166 256 363) llvers of 4-week old pullE:Jts ' ' ' • After prolonged 
oestrogen treatment (4 mg S-oestradiol-3-benzoate/bird/day for 6 days), 
increased total and specific activities of fatty acid synthetase have 
been demonstrated in the oviduct and liver of 1-month old pullets ( 31 ). 
(235) Pageaux et al. have reported a rapid increase in the specific 
activity of hepatic acetyl-CoA carboxylase in 16-day old female quail 
following a single injection of oestradiol benzoate (0·2 mg/kg body wt.), 
with peak activity being recorded at 3 hours after injection. However, 
the lack of control values at the varying times after injection does 
not allow conclusive interpretation of the data. It is possible that 
the increased acetyl-CoA carboxylase activity registered at 3 hours was 
a stress-evoked response. It could be argued that stress would not be 
186 
expected to lead to an increase in lipogenic enzyme activity but rather, 
if any, to an increase in lipolytic enzyme activity. However, if stress 
due to handling and/or injection resulted in hyperphagia, then increased 
lipogenic enzyme activities might be expected (270 ), This study clearly 
shows the need for sham-injected control animals at all stages of experi-
mental work, since untreated animals do not provide a valid comparison. 
As regards mammals, oestrogen treatment of female rats has been shown to 
cause increased uterine activities of fatty acid synthetase, ATP citrate 
lyase, ~alid enzyme and other related enzymes (285 ), and also increased 
hepatic activities of fatty acid synthetase, acetyl-CoA carboxylase and 
3-hydroxy-3-methylglutaryl-CoA reductase (EC 1.1 .1.34) (366 , 462 ). 
It has been demonstrated that oestrogen treatment of male birds and 
amphibia initiates changes in liver met'abolism, including vitellogenesis 
and enhanced lipogenesis, similar to those found when the female comes 
. (63 81 115 141 265) . . 1nto lay ' ' ' ' It 1s reasonable to bel1eve that 
oestrogen treatment of male birds, resulting in fatty liver and lipaemia, 
involves hepatic lipogenic enzyme activity changes similar to those ob-
served as the hen approaches lay. In this situation, it is of interest 
to determine whether the concentrations of lipogenic enzymes are in-
creased, and if so, which enzymes are affected, and to elucidate the 
time courses and functional significance of such changes. 
An increase in the specific activity of ~alid enzyme was noted by 
de Vellis & Schjeide (244 ) for the livers of oestrogenized roosters. 
Lippiello et al. (296 ) obtained increased stearyl-CoA desaturase (EC 
1.14.99.5) specific activity in rooster liver, up to 48 hours after 
birds had received a single injection of 176-oestradiol (3·5 mg/100 g 
body wt.). After treating 1-week old male chicks with a daily in-
jection of 1 mg diethylstilbestrol for - 3 days, and killing the birds 
4 hours after the last injection in each case, the specific activity of 
187 
hepatic choline kinase (EC 2.7.1.32) was found to have increased 1·7-
fold at 4 hours after one injection of diethylstilbestrol, and this be-
came a 3-fold increase after 3 injections. In addition, the specific 
activity of hepatic phosphatidylethanolamine-N-methyltransferase (EC 
2.1.1.17) increased nearly 2-fold after 2 injections, and this increase 
was maintained after 3 injections (463 , 464 ) Treatment of male and 
female 6 to 11-day old chicks with daily injections of 2 mg diethylstil-
bestrol over 5 days resulted in increased total liver activities of 
fatty acid CoA ligase (AMP-forming) (EC 6.2.1.3), sn-glycerol 3-phosphate 
acyl-CoA acyltransferase (EC 2.3.1.15) and diacylglycerol acyltrans-
f ( Ec 2 3 1 20) . th t h . th . . f. t. . t. ( 254 ) erase .• • • , Wl ou c anges 1n e1r specl 1c ac lVl 1es • 
The total hepatic activity of diacylglycerol cholinephosphotransferase 
(EC 2.7.8.2) was found to increase, with a concomitant decrease in 
specific activity. 
The reaction catalysed by acetyl-CoA carboxylase has been impli-
cated by Philipp & Shapiro (140 ) as the regulatory step in hepatic fatty 
acid synthesis following oestrogen treatment of.male Xenopus laevis. 
These workers showed that the administration of 17S-oestradiol in vivo 
resulted in increased hepatic fatty acid and cholesterol synthesis with 
concurrent increases in acetyl-CoA carboxylase and 3-hydroxy-3-
methylglutaryl-CoA reductase activities, whilst fatty acid synthetase 
activity remained unchanged. Once again, control values were not pre-
sented, so it is not possible to make conclusive deductions about the 
action of the hormone from the data supplied. 
An interesting point arising from the gonadal hormone studies is 
that, although lipogenic enzyme activities may be increased at early 
times after hormone treatment, prolonged treatment and/or high doses 
. d 1 1 f t' 't (166, 246, 253, often result 1n normal or depresse eve s o ac lVl y · 
256 ) It would appear that short-term hormone treatment(~ 2 days), at 
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a carefully selected dose, is more indicative of physiological effects 
than long-term administration and/or high dosage when pharmacological 
effects might predominate (256 ). 
Some of the enzyme studies carried out on birds have demonstrated 
interesting contradictions to the observations of coordinate changes in 
the rate of lipogenesis and lipogenic enzyme activities which occur under 
. t ( 395) M t h . many c1rcums ances • os notable are t e reports of changes 1n 
lipogenic enzyme activities that are not accompanied by changes in the 
(49 351 424) . 
rate of lipogenesis ' ' , changes 1n the rate of lipogenesis 
that occur without, or before, changes in lipogenic enzyme activities 
(33, 45, 46, 375, 410, 420, 424) h . th t f 1. . 
, c anges 1n e ra e o 1pogenes1s 
and enzyme activity which are similar in direction but very different in 
. t d ( 46' 49' 50) d d. t h . 1. . magn1 u e , an non-coor 1na e c anges 1n 1pogen1c enzyme 
t . . t. ( 49' 424) ac lVl 1es • These findings infer that increases in the con-
centrations of lipogenic enzymes may not always be responsible for in-
creased rates of lipogenesis, and that changes in lipogenesis may involve 
an altered flux of metabolites through the biocbemical pathways and the 
regulation of the activities of constant amounts of enzymes (276 , 393 , 
465) 
The catalytic capacities of the fully activated acetyl-CoA carbo-
xylase and fatty acid synthetase have been shown to be similar in some 
animal tissues (395 ' 466 ), but it is suggested that, in vivo, the car-
boxylase is inhibited to a variable extent and does not ~xhibit maximum 
t 1 t . ff. . (44, 375, 394, 395, 467, 468) A t f th ca a y 1c e 1c1ency par rom e 
obvious limit imposed by substrate availability, acetyl-CoA carboxylase 
activity is controlled by covalent and allosteric modifications of the 
enzyme (407 , 469 ). Acetyl-CoA carboxylase exists in a depolymerized 
t t d 1 · d actl·ve form (470 ' 471 ) The l·nter-inactive s a e, an a po ymer1ze 
conversion of these states can be effected by phosphorylation and 
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dephosphorylation of the enzyme, the phosphorylated form being less 
active, largely because of the reduced affinity of the enzyme for the 
allosteric activator citrate (403 ' 404 ' 472 - 478 ). The allosteric 
regulation of acetyl-CoA carboxylase is also considered to operate 
through changes in the aggregation state of the enzyme. Therefore, 
citrate and isoci trate enhance polymerization wi_th an increase in enzyme 
t . . t ( 406' 4 79' 480) h .1 1 h . 1 ac lVl y , w 1 e ong-c a1n acy -CoA esters encourage 
depolymerization and reduced activity (396 , 468 , 469, 471, 481 - 483) 
In addition, physiological concentrations of CoA have been shown to 
activate acetyl-CoA carboxylase (484 ' 485 ). Fatty acid synthetase has 
also been found to exist in a phosphorylated form with reduced activity, 
and a dephosphorylated active form (486 ). Fatty acid synthetase is 
(487, 488) 
activated by various phosphorylated sugars , and inhibited by 
fatty acyl-CoA derivatives (489 - 492 ) and high concentrations of CoA 
(493) In addition, both acetyl-CoA carboxylase and fatty acid syn-
th t . h. b. t d b h. h t t. f 1 1 C A ( 395 ' 466 ' e ase are 1n 1 1 e y 1g concen ra 1ons o ma ony - o 
488, 494, 495) It is, therefore, possible that in vivo, in addition 
to alterations in the rates of synthesis and degradation of fatty acid 
synthetase, covalent modulators and allosteric effectors may signifi-
cantly alter the activity of fatty acid synthetase. It has been 
suggested that acetyl-CoA carboxylase may not be the rate-limiting 
. f . d th . d 11 d. t. ( 401 ' 466' 496) enzyme 1n atty ac1 syn es1s un er a con 1 1ons • 
The possibility of chicken liver fatty acid synthetase exerting a re-
gulatory effect on the rate of de novo fatty acid synthesis, at early 
times after oestrogen treatment, has not been excluded. 
The aim of the present study was to investigate the effect of oes-
trogenization on hepatic fatty acid synthetase activity in the male 
chick. Optimum conditions for assay of the enzyme were determined, and 
used to study the effect of varying 176-oestradiol dose level and varying 
time after hormone injection on enzyme activity. 
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METHODS 
1. Preparation and assay of acetyl-CoA solutions 
Acetyl-CoA was prepared by the method of Smith et al. (399 ), in 
which acetic anhydride was reacted with CoA in bicarbonate solution. 
The method of Chase (497 ) was used to determine the concentration of 
acetyl-CoA. In this assay, given an excess of oxaloacetate and DTNB, 
the difference between the free thiol content of the preparation and 
the total thiol groups resulting after incubation with citrate synthase 
was used as an estimate of acetyl-CoA concentration. The release of 5-
thio-nitrobenzoate was registered by an increase in absorbance at 412 nm. 
Acetyl-CoA solutions were diluted to the required concentration (0·5 mM) 
with distilled water, and were stored at -20°C at pH 1 - 3. Fresh 
acetyl-CoA solutions were prepared every fortnight. 
2. Preparation and storage of other solutions 
Potassium phosphate buffers (1 M) of a variety of pH values (6·2 -
8·0), and 100 mM-EDTA solutions adjusted to pH 7·0 with KOH, were stored 
at 4°C and replaced at weekly intervals. 
OTT (100 mM) and malonyl-CoA (1 mM) solutions were stored at -20°C, 
and fresh solutions were made fortnightly. 
NADPH solutions (4 mM) were made just before use. The concen-
' tration of NADPH solutions was determined spectrophotometrically at 
340 nm, given that an absorbance of 0·622 corresponds to a concentration 
of 100 nmoles NADPH/ml, using a 1 em light path. 
Homogenization buffer, comprising 0·2 M-potassium phosphate buffer 
(pH 7·0) and 1 mM-DTT, was prepared fresh each day. An assay 'cocktail•, 
containing 0·25 M-potassium phosphate buffer (pH 6·2 - 8·0), 1 ·25 mM-DTT 
and 1 ·25 mM-EDTA (pH 7·0), was prepared just before use. 
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3. Protein determination 
The protein concentration of each enzyme preparation was deter-
mined by the biuret method as described by Hubscher et al. (498 ), with 
some modification. The biuret reagent of Weichselbaum (499 ) was 
modified in the following way. Biuret reagent (200 ml) and 1 M-NaOH 
(160 ml) were mixed. Potassium iodide (4 g) was added and dissolved, 
and the solution was made up to 1 litre with distilled water. The re-
sulting solution was stored at 4°C. 
Duplicate protein samples were precipitated with an equal volume 
of ice-cold 10% (~/v) TCA, and th~ precipitate was collected by centri-
fugation at 4°C. The supernatant was decanted, and the pellet was dis-
solved in 1 ml 0·1 M-NaDH. The modified biuret reagent (2 ml) was 
added and colour, as measured by absorbance at 555 nm, was developed by 
incubation at 37°C for 15 minutes. Bovine serum albumin (fatty acid 
poor) was used as the standard over the protein range 0 - 10 mg. 
4. Procedure for enzyme preparation 
Since fatty acid synthetase is a soluble cytoplasmic enzyme (496 , 
500 ), a particle-free supernatant (PFS) was prepared from each liver 
under investigation. All operations were performed at 0 - 4°C. 
Birds were killed by decapitation, and their livers were removed 
and weighed. Portions of the livers were homogenized in 9 or 18 
volumes of 0·2 M-potassium phosphate buffer (pH 7·0) containing 1 mM-
OTT. A teflon-glass ho~ogenizer was used, and care was taken to homo-
genize the tissue without causing too much foaming. The tissue was 
disrupted with 10 'up and down' strokes of the rotating pestle. Homo-
genates were centrifuged at 100,000 g (r 6·4 em) for 1 hour in a 
av. 
MSE Prepspin 50 centrifuge. The resulting supernatants were either 
used directly for enzyme assay, or were diluted with homogenization 
buffer prior to assay. 
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5. Assay of fatty acid synthetase activity 
Fatty acid synthetase activity was determined by a spectrophoto-
metric assay which measured malonyl-CoA-dependent NADPH oxidation. 
The rate of disappearance of NADPH, as measured by the decrease in ab-
sorbance at 340 nm, was followed by means of a Pye Unicam SPB-100 UV-vis 
spectrophotometer fitted with a chart recorder and a temperature probe. 
Enzyme assays were performed in semi-micro polystyrene cuvettes, with a 
path length of 1 em, maintained at 30°C in the constant temperature cell 
housing of the spectrophotometer. 
Unless stated otherwise, the assay system contained, in a final 
volume of 1 ml, 200 mM-potassium phosphate buffer (pH 7·0), 1 mM-DTT, 
1 mM-EDTA, x ~M-acetyl-CoA, y ~M-malonyl-CoA, z ~M~NADPH and enzyme 
(110- 300 ~g protein). The reaction was started by the addition of 
malonyl-CoA, and the rate of NADPH oxidation at 30°C was monitored at 
340 nm for about 2 minutes. In each case, the initial slope of the 
recorder trace, which was linear with time, was used to calculate enzyme 
activity. Assays were performed in duplicate, using q and 2q volumes 
of enzyme preparation, to ensure linearity with respect to protein con-
centration. 'Blank' cuvettes contained 200 mM-potassium phosphate 
buffer (pH 7·0), 1 mM-DTT, 1 mM-EDTA, and varying aliquots of enzyme and 
distilled water to a final volume of 1 ml. 
In order to maintain the reaction mixture at 30°C during the assay, 
it was necessarytopre-incubate a mixture (cocktail) of the potassium 
phosphate buffer, OTT and EDTA (in 0·8 ml) in a cuvette at 45°C for 5 
minutes. After transfer to the spectrophotometer cell holder (set at 
30°C), the other assay components (stored in ice) were added to give a 
total volume of 1 ml. Approximately 2 minutes after starting the re-
action, the temperature in the cuvette, determined by the temperature 
probe, was found to be near 30°C. All reaction rates were corrected to 
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30°C using the following equation~-
= 
10 (Log K1 - Log K2) 
t1 - t2 
where K1 and K2 are the rates at the two temperatures t 1 and t 2, res-
pectively. 
One unit of fatty acid synthetase was defined in this study as the 
amount of enzyme required to catalyse the oxidation of 1 nmole NAOPH per 
minute at 30°C. 
6. Statistical analysis 
Standard errors are provided to show the degree of variance in the 
data. Data were analyzed statistically by Student's 't' test, and 
levels of statistical significance are indicated where appropriate. 
Probability values (P) of 0·05 or less were considered to be significant. 
RESULTS 
1. Optimum conditions for the assay of fatty acid synthetase activity 
Optimum conditions for the assay of fatty acid synthetase activity 
were determined for the enzyme extracted from the livers of untreated 
and oestrogenized chicks. Oestrogen-treated birds received an intra-
muscular injection of 1 mg 178-oestradiol in propane-1,2-diol/100 g body 
weight 36 - 48 hours before death. 
Initially, the conditions reported by Katiyar & Porter (494 ) for 
the assay of fatty acid synthetase from pigeon liver were adopted. The 
enzyme was assayed at pH 7·0, in the presence of 100 ~M-NAOPH, 15 ~M-
acetyl-CoA and 60 ~M-malonyl-CoA. Each factor was then varied in turn, 
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keeping all other parameters constant, and the effect on enzyme activity 
was measured. As each factor was optimized, this value was inserted 
into the conditions used for subsequent determinations. 
The optimum pH for the assay of fatty acid synthetase activity was 
found to be 7·0 (Fig. 25), in agreement with the results of Katiyar & 
Porter (494 ). Maximum enzyme activity was obtained with NAOPH concen-
trations of 80 - 200 ~M (Fig. 26). Subsequent assays were conducted at 
pH 7·0 and contained 100 ~M-NADPH. The concentrations of acetyl-CoA 
giving maximum enzyme activity were 15 - 30 (40) ~M (Fig. 27). Subse-
quent assays contained 20 ~M-acetyl-CoA. Malonyl-CoA concentrations of 
30- 40 ~M produced optimum activity for the enzyme extracted from the 
livers of untreated chicks (Fig. 28(a)), and slight substrate inhibition 
was observed with higher concentrations of malonyl-CoA (up to 80 ~M). 
This effect was not apparent for the enzyme extracted from the livers of 
oestrogen-treated birds (Fig. 28(b)), for which optimum activity was 
obtained with malonyl-CoA concentrations of 30 - 80 ~M. Consequently, 
subsequent assays contained 30 ~M-malonyl-CoA. 
Oestrogen treatment did not signif1cantly affect the optimum con-
ditions obtained (Figs. 25 - 28). Therefore, all subsequent assays of 
the enzyme extracted from the livers of untreated, control and oestrogen-
treated chicks were performed at pH 7·0, with final concentrations of 
100 ~M-NADPH, 20 ~M-acetyl-CoA and 30 ~M-malonyl-CoA. 
2. sin le intramuscular in'ection of 176-oestradiol 
wt. on the activity of hepatic fatty acid 
In a preliminary experiment, the effect of a single intramuscular 
injection of 17B-oestradiol (1 mg/100 g body wt.) on the activity of 
hepatic fatty acid synthetase was examined at various times (6 - 96 h) 
after injection. In addition, one group of chicks received an injection 
FIGURE 25 
The effect of pH on the activity of fatty acid synthetase from livers 
of untreated and oestrogenized male chicks 
Enzyme assays were performed at 30°C as described in the text. 
The enzyme was assayed at varying pH values, in the presence of 
200 mM-potassium phosphate buffer (pH 6·2 - 8·0), 1 mM-DTT, 1 mM-
EDTA, 100 ~M-NADPH, 15 ~M-acetyl-CoA and 60 ~M-malonyl-CoA. 
(a) Activity of fatty acid synthetase from untreated chick liver 
(b) Activity of fatty acid synthetase from oestrogenized chick liver 
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FIGURE 26 
The effect of NADPH concentration on the activity of fatty acid 
synthetase from livers of untreated and oestrogenized male chicks 
Enzyme assays were performed at 30°C as described in the text. 
The enzyme was assayed in the presence of 200 mM-potassium phosphate 
buffer (pH 7·0), 1 mM-DTT, 1 mM-EDTA, 0 - 200 ~M-NADPH, 15 ~M-acetyl­
CoA and 60 ~M-malonyl-CoA. 
(a) Activity of fatty acid synthetase from untreated chick liver 
(b) Activity of fatty acid synthetase from oestrogenized chick liver 
-c 
G) 
.... 
0 
~ 
c. 
(/) 
u. 
Q. 
C) 
E 
' c E 
' "C ., 
.~ 
:2 
)( 
0 
J: 
Q. 
0 
c( 
z 
0 
E 
c 
-
>-
:t: 
.!: 
.... (,) 
«< 
.~ 
:: 
(,) 
., 
c. (/) 
(a) 
(b) 
75 
60 
45 
30 
15 
0 
0 100 200 
NADPH (fJM) 
75 
60 
0 
45 
30 
15 
OL---------~--------~--------~----------
0 100 
NADPH ( fJM) 
200 
FIGURE 27 
The effect of acetyl-CoA concentration on the activity of fatty acid 
synthetase from livers of untreated and oestrogenized male chicks 
Enzyme assays were performed at 30°C as described in the text. 
The enzyme was assayed in the presence of 200 mM-potassium phosphate 
buffer (pH 7·0), 1 mM-OTT, 1 mM-EDTA, 100 ~M-NADPH, 0 - 40 ~M­
acetyl-CoA and 60 ~M-malonyl-CoA. 
(a) Activity of fatty acid synthetase from untreated chick liver 
(b) Activity of fatty acid synthetase from oestrogenized chick liver 
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FIGURE 28 
The effect of malonyl-CoA concentration on the activity of fatty acid 
synthetase from livers of untreated and oestrogenized male chicks 
Enzyme assays were performed at 30°C as described in the text. 
The enzyme was assayed in the presence of 200 mM-potassium phosphate 
buffer (pH 7·0), 1 mM-DTT, 1 mM-EDTA, 100 ~M-NADPH, 20 ~M-acetyl-CoA 
and D - 80 ~M-malonyl-CoA. 
(a) Activity of fatty acid synthetase from untreated chick liver 
(b) Activity of fatty acid synthetase from oestrogenized chick liver 
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of 17B-oestradiol (1 mg/100 g body wt.) at 0, 24 and 48 hours, and these 
birds were sacrificed 24 hours after the last injection to determine the 
effect of long-term oestrogen administration. 
experiment are shown in Table 13 and Fig. 29. 
The results of this 
In this preliminary 
experiment, relatively few chicks were included in each treatment group, 
and large variations in enzyme activity were observed within each group, 
making it impossible to detect any significant changes in enzyme activity 
as a result of oestrogen treatment. The most notable observation re-
sulting from this experiment, apart from the considerable variation in 
enzyme activity, was the apparent decrease in the soluble protein con-
tent of a unit weight of liver from oestrogenized chicks as compared 
with values for untreated and control chicks (Fig. 29(b)). 
3. 
It seemed pertinent to pursue this investigation further by varying 
the dose of 17&-oestradiol administered, in case the dose of 1 mg/100 g 
body weight used in the preliminary experiment was unsuitable to demon-
strate effects on the activity of hepatic fatty acid synthetase. Each 
bird received a single intramuscular injection of 17S-oestradiol in 
propane-1,2-diol, equivalent to one of the following doses:-
0·25, 0·50, 0·75, 1 ·DO, 1 ·25 mg 17S-oestradiol/100 g body weight 
Control chicks, receiving no 17S-oestradiol, were injected with an 
equivalent volume of propane-1,2-diol only. Chicks were sacrificed 48 
hours after injection, and the enzyme activities in the high-speed super-
natants prepared from the livers were measured. 
The results of this experiment are shown in Table 14 and Fig. 30. 
Again, there was considerable variation in enzyme activity between indi-
vidual birds within each treatment group, and this is reflected in the 
TABLE 13 
The effect of 17S-oestradiol on the soluble protein content of chick liver and on the activity of hepatic fatty acid 
synthetase at various times after injection 
The effect of a single intramuscular injection of 17S-oestradiol (1 mg dissolved in propane-1,2-diol/100 g body 
wt.) on the activity of hepatic fatty acid synthetase was examined at various times (6- 96 h) after injection. To 
determine the effect of long-term oestrogen treatment, one group of chicks, (x 3), received an injection of 17S-
oestradiol (1 mg/100 g body wt.) at 0, 24and 48 hours, and these birds were sacrificed 24 hours after the last in-
jection. The experiment included control chicks injected with propane-1,2-diol only, and untreated chicks. 
Chicks were killed at the indicated times after injection, and enzyme preparations were obtained as described 
in the Methods section. Fatty acid synthetase activity in the high-speed supernatant was assayed at 30°C in the 
presence of final concentrations of 200 mM-potassium phosphate buffer (pH 7·0), 1 mM-DTT, 1 mM-EDTA, 100 ~M-NADPH, 
20 ~M-acetyl-CoA and 30 ~M-malonyl-CoA. The protein contents of the high-speed supernatants were assayed by a modi-
fied biuret method as described in the text. 
The number of chicks in each group is shown in parentheses. 
The results are expressed as means plus or minus half the range of equivalent determinations. 
These results are illustrated graphically in Fig. 29(a- d). 
Chicks were aged 3 - 5t weeks . 
specific activity 
mg soluble protein units of enzyme units of enzyme Enzyme source (nmol NADPH oxidized /g liver activity/g liver activity/liver /min/mg PFS protein) 
Untreated chicks (4) 62 ·1 5 ± 1 4. 58 110·2 ± 4·5 6836 ± 1534 101515 ± 26732 
Control chicks 
6 h (2) 59·35 ± 6·39 105·5 ± 0·3 6260 ± 689 100902 ± 26190 
12 h (2) 61 ·04 ± 0·04 1 06·4 ± 0·3 6492 ± 20 97921 ± 1296 
18 h (2) 56·88 ± 4·76 107 ·0 ± 3·8 6104 ± 725 92271 ± 8792 
24 h (5) 54·44 ± 14·76 103 ·3 ± 2·8 5633 ± 1670 65656 ± 50621 
48 h (3) 61·04 ± 1 ·35 1 DB ·5 ± 4·4 6628 ± 413 48262 ± 3574 
72 h (3) 73·35 ± 13·54 1 00·9 ± 5 ·1 7421 ± 1456 94146 ± 18615 N 0 
__,. 
96 h (3) 70· 61 ± 1 ·60 100·7 ± 5 ·1 7114 ± 448 61087 ± 14939 
X 3 (3) 49·09 ± 5·00 107 ·0 ± 2·4 5259 ± 645 60610 ± 5476 
Oestrogenized chicks 
6 h (2) 72·41 ± 9·39 89·3 ± 8·8 6381 ± 205 106189 ± 4965 
12 h (2) 51·43 ± 2·95 102 ·7 ± 4·3 5267 ± 84 77971 ± 7592 
18 h (2) 48·01 ± 4·91 92 ·o ± 4·8 4394 ± 222 78534 ± 11405 
24 h (5) 41 ·72 ± 9·35 90.6 ± 12 ·1 3752 ± 776 53922 ± 28527 
48 h ( 3) 61 ·67 ± 11·76 88·6 ± 12 ·1 5366 ± 410 76058 ± 24636 
72 h (3) 45·34 ± 12·26 96·1 ± 2·4 4369 ± 1256 67070 ± 24967 
96 h (3) 69·55 ± 14·53 92·4 ± 3·6 6390 ± 1095 83909 ± 19580 
X 3 (3) 38·52 ± 10·53 91 ·2 ± 5·0 3479 ± 821 68348 ± 25987 
FIGURE 29 
The effect of 17S-oestradiol on the soluble protein content of chick 
liver and on the activity of hepatic fatty acid synthetase at various 
times after injection 
Consult the legendofTable 13 for details of experimental 
procedure. 
(a) specific activity (nmoles NADPH oxidized/min/mg PFS protein) 
(b) mg soluble protein/g liver 
A values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
The results are expressed as means plus or minus half the range 
of equivalent determinations. 
FIGURE 29 (continued) 
(c) units of enzyme activity/g liver 
(d) units of enzyme activity/liver 
• values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
The results are expressed as means plus or minus half the range 
of equivalent determinations. 
TABLE 14 
The effect of varying doses of 176-oestradiol on liver weight, the soluble protein content of the liver and the activity 
of hepatic fatty acid synthetase 2 days after injection 
Each oestrogen-treated chick received a single intramuscular injection of 17S-oestradiol in propane-1,2-diol, 
equivalent to one of the following doses:-
0·25, 0·5, 0·75, 1·0, 1·25 mg 17S-oestradiol/100 g body weight. 
Control chicks received an equivalent volume of propane-1,2-diol only. Chicks were sacrificed 48 hours after 
injection, and liver enzyme preparations were obtained as described in the Methods section. Fatty acid synthetase 
activity in the high-speed supernatant was assayed at 30°C in the presence of final concentrations of 200 mM-potassium 
phosphate buffer (pH 7·0), 1 mM-DTT, 1 mM-EDTA, 100 ~M-NADPH, 20 ~M-acetyl-CoA and 30 ~M-malonyl-CoA. 
tents of the high-speed supernatants were assayed by a modified biuret method as described in the text. 
Values are the means (± S.E.M.) for 6 chicks. 
*These values are the means (± S.E.M.) for 5 chicks. 
The protein con-
Data were analyzed statistically by Student's 't' test, and levels of statistical significance are presented with 
respect to values for both control and untreated chicks. 
t significant at P < 0·05 
* significant at P < 0·02 
The enzyme activity results are illustrated graphically in Fig. 30(a- c). 
Chicks were aged 4t- st weeks. 
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17S-oestradiol administered (mg/100 g body wt.) 
0 0 
* Control Untreated 0·25 0·50 0·75 - 1 ·DO 1 ·25 
Body weight (g) 412 ± 15 395 ± 5 299 ± 7 348 ± 5 394 ± 17 396 ± 12 390 ± 22 
Liver weight (as % 3·51 ± 0·22 3·46 ± 0·05 3·97 ± 0·07 4·42 ± 0·12 5 ·DO ± 0 ·14 5·43 ± 0·12 6·09 ± 0·21 
of body wt.) 
Specific activity of 38·80 ± 1 ·94 38·94 ± 2·96 42·90 ± 2·02 48·05 ± 4·48 50·01 ± 6·47 43·20 ± 3·63 40·81 ± 3·07 
fatty acid synthe-
tase (units of ac-
tivity/mg PFS N 
protein) D Ul 
t 
Amount of soluble 106.9 ± 1 . 8 109.9 ± 1 . 5 104.3 ± 0. 9 112·1 ± 1·1 103·2 ± 2•4 101 . 2 ± 3. 5 97·9 ± 2·9 
protein/g liver 
(mg) 
Units of fatty acid 4156 ± 242 4287 ± 359 4467 ± 184 5396 ± 530 5147 ± 649 4333 ± 309 3962 ± 230 
synthetase acti-
vity/g liver 
t :j: :j: 
Units of fatty acid 59087 ± 2307 58747 ± 5453 52987 ± 2510 83627 ± 9435 1 03873 ± 1 61 71 94013 ± 9004 95850 ± 10986 
synthetase acti-
vity/liver 
The body weight and liver weight data have been presented in Table 2 . 
FIGURE 30 
The effect of varying doses of 17S-oestradiol on the activity of 
hepatic fatty acid synthetase 2 days after injection 
Consult the legend of Table 14 for details of experimental 
procedure. 
A values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
(a) specific activity (nmoles NADPH oxidized/min/mg PFS protein) 
(b) units of enzyme activity/g liver 
(c) units of enzyme activity/liver 
The results are expressed as means (± S.E.M.) of 5 or 6 
observations. 
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large S.E.M. values. The results indicate a slight increase in the 
mean specific activity of fatty acid synthetase as a result of oestrogen 
treatment, reaching a maximum with a dose of 0·75 mg hormone/100 g body 
weight, when the mean specific activity was approximately 29% higher 
than that of the control chicks (Fig. 30(a)). Higher doses of 17S-
oestradiol (~ 1 mg/100 g body wt.) caused a decrease in the mean specific 
activity of the enzyme, but at all hormone doses the mean specific 
activity was higher than the values for the control and untreated groups. 
Similar results were obtained when the data were expressed as enzyme 
activity/g liver, but in this case, the maximum mean activity occurred 
with a dose of 0·5 mg hormone/100 g body weight, and the mean activity 
with a dose of 1 ·25 mg hormone/100 g body weight was slightly lower than 
the mean values for the control and untreated birds (Fig. 30(b)). 
Statistical analysis of these results, using Student's 't' test, indi-
cated no significant differences in specific activity (or activity/g 
liver) between control, untreated, and oestrogen-treated chicks at any 
dose of hormone administered, in this experiment. 
Expression of enzyme activity as total organ activity revealed a 
slight decrease in mean total activity with the lowest dose of 17S-
oestradiol (0·25 mg/100 g body wt.). This was followed by a sub-
stantial increase in mean total activity at higher doses. The mean 
total activity reached a maximum at 0·75 mg 17S-oestradiol/100 g body 
weight, when this value was approximately 76% higher than that of the 
control chicks (Fig. 30(c)). Further increases in 17S-oestradiol dose 
caused a slight decrease in mean total activity. Statistical analysis 
of these results indicated that oestrogen treatment caused a significant 
increase in total enzyme activity at all doses in the range 0·75 - 1 ·25 mg 
hormone/100 g body weight. The total organ enzyme activities after 
treatment with 17S-oestradiol, over the dose range 0·5 - 1 ·25 mg/100 g 
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body weight, did not differ significantly from each.other. On the 
basis of these results, a dose of 0·75 mg 17S-oestradiol/100 g body 
weight was selected for future use, since this dose gave the maximum 
mean specific activity and maximum mean total activity in the experiment 
described above. It was noted that, with the exception of the result 
obtained with the 0·5 mg hormone dose, slight decreases in the mean 
soluble protein content of a unit weight of liver were observed for 
oestrogenized chicks (Table 14). The soluble protein content values 
for oestrogenized birds only attained significance with respect to the 
values for untreated and control birds with a dose of 1·25 mg hormone/ 
100 g body weight. A dose-related increase in liver weight, as a per-
centage of body weight, was evident over the 17S-oestradiol dose range 
used in this experiment. This phenomenon has been discussed in Chapter 
2. 
4. le intramuscular in'ection of 17S-oestradiol 
The next experiment was conducted to investigate the effect of a 
single intramuscular injection of 17S-oestradiol (0·75 mg/100 g body 
wt.) on the activity of hepatic fatty acid synthetase at various times 
(3 - 40 h) after injection. The results are shown in Table 15 and 
Fig. 31. Hormone treatment caused a substantial increase in the mean 
specific activity of the enzyme at 3 and 6 hours after injection, com-
pared with that of untreated chicks. Maximum mean specific activity 
was obtained 6 hours after hormone injection, when this value was more 
than double the value for untreated chicks (Fig. 31(a)). Following 
this, the mean specific activity declined sharply (at 14 hours post-
injection), and the~ increased slowly over the next 26 hours. At all 
times after hormone injection up to 40 hours, the mean specific activity 
TABLE 15 
The effect of a single dose of 17S-oestradiol (0·75 mg/100 g body wt.) on liver weight, the soluble protein content of the 
liver and the activity of hepatic fatty acid synthetase at varying times after injection 
Each oestrogen-treated chick received. a single intramuscular injection of 0·75 mg 17S-oestradiol in propane-1,2-diol/ 
100 g body weight. At the indicated times after injection (3 - 40 h) chicks were sacrificed, and liver enzyme pre-
parations were obtained as described in the Methods section. Fatty acid synthetase activity in the high-speed super-
natant was assayed at 30°C in the presence of final concentrations of 200 mM-potassium phosphate buffer (pH 7·0), 1 mM-OTT, 
1 mM-EDTA, 100 wM-NAOPH, 20 wM-acetyl-CoA and 30 wM-malonyl-CoA. 
assayed by a modified biuret method as described in the text. 
The protein content of the high-speed supernatant was 
Values are the means (± S.E.M.) for 5 chicks. 
Data were analyzed statistically by Student's 't' test, and levels of statistical significance are presented with respect 
to values for untreated chicks. 
t significant at P < 0·05 
* 
significant at P < 0·02 
tt significant at P < 0·01 
~ significant at P < 0·002 
! significant at P < 0·001 
The enzyme activity results are illustrated graphically in Fig. 31(a- c). 
Chicks were aged 4 - 5 weeks . 
The body· weight and liver weight data have been presented in Table 3 . 
FIGURE 31 
Hepatic fatty acid synthetase activity at varying times after a 
single injection of 17B-oestradiol (0·75 mg/100 g body wt.) 
Consult the legend of Table 15 for details of experimental 
procedure. 
A values for untreated chicks 
0 values for oestrogen-treated chicks 
(a) specific activity (nmoles NADPH oxidized/min/mg PFS protein) 
(b) units of enzyme activity/g liver 
(c) units of enzyme activity/liver 
The results are expressed as means (± S.E.M.) of 5 observations. 
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was greater than that for untreated chicks. A similar response was ob-
served when the enzyme activity was expressed as activity/g liver or as 
total organ activity (Fig. 31(b) & (c)). In both cases, maximum res-
ponse was obtained 6 hours after hormone injection, when the mean values 
were approximately 70% higher than those of the untreated birds. 
Statisti~al analysis of these results, using Student's 1 t 1 test, 
indicated significant differences in specific activity between untreated 
and oestrogenized chicks at 3, 6 and 40 hours after hormone injection 
(Table 15). When the enzyme activity was expressed as activity/g 
liver, significant increases were obtained at 3 and 6 hours. Total 
organ activities were significantly greater than those of untreated 
chicks at 6, 27 and 40 hours after oestrogen injection. The mean 
soluble protein content of a unit weight of liver for oestrogenized 
chicks, at all the time points studied, was noted to be lower than the 
value for untreated chicks. These hepatic soluble protein content 
values for oestrogenized chicks attained statistical significance with 
respect to the untreated chick values at 6, 19, 27 and 40 hours after 
hormone injection. With the exception of the value obtained at 14 
hours, a time-related increase in liver weight, as a percentage of body 
weight, was observed up to 40 hours after 17S-oestradiol injection. 
This trend has been discussed fully in Chapter 2. 
The lack of control chicks, injected with propane-1,2-diol only, 
in this latter experiment, raised the question that the enzyme activity 
differences observed may have been caused merely by handling and/or the 
injection of propane-1,2-diol, and not by the administered 17S-
oestradiol. This possibility prompted the design of an experiment to 
include adequate controls. The effect of a single intramuscular in-
jection of 17S-oestradiol (0·75 mg/100 g body wt.) on the activity of 
hepatic fatty acid synthetase was again investigated at various times 
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(3 - 26 h) after hormone injection. Control chicks, injected with an 
equivalent volume of propane-1,2-diol only, were included at each time 
point. The results of this experiment are shown in Table 16 and Fig. 
32. 
As in previous experiments, there was considerable variation in 
enzyme activity between individual birds within each treatment group. 
The results show an increase in the mean specific activity of hepatic 
fatty acid synthetase from oestrogenized and control chicks, above the 
value for untreated chicks, at all the time poi~ts studied. This in-
dicates that handling and/or the injection of propane-1,2-diol was 
primarily responsible for the changes in specific activity observed. 
The mean specific activities of the enzyme from control and oestrogen-
ized chicks were very similar up to 6 hours after injection, and maximum 
values were obtained at 14 hours. At this time, the mean values for 
control and oestrogenized chicks were approximately 50% and 40% higher, 
respectively, than that for the untreated chicks (Fig. 32(a)). A de-
crease in mean specific activity was observed at 26 hours, with the 
oestrogenized value declining to a greater extent than the control 
value. At 26 hours after injection, the mean specific activities of 
the enzyme from control and oestrogen-treated chicks were approximately 
42% and 11% higher, respectively, than the mean value for untreated 
chicks. A similar pattern of response was observed when enzyme acti-
vity was expressed/g liver (Fig. 32(b)). 
A slightly different response pattern was observed when the enzyme 
activity was expressed as total organ activity (Fig. 32(c)). In this 
case, the mean values for injected birds were once again greater than 
the mean value for the untreated birds. The mean total activity for 
oestrogen-treated chicks increased to a maximum at 6 hours after in-
jection, when this value was approximately 37% higher than that of un-
TABLE 16 
The effect of a single dose of 178-oestradiol (0·75 mg in propane-1,2-diol/100 g body wt.), or of propane-1,2-diol only, 
on liver weight, the soluble protein content of the liver and the activity of hepatic fatty acid synthetase at varying 
times after injection 
Each oestrogen-treated chick received a single intramuscular injection of 0·75 mg 17S-oestradiol in propane-1,2-
diol/100 g body weight. Control chicks received an equivalent volume of propane-1,2-diol only. At the indicated times 
after injection (3 - 26 h) chicks were sacrificed, and liver enzyme preparations were obtained as described in the Methods 
section. Fatty acid synthetase activity in the high-speed supernatant was assayed at 30°C in the presence of final con-
centrations of 200 mM-potassium phosphate buffer (pH 7·0), 1 mM-DTT, 1 mM-EDTA, 100 ~-NADPH, 20 WM-acetyl-CoA and 30 wM-
malonyl-CoA. The protein content of the high-speed supernatant was assayed by a modified biuret method as described in 
the text. 
E = values for oestrogen-treated chicks 
C = values for control chicks 
Values are the means (± S.E.M.) for 5 chicks. 
*These values are the means (± S.E.M.) for 4 chicks. 
Data were analyzed statistically by Student's 't' test. Levels of statistical significance presented with values for 
oestrogenized chicks are with respect to corresponding control values. Levels of significance presented with values 
for control chicks are with respect to the values for untreated chicks. 
t significant at P < 0·05 
tt significant at P < 0·01 
The enzyme activity results are illustrated graphically in Fig. 32(a - c). 
Chicks were aged 4 - 5 weeks . 
Body weight (g) 
Liver weight (as% of body wt.) 
Specific activity of fatty acid 
synthetase (units of activity/ 
mg PFS protein) 
Amount of soluble protein/g 
liver (mg) 
Units of fatty acid synthetase 
activity/g liver 
Units of fatty acid synthetase 
activity/liver 
* Untreated 
396 ± 9 
3·54 ± 
0·06 
39·63 ± 
1 ·16 
107 ·0 ± 
2·9 
4239 ± 
153 
59709 ± 
3987 
Time after injection (h) 
3 6 14 26 
E c E c E c E c 
368 ± 31 393 ± 16 405 ± 22 400 ± 22 320 ± 15 323 ± 20 344 ± 18 358 ± 7 
4·00 ± 3·86 ± 4·01 ± 3·57 ± 4·54 ± 3. 61 ± 5·03 ± 3·59 ± 
0·22 0 ·13 0·1 0 0 ·11 0·18 0·06 0·26 0 ·17 
tt tt 
43·84 ± 42·36 ± 47·80 ± 47·48 ± 55·33 ± 59·50 ± 43·94 ± 56·24 ± 
3·03 2 ·12 3·28 3·63 5·98 4·47 4·17 3·57 
105 ·1 ± 105 ·7 ± 106 ·1 ± 106·6 ± 97·2 ± 105·0 ± 98·8 ± 108·8 ± 
2·7 1 • 9 3 ·1 2·3 3·5 2·5 2·7 4 ·1 
tt t t 
4601 ± 4479 ± 5071 ± 5050 ± 5379 ± 6239 ± 4323 ± 6159 ± 
304 245 373 370 612 465 375 574 
66969 ± 67769 ± 81873 ± 72689 ± 76696 ± 71917 ± 76649 ± 79618 ± 
7248 4320 6492 9174 6782 5065 11620 9766 
The body weight and liver weight data have been presented in Table 4 . 
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FIGURE 32 
Hepatic fatty acid synthetase activity at varying times after a 
single injection of 0·75 mg 17~oestradiol in propane-1,2-diol/100 g 
body weight, or of propane-1,2-diol only 
Consult the legend of Table 16 for details of experimental prq-
cedure. 
£ values for untreated chicks 
e values for control chicks 
0 values for oestrogen-treated chicks 
(a) specific activity (nmoles NADPH oxidized/min/mg PFS protein) 
(b) units of enzyme activity/g liver 
(c) units of enzyme activity/liver 
The results are expressed as means (± S.E.M.) of 4 or 5 
observations. 
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treated chicks, and then decreased slottlly to a value at 26 hours which 
was approximately 28% higher than that of untreated chicks. On the 
other hand, the mean total activity for control chicks increased during 
the first 6 hours to a value which was approximately 22% higher than 
that of untreated chicks, and then increased to a maximum at 26 hours, 
when this value was 33% higher than that of untreated chicks. 
Statistical analysis of these data showed that the specific activ-
ities of hepatic fatty acid synthetase from oestrogen-treated chicks did 
not differ significantly from the specific activities of the enzyme from 
their corresponding groups of control chicks, at any of the post-
injection times studied. The specific activities for control chicks 
at14and 26 hqurs after injection were significantly greater than the 
specific activities for the untreated chicks (Table 16). When the 
enzyme activity was expressed/g liver, the values for oestrogenized 
chicks at 26 hours after injection were significantly lower than the 
values for the corresponding group of control chicks. As was the case 
with the specific activities, the activity/g liver values for control 
chicks at 14 and 26 hours afte~ injection were significantly greater 
than the values for the untreated chicks. Total organ activities for 
the groups of oestrogen-treated chicks did not differ significantly 
from those of their corresponding control groups, and the values for the 
control groups did not differ significantly from those of the untreated 
chicks. 
The mean soluble protein content/g liver was noticeably low for 
oestrogenized chicks at 14 and 26 hours after 17S-oestradiol injection, 
but these observations did not attain statistical significance. A 
similar decrease was not evident for the control birds. As noted pre-
viously, a time-related increase in liver weight, as a percentageofbody 
weight, was observed after injection of 0·75 mg 17S-oestradiol/100 g 
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body weight (Table 16). This observation was evident as early as 3 
hours after injection, although the mean values at 3 and 6 hours were 
virtually identical. The mean values at 14 and 26 hours were pro-
gressively larger. This response was not observed for the control 
chicks. This phenomenon has been discussed in Chapter 2. 
DISCUSSION 
1. Optimum conditions for assaying the activity of fatty acid 
synthetase from chick liver 
Fatty acid synthetase from chick liver gave optimum activity when 
assayed at pH 7·0, with final concentrations of 100 wM-NADPH, 20 wM-
acetyl-CoA and 30 wM-malonyl-CoA. These optimum conditions differ 
somewhat from the conditions employed by other workers to assay fatty 
acid synthetase from avian liver. Katiyar & Porter (494 ) demonstrated 
optimum activity of the enzyme from pigeon liver in the presence of 
200 mM-potassium phosphate buffer at pH 7·0, with final concentrations 
of 100 wM-NADPH, 15 wM-acetyl-CoA and 60 wM-malonyl-CoA. Goodridge 
(468 ) performed assays of chicken liver fatty acid synthetase with 
100 mM-potassium phosphate buffer (pH 7·0), and final concentrations of 
180 wM-NADPH, 25 wM-acetyl-CoA and 100 wM-malonyl-CoA. Aprahamian et 
al. ( 31 ) employed 60 mM-potassium phosphate buffer at pH 6·5, and final 
concentrations of 112 wM-NADPH, 20 wM-acetyl-CoA and 60 wM-malonyl-CoA, 
to assay the enzyme from chicken liver and oviduct. Fatty acid syn-
thetase from pigeon liver has been shown to be very susceptible to loss 
of activity in low ionic strength buffer (501 ), and therefore, 200 mM-
potassium phosphate buffer was employed in the present study. Clearly, 
the principal difference between the conditions used in the present study 
and those referred to above lies in the concentration of malonyl-CoA 
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employed in the assay. In the present investigation, high concen-
trations of malonyl-CoA (>40 uM) were found to give a small but pro-
gressive inhibition of the enzyme extracted from the livers of 
untreated chicks. A similar effect, and also inhibition by acetyl-CoA, 
have been reported by other workers, and it has been shown that acetyl-
CoA and malonyl-CoA exhibit a competitive inhibition with respect to 
h th ( 488' 492' 494' 495' 502) c tl t t. f eac o er onsequen y, a concen ra 1on o 
30 uM-malonyl-CoA was selected for subsequent assays. In addition, the 
finding that oestrogen treatment of chicks in vivo did not affect the 
optimum assay conditions of the enzyme in vitro, meant that all subse-
quent assays of the enzyme could be performed under the same optimum 
conditions. 
2. The effect of var in doses of 17S-oestradiol (0 - 1 ·25m /100 
body wt. activity of hepatic fatty acid synthetase 
Variation in the dose of 17S-oestradiol administered to chicks in 
vivo, within the range 0·25- 1·25 mg hormone/100 g body weight, caused 
moderate increases in the mean specific activity of fatty acid synthe-
tase in liver cell extracts prepared 48 hours after hormone administration. 
A similar response pattern was observed when enzyme activity was ex-
pressed as total organ activity, although a slight decrease in the mean 
value was observed with a dose of 0·25 mg when compared with the mean 
values for control and untreated chicks. 
Mean specific activity and mean total activity reached maximum 
values with a dose of 0·75 mg hormone/100 g body weight. These values 
corresponded to a 29% increase in mean specific activity and a 76% in-
crease in mean total activity compared with the control values. Only 
the total activity values were found to differ significantly from those 
of the control and untreated chicks. With a dose of 0·75 mg hormone/ 
100 g body weight, the mean liver weight (as% of body wt.) increased 
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by 42 - 45%. Under the same conditions, the soluble protein content/g 
liver did not alter significantly. These results suggest that the 
significant increase in total fatty acid synthetase activity may be due 
largely to new enzyme activity appearing concurrently with organ 'growth'. 
Higher doses of 17e-oestradiol (1 & 1 ·25 mg hormone/100 g body wt.) 
caused a slight decrease (approx. 8 - 9%) in mean total activity com-
pared with that observed with the 0·75 mg dose. Increases in mean 
liver weight (as% of body wt.) were obtained with doses of 1 and 1·25 mg 
hormone, for which values were 9% and 22% higher, respectively, than 
that obtained with the 0·75 mg dose. A significant decrease in soluble 
protein content/g liver was obtained with a dose of 1 ·25 mg hormone. 
With doses of ~ mg and 1 ·25 mg hormone, there were decieases in mean 
specific activity and mean activity/g liver. These observations 
suggest that, at higher oestrogen levels, organ 'growth' is accompanied 
by accumulation of proteins other than fatty acid synthetase, and also 
by decreased synthesis and/or increased degradation of selected proteins 
including fatty acid synthetase. 
Pearce & Balnave (256 ) reported similar effects of variations in 
' ) 
oestrogen dose on the activities of ATP citrate lyase and malic enzyme 
in liver extracts from immature pullets 2 days after oestrogen treat-
ment. Using oestradiol dipropionate, these workers reported maximum 
specific activities of these enzymes with 2 mg hormone/bird and 1 mg 
hormone/bird, respectively. Thus, after correction for body weight 
and quantity of oestradiol, the maximum specific activities were ob-
tained with approximate doses of 0·57 mg oestradiol/100 g body weight 
for ATP citrate lyase, and 0·28 mg oestradiol/100 g body weight for 
( ) 
malic enzyme. In the present investigation, therefore, maximum spec-
ific activity of fatty acid synthetase was observed at a higher dose of 
oestradiol (0·75 mg/100 g body wt.) than reported for ATP citrate lyase 
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and ~alid enzyme. This difference in dose levels may be the result of 
sex differences, since male chicks were used throughout the present 
study, whilst Pearce & Balnave (256 ) used immature females. It is 
possible that immature pullets at 4 weeks of age possess endogenous 
oestrogen levels capable of exerting effects on enzyme activity, and/or 
higher levels of oestrogen receptor proteins in the liver cells than do 
male chicks. In addition, different enzymes may have different suscept-
ibilities to oestradiol treatment. 
3. The effect of a single intramuscular injection of 17S-oestradiol 
(0·75 mg/100 g body wt.) on the activity of hepatic fatty acid 
synthetase 
Pearce &·Balnave (256 ) observed reduced specific activities of ATP 
citrate lyase and 'malic enzyme after administering oestrogen to immature 
pullets over a period of 8 days, and consequently recommended that short-
term investigations, within 2 days of hormone administration, would be 
more indicative of induced physiological effects, since pharmacological 
effects might predominate after longer times. As the initial enzyme 
changes after oestrogenization were of major interest in the present 
study, investigations were performed within 2 days of hormone treatment. 
The activity of hepatic fatty acid synthetase, determined at various 
times (3 - 40 h) after a single intramuscular injection of 17S-oestradiol 
(0·75 mg/100 g body wt.), was considerably increased (Fig. 31). The 
maximum mean specific activity and mean total organ activity were ob-
served at 6 hours after 17S-oestradiol injection. At this time, the 
mean specific activity was more than double that of the untreated chicks, 
whilst the mean total activity was approximately 68% higher than that of 
the untreated chicks. 
At 6 hours after hormone injection, values for the soluble protein 
content/g liver were significantly lower than values from untreated 
222 
chicks, and the mean liver weight (as% of body wt.) was approximately 
11% greater than the value for untreated chicks. These results suggest 
that the increased liver weight at this early time point may be the re-
sult of cell expansion caused by water uptake, rather than, or in 
addition to, increased cell growth with concomitant protein synthesis. 
The significant increases in specific activity at 3 and 6 hours post-
injection indicate that a greater proportion of soluble cell protein 
exhibits fatty acid synthetase activity at these time points. The sig-
nificant increase in total fatty acid synthetase activity at 6 hours 
after injection implies new enzyme activity appearing simultaneously 
with the increase in organ size. The decrease in mean specific activity 
observed at 14 hours is accompanied by a decrease in mean total activity, 
but both of these values increase slowly again over the following 26 
hours. 
The values for soluble protein content/g liver at 19, 27 and 40 
hours after 17B-oestradiol injection were significantly lower than un-
treated chick values, and the mean specific activities at these time 
points were considerably lower than the mean value at 6 hours. These 
results indicate that, at these later time points after oestrogenization, 
a lesser proportion of soluble cell protein exhibits fatty acid synthe-
tase activity than at the 6-hour time point. The data illustrated in 
Fig. 31(c) show that the total enzyme activity does not continue to in-
crease as liver size increases. 
Since control chicks, receiving the injection vehicle only, were not 
included in this experiment, it was not possible to distinguish the 
cause of the changes in enzyme activity. The fact that substantial 
activity changes were obtained at such short time intervals after oes-
trogen injection (3 & 6 h), posed the suggestion that stress might have 
contributed to the changes. The experiment illustrated in Fig. 32 
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incorporated control chicks, injected with propane-1,2-diol only, at 
each of the post-injection time points studied. Again, oestrogen-
treated chicks exhibited increased mean specific activities at all time 
points up to 26 hours after injection, but a similar response was also 
observed with control chicks. Maximum mean specific activities for 
both control and oestrogenized chicks were obtained at 14 hours after 
injection, which is rather later than the peak in mean specific activity 
at 6 hours observed in the previous experiment. The specific activities 
for control chicks at 14 and 26 hours after injection were the only 
specific activity values to attain significance with respect to the 
values for untreated chicks. The mean specific activities for control 
and oestrogeni~ed chicks were very similar up to 6 hours after injection, 
but at 14 hours the value for control chicks was approximately 7·5% 
higher than that for the corresponding group of oestrogenized chicks . 
. At 26 hours, the mean specific activity for control chicks was approxi-
mately 28% higher than that for oestrogenized chicks at this time. 
The sharper decline in the mean specific activity of hepatic fatty 
acid synthetase for oestrogen-treated chicks than for control chicks, 
from 14 to 26 hours, may be the result of end product inhibition of the 
enzyme from oestrogen-treated chicks by accumulating lipid. It is well-
known that after oestrogen treatment in vivo, the chicken liver becomes 
fatty and lipaemia develops, and this has been shown to be evident at 14 
hours after hormone administration (see Chapter 2). This increase in 
lipid production is undoubtedly the result of increased hepatic lipogenic 
enzyme activities, brought about either by increases in the concentrations 
of enzymes or by the activation of constant amounts of enzymes. Fatty 
acid synthetase may, or may not, be involved in these enzyme changes 
after oestrogen treatment, but the resulting accumulating lipid may 
have an inhibitory effect on fatty acid synthetase and other lipo-
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genic enzyme activities. Such inhibition may be the cause of the sharp 
decline in mean specific activity (and mean activity/g liver) observed 
in Fig. 32. Since control chicks do not develop fatty liver and 
lipaemia after propane-1,2-diol injection, no such inhibitory effect 
would be expected for control chicks, and this is substantiated by only 
a small decline in mean specific activity (and mean activity/g liver) 
from 14 to 26 hours. 
The maximum mean total activity for the enzyme of oestrogen-treated 
chicks was observed at 6 hours, as was the case in the previous experi-
ment (Fig. 31(c)). Inhibitory effects may be operative, as described 
above, to cause the decrease in mean total activity after this time. 
This 6-hour value for oestrogenized chicks was only slightly higher than 
the maximum mean total activity attained at 26 hours for control chicks. 
These data imply that handling and/or the injection of propane-1,2-diol 
may be the major cause of the increases in enzyme activity observed up 
to 26 hours after injection. This is of particular interest when com-
pared with the results presented in Table 10 in Chapter 3, in which the 
incorporation of tritium from 3H2o into total lipid was measured in chick 
liver slices. In those experiments, the incorporation values for con-
trol chicks, that had received an injection of propane-1,2-diol 3~- 7! 
or 14 - 17 hours before death, were significantly greater than the values 
for untreated chicks. This suggests that fatty acid synthesis was stim-
ulated at these early times by handling and/or the injection of propane-
1,2-diol. This may, however, be a short-term phenomenon, since it has 
been shown that 48 hours after injection greater hepatic fatty acid syn-
thetase activities are observed for oestrogen-treated chicks than for 
control chicks (Fig. 30), and the 3H20 incorporation values for control 
chicks at times later than 17 hours after injection were not signifi-
cantly different from untreated values (Table 10). These data, there-
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fore, suggest that an oestrogen-dependent increase in fatty acid syn-
thetase activity occurs at some point between 26 and 48 hours after in-
jection of 17S-oestradiol (0·75 mg/100 g body wt.). 
In this experiment (Table 16), no significant differences in soluble 
protein content/g liver were obtained, although noticeably lower mean 
values were observed at 14 and 26 hours after oestrogenization. As 
in the previous experiment, a time-related increase in liver weight (as 
%of body wt.) was evident as early as 3 hours after 17S-oestradiol in-
jection. No such response was observed for control chicks at any time 
point, confirming that this phenomenon is the result of oestrogen treat-
ment and not of handling and/or the injection of propane-1,2-diol. 
The results of this latter experiment throw some doubt upon the 
conclusions drawn from the data of Pageaux et al. (235 ). These workers 
reported a rapid increase in hepatic acetyl-CoA carboxylase activity 
after treating 16-day old female quail with a single injection of oes-
tradiol benzoate (0·2 mg/kg body wt.). A peak in specific activity was 
reached at 3 hours after injection, and the values at 3 and 6 hours were 
significantly higher than 'control' values. The hormone dose used by 
these workers was extremely low compared with the dose levels adminis-
tered to birds by other workers (31 ' 256 ) and those used in the present 
study. At 3 hours after oestrogen injection, Pageaux et al. (235 ) ob-
served a 37% increase in mean acetyl-CoA carboxylase specific activity 
compared with that of 'control' birds. However, the description of the 
experimental procedure suggests that the 'control' birds were injected 
with the olive oil vehicle immediately before death, and were not sacri-
ficed at the same post-injection times as the oestrogenized birds. It 
appears, therefore, that adequate controls were not performed, so that 
effects due to stress or administration of the injection vehicle could 
not be excluded. As a result of their experimental design, data ob-
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(235) tained from the 'control' birds used by Pageaux et al. may be 
comparable with those obtained from the untreated chicks in the present 
study. The values obtained by Pageaux et al. (235 ) at 1 hour and 24 
hours after hormone injection were very similar. The description of 
the experimental procedure implies that these 2 groups of birds were 
sacrificed at approximately the same time on consecutive days. The 
enzyme activity variations obtained at the other time points may, there-
fore, have been influenced by the time of day. In the present study, 
chicks were killed at or near midday whenever possible, so that any 
diurnal effects did not obscure the investigation. 
Philipp & Shapiro (140 ) have ~easured acetyl-CoA carboxylase and 
fatty acid synthetase activities in liver extracts from oestrogenized 
male Xenopus laevis. These animals received a 17B-oestradiol injection 
(0·4 mg/100 g body wt.) at 0 and 24 hours, and were sacrificed for enzyme 
assay over an extended period (1 - 14 days). Oestrogen treatment re-
sulted in increased hepatic fatty acid synthesis and a concurrent in-
crease in acetyl-CoA carboxylase activity, with peaks in both of these 
parameters on the 6th day. No change in fatty acid synthetase activity 
was observed during their study. However, another substantial increase 
in fatty acid synthesis was observed from the Bth to the 13th day of the 
experiment, without a concomitant increase in acetyl-CoA carboxylase 
activity. This observation, together with the small number of animals 
examined (2 at each time point) and the lack of control values for com-
parison, casts some doubt on the conclusions drawn from the data by 
these workers about the action of the oestrogen. 
Aprahamian et al. ( 31 ) examined hepatic fatty acid synthetase ac-
tivity after treating 1-month old pullets with oestrogen. After pro-
longed oestrogenization (4 mg~oestradiol-3-benzoate/bird/day for 6 
days), a 3-fold increase in total organ enzyme activity was observed. 
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This increase was accompanied by a 2-fold increase in specific activity 
and an approximately 66% increase in liver weight. These workers also 
assayed the fatty acid synthetase from chicken oviduct, and found an 
enormous increase in total and specific activity of the enzyme in this 
organ after oestrogenization. The total enzyme activity of the ovi-
duct increased 180-fold, whilst that of the liver only tripled after 
oestrogen treatment. However, it should be noted that the total acti-
vity of fatty acid synthetase in the liver was approximately 150-fold 
higher than that in the oviduct. The lipid produced by the oviduct 
undoubtedly passes into the egg, but it is well-documented that the liver 
makes a considerable contribution to the lipids of the developing ovum. 
Therefore, as .regards the lipid requirements of the egg, the increase in 
the fatty acid synthetase activity of the liver would appear to be quan-
titatively more significant than the increase in enzyme activity of the 
oviduct. 
A decrease in soluble protein content/g liver is evident from the 
work of Aprahamian et al. ( 31 ), and a similar decrease has been observed 
during the present study. The specific activities obtained in the 
current work are greater than those reported by Aprahamian et al. ( 31 ) 
for chicken liver fatty acid synthetase. These workers reported a 
specific activity of about 5 nmoles NADPH oxidized/min/mg protein for 
control hen liver enzyme, which was doubled after oestrogen treatment. 
Several factors may be responsible for the discrepancies between the 
values from this work and those obtained in the present investigations. 
Notable differences are evident in the preparation of the enzyme, in 
substrate concentrations, and in the concentration of the potassium 
phosphate buffer and pH of the assay. Aprahamian et al. (31 ) used a 
lower temperature (23 - 26°C) for assaying the enzyme, and a different 
method of protein estimation based on absorbance at 280 nm. In the 
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present study, the tissue was homogenized in large volumes of buffer, 
and it may be that an inhibiting factor was diluted out in this pro-
cedure, contributing to the high specific activities observed. 
Goodridge (424 ) recorded a mean specific activity of about 52 nmoles 
NADPH oxidized/min/mg protein for fatty acid synthetase from 16-day old 
male and female chick livers. However, the temperature of assay (40°C) 
was very much higher than that used in the present study. Similarly, 
Muiruri et al. (46 ) assayed fatty acid synthetase at 37°C, and reported 
a mean specific activity of 43 nmoles NADPH oxidized/min/mg protein for 
the hepatic enzyme from ad libitum-fed male and female chickens. In 
addition to the temperature differences, the studies of Goodridge (424 ) 
and Muiruri et al. (46 ) differ from each other and from the present 
study in the enzyme preparation and assay conditions used, and therefore 
the results are not directly comparable. 
Measurements of enzyme activities in subcellular preparations 
under optimum conditions give an estimate of the total activity potential 
in the tissue. These conditions may not exist in vivo, and the enzyme 
may be affected in the cell by substrate deprivation or by regulatory 
metabolites. Changes in the activity of fatty acid synthetase could 
be the result of alterations in the catalytic efficiency of existing 
enzyme protein, or of variations in the amount of enzyme protein caused 
by changes in the rate of enzyme synthesis and/or degradation. 
In general, steroid hormones act by stimulating the transcription 
of selected genes, causing increased synthesis of selected enzymes and 
. ( 130 - 132) 
other protelns • This mechanism may account for changes in 
enzyme activity observed after oestrogen treatment of birds and Xenopus 
laevl. s ( 31 ' 140' 235' 256) 0 . t. . t t 1 ecreases ln enzyme ac lVl y a anger 
times after oestrogenization (Fig. 32) (166 ' 256 ) could be the result 
of a decrease in the amount of enzyme protein or of end product 
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inhibition of enzyme activity by accumulating lipid. The present ex-
periments, however, do not allow us to distinguish between these alter-
native mechanisms. 
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CHAPTER 5 
GENERAL DISCUSSION AND SUGGESTIONS FOR FURTHER WORK 
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GENERAL DISCUSSION 
1. The use of model systems for studying vitellogenesis in the 
domestic fowl 
Increases in the levels of vitellogenin and VLDL in blood, which are 
observed as the female domestic fowl approaches the point of lay, are 
thought to be due primarily to the oestrogen-dependent stimulation of 
lipid and protein biosynthesis in the female liver. This situation can 
be simulated in male or sexually-immature female birds by administration 
of exogenous oestrogen in vivo, providing a convenient model system for 
the investigation of the molecular events involved in these changes. 
In particular, male birds, with no endogenous oestrogen, have been used 
extensively to study the oestrogen-dependent stimulation of the hepatic 
b . th f VLDL (113 - 119, 206) d 't ll . (81, 141, 162, 163) losyn eses o an Vl e ogenln • 
The physiological state of the mature laying hen is, however, un-
doubtedly under the influence of a number of internal secretions in 
addition to oestrogen. The administration of oestrogen to male and 
immature female birds, therefore, cannot be expected to completely repro-
duce the natural state of fatty acid metabolism existing in the laying 
hen. Several notable differences in lipid metabolism between oestrogen-
treated birds and laying hens have been reported in the literature, al-
though these may simply be the result of the high oestrogen doses 
administered compared with the endogenous oestrogen levels that exist in 
the hen. ( 164) For example, Balnave observed heavier livers and higher 
liver and blood levels of fatty acids for immature pullets treated with 
oestrogen than for mature laying hens. In addition, the retention of 
dietary linoleic acid is increased at the onset of sexual maturity in 
the female bird (164 ), whilst the administration of oestrogen to imma-
ture pullets has no effect on dietary linoleic acid retention (503 ) 
Significant increases in the percentage of palmitic acid in blood and 
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liver fatty acids have been observed for oestrogen-treated pullets but 
not for the mature hen, suggesting that palmitic acid might be meta-
. ( 1 64, 464) It . bolized abnormally 1n the oestrogen-treated pullet • lS 
interesting to note that palmitic acid is the principal fatty acid syn-
th . d b h. k l" d . d l" . ( 276 ' 504 ) d th t es1ze y c lC 1ver ur1ng ~ novo 1pogenes1s , an a 
there may be a differential utilization of palmitic acid, compared with 
other fatty acids, for neutral lipid synthesis (351 ). 
Some of the forementioned differences between observations from 
oestrogen-treated immature birds and laying hens are undoubtedly a re-
sult of the egg-laying process. In the laying hen, lipid is continually 
being removed from the body by deposition in the developing oocyte and 
the laying of .eggs. This results in a continual demand for lipid, which 
is not manifested in the immature bird and cockerel after oestrogen 
treatment. In these latter cases, accumulation of lipid and egg yolk 
proteins in the liver cells and blood might be expected to exert feed-
back inhibition on their hepatic syntheses. For this reason, the events 
that occur at short intervals after oestrogen treatment of immature birds 
and cockerels are more likely to be indicative of the situation existing 
in the laying hen. 
However, the differences between oestrogen-treated birds and lay-
ing hens outlined above are considered to be relatively minor, and the 
administration of oestrogen to immature male and female birds and 
cockerels remains a useful model system for studying the major mole-
cular events involved in avian vitellogenesis. The investigations 
undertaken in the present study were designed to establish changes in 
hepatic lipogenesis in the male chick at relatively short intervals 
(~ 2 days) after oestrogen treatment. 
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2. The use of liver slices to measure hepatic lipogenesis in vitro 
The use of tissue slices for studying metabolism has several disad-
vantages, many of which have been outlined in Chapter 3. Major diffi-
culties associated with this preparation are the problems of diffusion 
of oxygen and substrates into the cells, and the presence of cut cells 
on the surface and 'shocked' cells in the interior of the slices. In 
connection with these problems, the use of isolated, perfused livers 
would be advantageous, since cells do not suffer mechanical damage, and 
diffusion problems are avoided. However, the adoption of this technique 
in the present study would have severely limited the number of experi-
ments performed and, therefore, the range of experimental conditions 
investigated. 
Isolated cells are often the system of choice for investigations 
such as those carried out in the present study. Pilot experiments in 
this laboratory, using a non-perfusion technique for cell isolation, pro-
duced very low yields of cells (approx. 7 x 106 cells/g liver) with 
rather low viability (approx. 70%) from livers of oestrogen-treated 
birds. Presumably this was due to the fragility of liver cells in these 
animals, and the low yield of viable cells made the technique unsuitable 
for this work. Consequently, tissue slices were considered to be the 
best whole cell preparation available under the circumstances. 
The fragility of cells from oestrogen-treated birds may have re-
sulted in a higher degree of cell damage on preparation of liver slices 
compared with that obtained for control liver slices, thus giving an 
artificially low rate of incorporation of precursors into lipids. 
Therefore, any stimulation of lipogenesis observed in liver slices from 
oestrogen-treated birds should be regarded as a minimum level. 
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3. Summary of results obtained in the present study 
The main features of the response of the male chick to oestrogen 
treatment, that resulted from the present study, are summarized below:-
(a) Liver weight 
Liver weight increased with time after a single injection of 176-
oestradiol (1 mg/100 g body wt.) up to 50 hours. Liver weights at 
about 50 hours after oestrogen treatment were up to 2·4-fold greater 
than those of untreated chicks and control chicks injected with propane-
1,2-diol only. 
A similar time-related increase in liver weight was observed up to 
40 hours after a single injection of 0·75 mg 17S-oestradiol/100 g body 
weight. 
A dose-related increase in liver weight was observed 48 hours after 
a single injection of 176-oestradiol over the dose range 0- 1·25 mg/ 
100 g body weight. 
(b) DNA content of liver 
Coincident with the increase in liver weight after oestrogen treat-
ment (1 mg 176-oestradiol/100 g body wt.) was a decrease in the DNA con-
tent of a unit weight of liver. 
(c) Plasma triacylglycerol concentration 
Plasma triacylglycerol concentrations of chicks, after a single in-
jection of 1 mg 176-oestradiol/100 g body weight, became significantly 
greater than control values at 5 - 7~ hours post-injection (P < 0·05h and 
increased progressively up to 50 hours after injection. The highest 
elevation of plasma triacylglycerol obtained represented a 33-fold in-
crease in concentration compared with control levels. 
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(d) Plasma phosphoprotein concentration 
Plasma phosphoprotein concentrations are indicative of vitellogenin 
levels, and after treating chicks with a single injection of 1 mg 17S-
oestradiol/100 g body weight, the levels of phosphoprotein became sig-
nificantly greater than control levels at 14- 18 hours post-injection 
(P < 0·02). Values for oestrogen-treated chicks increased progressively 
up to about 42~ hours, although values remained high up to 55 hours post-
injection. The greatest elevation of plasma phosphoprotein concen-
tration represented an 8-fold increase compared with control values. 
(e) Liver slice lipogenesis 
In the studies described below, oestrogen-treated chicks received 
a single injection of 17S-oestradiol (1 mg/100 g body wt.) in propane-
1,2-diol, and control chicks received an equivalent volume of propane-
1,2-diol only. 
(i) [1-14c] Acetate incorporation studies 
Maximum differences in acetate incorporation into total lipid be-
tween oestrogen-treated and control chicks occurred at 17 - 21~ hours 
after injection. When results were expressed as nmoles acetate incor-
porated/100 mg liver/hour, values for oestrogen-treated chicks at this 
time were significantly greater (P < 0·01) than those for control chicks. 
This difference between oestrogen-treated and control values at 17 -
21~ hours became greater when the results were expressed on a total 
liver or a cellular basis. The mean total incorporation for oestrogen-
treated chicks at this time was 3-fold greater than that for control 
chicks. 
Significantly greater incorporation values were obtained for 
oestrogen-treated chicks than for control chicks at 48~ - 55~ hours 
after injection when results were expressed on a cellular basis 
(P < 0·05). 
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Saponification analyses of lipid extracts from liver slices re-
vealed that the majority of the recovered radioactivity (> 84%) was 
located in fatty acids derived from complex lipids. The percentage of 
the recovered radioactivity in non-saponifiable lipids was significantly 
greater for liver slices from oestrogen-treated chicks than for those 
from control chicks (P < 0·05). Analyses of lipid extracts from liver 
slices by t.l.c. demonstrated that 66·5 - 69·5% of the recovered radio-
isotope was located in triacylglycerol. A significantly greater per-
centage of the recovered radioactivity was located in phospholipid in 
lipid extracts from control chick liver slices, than was obtained for 
lipid extracts from oestrogen-treated chick liver slices (P < 0·02). 
(ii) 3H2D incorporation studies 
3 Expression of the results for H2o incorporation into total lipid 
on a total liver or a cellular basis, revealed significantly greater 
values for oestrogen-treated chicks than for control chicks at 14 - 17, 
19 - 21~, 25~ - 28~ and 40~ - 43~ hours after injection. The greatest 
differences between results for oestrogen-treated and control chicks 
were obtained at 40~ - 43~ hours. The mean total organ incorporation 
for oestrogen-treated chicks was 2·4-fold greater than that for control 
chicks at this time. 
Expression of the incorporation results as ~g atoms H incorporated/ 
100 mg liver/hour, as ~g atoms H incorporated/liver/minute or as ~g atoms 
H incorporated/0·1 mg liver DNA/ hour, revealed that ~alues for untreated 
chicks were significantly lower than the results for control chicks at 
3~- 7~ hours and 14- 17 hours after injection of propane-1,2-diol. 
Saponification analyses of lipid extracts from liver slices re-
vealed that the majority of the recovered radioactivity (> 93%) was 
located in fatty acids derived from complex lipids. T.l.c. analyses of 
lipid extracts from slices demonstrated that approximately 87% of the 
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recovered radioisotope was located in triacylglycerol. There were no 
significant differences between the results for control and oestrogen-
treated liver lipid extracts. 
(iii) [9,10-3H] Palmitate incorporation studies 
When results of the [9,10-3H] palmitate incorporation studies were 
expressed as nmoles palmitate incorporated into triacylglycerol/100 mg 
liver/hour, values for oestrogen-treated chicks at 19 - 22~, 28 - 31~ and 
40~ - 44 hours after injection were significantly greater than those for 
control chicks. Expression of the results on a total liver basis or on 
a cellular basis, revealed significantly greater values for oestrogen-
treated chicks than for control chicks at 14~ - 18~, 19 - 22~, 28 - 31~ 
and 40~ - 44 hours after injection. 
The greatest differences between oestrogen-treated and control 
chicks were obtained at 40~ - 44 hours post-injection. The mean total 
organ incorporation for oestrogen-treated chicks was 2·47-fold greater 
than that for control chicks at this time. 
T.l.c. analyses of lipid extracts from liver slices showed that the 
majority of the recovered radioactivity (> 92%) was located in triacyl-
glycerol. A significantly greater percentage of the recovered radio-
activity was located as free fatty acid in control and untreated chick 
liver slices than in oestrogen-treated chick liver slices (P < 0·01). 
In addition, a significantly greater percentage of the recovered radio-
activity was located in triacylglycerol for oestrogen-treated chick 
liver slices than for liver slices of control chicks (P < 0·01). 
(f) Hepatic fatty acid synthetase activity 
Chicks received a single injection of 176-oestradiol (0·25 -
1·25 mg/100 g body wt.) in propane-1,2-diol or of propane-1,2-diol only, 
and hepatic fatty acid synthetase activity was assayed 48 hours later. 
Maximum mean specific activity and mean total organ activity were ob-
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served with a dose of 0·75 mg 176-oestradiol/100 g body weight. 
Treatment of chicks with 0·75 mg 176-oestradiol/100 g body weight 
yielded results for hepatic fatty acid synthetase activity which suggested 
that early increases in specific activity and total organ activity 
(~ 26 h) are caused by handling and/or injection of propane-1,2-diol, 
and that oestrogen-dependent increases occur within 48 hours. 
In many cases, the mean soluble protein content/g liver was ob-
served to decrease significantly after oestrogen treatment, compared 
with the levels for untreated and control chick livers. 
4. Sequence and correlation of changes in plasma triacylglycerol and 
phosphoprotein levels, liver slice lipogenesis and hepatic fatty 
acid synthetase activity 
The sequence of the changes in lipid metabolism that occur after 
oestrogen treatment of the male chick is important if the significance 
and a full understanding of these events is to be appreciated. 
Examination of results obtained in Chapters 3 and 4 indicate that, 
compared with untreated chicks, the control chicks exhibited:-
(a) significantly greater incorporation of tritium from 3H2o into 
total lipid of liver slices up to 17 hours post-injection 
(Chapter 3). 
(b) significantly greater specific activities and activities/g 
liver of hepatic fatty acid synthetase up to 26 hours post-
injection (Chapter 4). 
The results obtained from these two lines of approach, therefore, 
indicate that a stimulation of fatty acid synthesis at early times after 
injection may be caused by handling and/or injection of propane-1,2-
dial, and emphasize the need to include suitable control animals in all 
experiments. The inclusion of control animals at all stages is ex-
tremely important, particularly when using young animals for experimen-
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tation, since metabolic pathways such as lipogenesis and the activities 
of associated enzymes are known to be extremely variable during the first 
. (30 359 413) few weeks of neonatal l1fe ' ' 
The results of the liver slice studies and fatty acid synthetase 
study are not directly comparable, since different hormone doses were 
administered in each case. In the liver slice studies, oestrogenized 
chicks were treated with 1 mg 17S-oestradiol/100 g body weight, whilst 
in the enzyme study they received 0·75 mg 17S-oestradiol/100 g body 
weight. The responses to oestrogenization may, therefore, differ in 
time course and magnitude because of this dose difference. 
The greatest difference in the rate of lipogenesis between 
oestrogen-treated and control chicks, as measured by the incorporation 
of [1-14c] acetate into total lipid, occurred at 17- 21~ hours after 
injection, when the mean total organ incorporation for oestrogen-treated 
chicks was 3-fold greater than that for control chicks. In comparison, 
the greatest difference in the rate of lipogenesis between oestrogen-
treated and control chicks, assayed by 3H2o incorporation into lipids, 
occurred at 40k - 43k hours after injection, when the mean total organ 
incorporation for oestrogen-treated chicks was 2·4-fold greater than 
that for control chicks. These stimulations of the rate of lipogenesis 
are greater than the stimulations obtained in fatty acid synthetase 
activity after oestrogen treatment of chicks. The greatest difference 
in total liver fatty acid synthetase activity between oestrogen-treated 
(0·75 mg 17S-oestradiol/100 g body wt.) and control chicks was observed 
at 48 hours after injection, when the mean total organ activity for 
oestrogen-treated chicks was 1·76-fold greater than that for control 
chicks. The differences in magnitude of these responses may be the 
result of the differing hormone dose. It would appear, therefore, 
that an increase in fatty acid synthetase activity could well contribute 
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to the increases in the rate of lipogenesis observed in oestrogen-
treated chicks, compared with control chicks, at times later than 26 
hours post-injection. Differences in the rate of lipogenesis between 
oestrogen-treated and control chicks observed at times earlier than 
26 hours after injection would appear to occur independently of an 
increase in fatty acid synthetase activity, since fatty acid synthetase 
activity, measured in vitro under extracellular 'optimum' conditions, 
was found to be unaffected by oestrogen until after 26 hours. These 
earlier changes in fatty acid synthesis could, however, be governed 
by increased activities of other lipogenic enzymes such as acetyl-CoA 
carboxylase, and/or by increased substrate availability. 
[1-14c] acetate is a relatively poor precursor to use in monitor-
ing de novo fatty acid synthesis in chick liver cells, since it is not 
a highly physiological substrate and also does not define changes in 
3 de novo lipogenesis as well as H2o (Chapter 3). Hence, measurement 
of the rate of lipogenesis using [1-14c] acetate may be deceptive if 
there are changes in the pool size of acetyl-CoA, and if there are 
problems associated with the conversion of acetate to acetyl-CoA in 
chick liver cells. 
The results of the 3H20 and [9,10-
3H] palmitate studies revealed 
that significantly greater total organ incorporation values were ob-
tained for oestrogen-treated chicks than for control chicks from 14 to 
44 hours after injection. The greatest difference, in both cases, was 
in the approximately 40 - 44 h group, and the relative magnitude of 
stimulation of incorporation was similar in the two instances. A 
2·40-fold increase in mean total incorporation was obtained in the 
3H20 studies, compared with a 2·47-fold increase in the [9,10-
3H] 
palmitate studies. This suggests that de novo fatty acid synthesis 
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may be as important as complex lipid formation from fatty acids in 
the hepatic lipogenic response of the chick after oestrogen treat-
ment • 
. Comparison of the time courses of the increases in plasma triacyl-
glycerol and phosphoprotein concentrations after oestrogen treatment 
of male chicks, reveals that the increase in plasma triacylglycerol 
levels became significant at 5 - 7~ hours after injection, which was 
several hours before a significant increase in phosphoprotein levels 
became detectable at 14 - 18 hours post-injection. This sequence of 
changes is in agreement with the report of Bergink et al. (81 ), in 
which the rise in concentration of plasma VLDL occurred earlier than 
the increase in plasma phosphoprotein concentration. 
In contrast, a significant oestrogen-dependent stimulation of the 
rate of de novo hepatic fatty acid synthesis (monitored by 3H2o incor-
poration into total lipid of liver slices), and of the rate of hepatic 
glycerolipid synthesis from pre-formed fatty acid (monitored by 
[9,10-3H] palmitate incorporation into triacylglycerol of liver slices), 
did not occur until at least 14 - 14~ hours post-injection. However, 
comparisons of mean incorporation values, expressed on a total organ 
basis and a cellular basis, indicate that de novo lipogenesis, assayed 
by measuring the incorporation of [1-14c] acetate or 3H2o into lipids, 
might be increased slightly during the approximately 3~ - 8 h period 
following oestrogen treatment and, hence, could contribute to the 
early increases in plasma triacylglycerol levels. On the other 
hand, oestrogen-induced increases in fatty acid synthetase activity, 
as measured in vitro, did not emerge until at least 26 hours after the 
injection of 17S-oestradiol (0·75 mg/100 g body wt.). This phenomenon 
of non-parallel and non-coordinate changes in fatty acid synthesis in 
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whole cells and the activities of lipogenic enzymes has been observed 
t . . th l't t (33, 45, 46, 49, 50, 351, 375, 410, 420, many 1mes 1n e 1 era ure 
424) 
SUGGESTIONS FOR FURTHER WORK 
1. In vitro measurement of hepatic lipogenesis 
A major problem associated with the use of [1-14c] acetate to study 
de novo lipogenesis in liver slices is the need to measure the intra-
cellular acetyl-CoA pool size, since variations would lead to differ-
ences in the specific radioactivity of acetyl-CoA. In addition, 
lipogenesis may be limited by the rate of entry of acetate into the 
cell, or by its conversion to acetyl-CoA. Hence, measurements of 
acetyl-CoA pool sizes in the cells of liver slices from oestrogen-
treated and control chicks would increase the validity of using [1-14c] 
acetate to measure de novo lipogenesis. This problem of measuring 
acetyl-CoA pool sizes was overcome in the present study by the use of 
3H20 to assay de novo lipogenesis in liver slices, although the use of 
this precursor may not be ideal. The increase in cell size and the 
cell water 1pool 1 caused by oestrogen treatment might lead to a decrease 
in the specific radioactivity of water in the cell, and hence to an 
underestimate of de novo lipogenesis. A pool size problem also occurs 
with studies of glycerolipid synthesis assayed by measuring the incor-
poration of [9,10-3H] palmitate into triacylglycerol. Hawkins & 
Heald ( 236 ) showed that the rate of incorporation of palmitate into 
neutral lipids by chick liver slices increased in a linear fashion with 
increasing free fattyacidconcentration, indicating the importance of 
determining fatty acid pool sizes in the livers, and blood fatty acid 
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levels, in order to elucidate the events actually occurring in vivo. 
Since hepatocytes eliminate many of the problems of diffusion and 
cell damage associated with liver slices, development of techniques to 
isolate chick hepatocytes in high yield, and their use in incorporation 
studies, would be particularly useful in extending the studies that 
have been carried out with liver slices. Isolated hepatocytes would 
provide a more flexible and controllable experimental system for the 
study of metabolic changes associated with oestrogen treatment, since 
the cells could be carried through into primary cell culture and main-
tained in the presence or absence of oestrogen. This cell preparation 
would prove extremely useful in studies of the synthesis and secretion 
of vitellogenin and VLDL, which could be monitored by immunoprecipi-
tation. 
2. In vivo measurement of hepatic lipogenesis 
A clear picture of the state of lipogenesis in the oestrogen-
treated male chick can only be achieved by a combination of in vivo 
and in vitro techniques, since in vitro studies are obviously artificial. 
In vivo studies that would extend the results obtained in the present 
investigation would be the simultaneous determinations of the initial 
rates of incorporation of injected 3H2D and 
14
c-labelled palmitate into 
liver lipids at various times after oestrogen treatment. This would 
give more information about the relative importance of de novo lipo-
genesis and of lipogenesis from pre-formed fatty acids in vivo. 
A more detailed knowledge of the time course of changes in tri-
acylglycerol and free fatty acid levels in the blood after oestrogen 
treatment would help in the search for any precursor/product relation-
ship that might exist. In this respect, studies of the lipid meta-
bolism of extra-hepatic sites, such as adipose tissue, after oestrogen 
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treatment, would clarify the importance of the liver and extra-hepatic 
sites as sources of fatty acids for hepatic glycerolipid synthesis. 
3. Changes in lipogenic enzymes in vivo and in vitro 
Assaying the activity of an enzyme in vitro, under extracellular 
'optimum' conditions, generally gives an indication of the total cata-
lytic activity of the enzyme rather than the activity that actually 
exists in vivo. Changing concentrations of lipogenic enzymes may not 
always be involved in fluctuating rates of lipogenesis, since alter-
ations in the flux of metabolites through the biosynthetic pathway, and 
regulation of the activities of constant amounts of enzymes, may be 
(276 393, 465) 
responsible · ' It is advisable to assay several enzymes 
in a metabolic pathway, since the activities of some enzymes may be 
altered, whilst the activities of others might remain unchanged. 
The importance of assaying a number of enzymes in a metabolic 
pathway, and having a detailed knowledge of the relative importance of 
enzymes in the normal animal, is illustrated by the activity of the 
pentose phosphate pathway in the fowl. In mammals, the pentose phos-
phate pathway is important in the provision of NADPH for lipogenesis 
(393, 416) However, this pathway is relatively unimportant in the 
. (49 412 - 416) liver of the domest1c fowl ' , and because of this, the 
specific activities of glucose 6-phosphate dehydrogenase and 6-
phosphogluconate dehydrogenase have not been found to be significantly 
different in the livers of laying hens and cockerels (414 ). Similarly, 
the specific activities of these enzymes do not increase in the liver 
during the first few days after hatching, at a time when hepatic lipo-
. . 1 . ( 30 ' 41 3) d f t. d f d. d t genes1s 1ncreases enormous y , an as 1ng an re ee 1ng o no 
significantly affect the activities of these enzymes in the liver (49 ) 
Consequently, determining the possible lipogenic capacity of the liver 
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of the domestic fowl on the basis of the activities of the pentose 
phosphate pathway enzymes would be incorrect. 
In the present study, the lack of an oestrogen-induced increase in 
fatty acid synthetase activity, as measured in vitro, during the first 
26 hours after oestrogen injection (0·75 mg 176-oestradiol/100 g body 
wt.) indicated that any oestrogen-induced increases in fatty acid syn-
thesis during this time may not be brought about by an increase in 
fatty acid synthetase activity. However, this does not rule out the 
possibility that acetyl-CoA carboxylase, another key enzyme in the 
fatty acid synthetic sequence, may increase in activity during the 26 
hours following oestrogen treatment. The activity of hepatic acetyl-
CoA carboxylase, after oestrogen treatment of male chicks, is currently 
being studied in this laboratory. Most hepatic enzyme studies per-
formed at short intervals after oestrogen treatment have been carried 
, , 
out using immature female chickens, and have concentrated on malic 
enzyme and ATP citrate lyase (166 ' 256 ' 363 ), although increased fatty 
acid synthetase activity has been demonstrated after longer periods of 
oestrogen treatment ( 31 ). On the other hand, very few studies of 
lipogenic enzyme activities have been reported for oestrogen-treated 
1 b . d (244, 254, 296, 464) rna e 1r s 
Any significant changes in enzyme activity resulting from such 
studies could be further characterized by:-
(a) purification of the enzyme and preparation of a monospecific 
antiserum. 
(b) use of the monospecific antiserum to monitor changes in the 
amount of enzyme protein, to distinguish between changes in 
the catalytic efficiency of a fixed amount of enzyme protein 
and changes in the quantity of enzyme protein. 
In addition, the turnover of lipogenic enzymes could be studied in 
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primary hepatocyte cultures, maintained in the presence or absence of 
oestradiol. The rates of synthesis of specific lipogenic enzymes 
could be quantified, after incubation of the cells with isotopically-
labelled amino acids, by disruption of the cells and isolation of the 
specific lipogenic enzymes by immunoadsorption techniques. The rates 
of degradation of specific enzymes could also be quantified in a 
similar way. After incubation of the cells with an isotopically-
labelled amino acid, cells could be placed into culture medium con-
taining non-radioactive amino acids, and at various times during this 
1chase 1 period specific isotopically-labelled lipogenic enzymes could 
be isolated by immunoadsorption and quantified. 
In the pr€sent study, the results for hepatic fatty acid synthetase 
activity suggested that early increases in activity (~ 26 h) were 
caused by handling and/or the injection of propane-1,2-diol. However, 
the experiments do not allow us to distinguish between a possible stress 
effect caused by the acts of handling and injection, and a possible 
effect of propane-1,2-diol on enzyme activity. The inclusion of further 
control chicks, injected with saline instead of propane-1,2-diol, would 
allow us to distinguish between these alternative explanations for the 
increases in enzyme activity up to 26 hours after injection. This 
procedure is currently being adopted in this laboratory, during studies 
of hepatic acetyl-CoA carboxylase activity after oestrogen treatment of 
male chicks. 
4. Effects of food intake 
In the present study, birds received food and water ad libitum 
until death, in the light of the observations of Yeh & Leveille (4S), 
who showed that hepatic fatty acid synthesis was depressed after fasting 
chicks for short periods. Thirty minutes after food had been withdrawn 
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fatty acid synthesis was reduced, and the rate of fatty acid synthesis 
was reduced to about 10% of the rate in ad libitum-fed chicks after 
fasting for 2 hours. The presence of the crop as a food storage organ 
in the chick prevents the imposition of uniform food deprivation and, 
therefore, it was considered important to ensure that all the chicks 
were well-fed. However, several workers have demonstrated that 
oestrogen-treated birds show an enhanced food intake (174 ' 246 ). This 
is contrary to the situation in mammals, in which reduced feeding has 
been shown to occur around ovulation and following oestrogen treatment 
(505 - 508) (270) Lepkovsky & Furuta demonstrated that hyperphagia 
leads to enhanced hepatic lipogenesis in White Leghorn cockerels. 
Similarly, Balnave (456 ) indicated that equalized food and water in-
takes prevent differences in chick hepatic lipid metabolism, caused by 
thyroxine treatment, being obscured by the effects of differing intakes. 
Therefore, the adoption of equalized food and water intakes in studies 
of oestrogen-treated and control chicks might clarify differences in 
hepatic lipid metabolism that are independent of food consumption. 
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APPENDIX 
COMPOSITION OF THE CHICK DIET 
404 Gold-Start Crumbs/ACS (Oalgety Agriculture Ltd., Oalgety House, 
Clifton, Bristol B.) 
Oil 3% 
Fibre 4% 
Ash 7% 
Protein 18% 
Permitted antioxidant 
Vitamin A ( i. u. /kg) 10000 
Vitamin 03 (i.u./kg) 2000 
Vitamin E ( i. u. /kg) 15 
Molybdenum (mg/kg) 2 
Selenium (mg/kg) 0·30 
Anti-coccidial supplement: Pancoxin (PL0025/4010):-
100 mg/kg Amprolium 
60 mg/kg Sulphaquinoxaline 
5 mg/kg Ethopabate 
